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Abstract 
 
 Farmers are required to increase their food productivity to meet the demand 
from a continually enlarging population. A major constraint on meeting this 
requirement is the damage created by insect pests. Agricultural pests and associated 
diseases destroy 30%-40% of the world’s crop produce. The withdrawal of broad-
spectrum chemical insecticides, the threat of the development of resistance in insect 
pests to remaining compounds and the possibility of new pest species spreading into 
the UK as a result of environmental change have prompted research into alternative 
pesticides. 
 
 Protein-based insecticides offer the possibility of producing compounds that 
are specific to pest species and environmentally benign. The production of orally 
active insecticidal fusion proteins, containing toxins from Segestria florentina (tube-
web spider) or Mesobuthus tamulus (Indian red scorpion) fused to a ‘carrier’ protein 
(snowdrop lectin; Galanthus nivalis agglutinin; GNA) which transports them across 
the insect gut epithelium, has shown that recombinant protein expression systems 
and protein engineering techniques can be used to produce novel insecticidal 
proteins. The main aim of the work described in this thesis is to extend this 
technology. 
 
 Avidin, a biotin-binding protein known to be insecticidal, was evaluated as a 
possible ‘carrier’ protein. Recombinant avidin was produced in high yields using 
Pichia pastoris and was compared to the native egg white protein. Recombinant 
avidin has insecticidal activity towards hemipteran plant pests. It was highly toxic to 
Acyrthosiphon pisum (pea aphid) when fed in liquid artificial diet, causing 100% 
mortality after four days when present at concentrations !0.25mg/ml (250ppm). The 
toxicity towards A. pisum was prevented by biotin supplementation of the diet. In 
contrast, recombinant avidin had no significant effects on the survival of Sitobion 
avenae (cereal aphid) at concentrations up to 2mg/ml (2000ppm) in liquid diet. 
Analysis of genomic DNA showed that symbionts from both aphid species lack the 
ability to synthesise biotin de novo. Cereal aphids appear to be less sensitive to sub-
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optimal levels of biotin and possess a more effective system for scavenging biotin 
from recombinant avidin in the diet. 
 
 Avidin is readily transported to the haemolymph of lepidopteran larvae after 
feeding, which suggested that it might replace GNA in synthetic insecticidal fusion 
proteins. Numerous attempts were made to produce a fully functional insecticidal 
avidin-based fusion protein containing scorpion or spider toxins by expression as 
recombinant proteins in P. pastoris but, following tests against Mamestra brassicae 
(cabbage moth) larvae, the fusion proteins were found to be non-toxic. The lack of 
toxicity was most likely due to incorrect folding of the toxin component of the 
fusion, since the avidin component was functional. 
 
 Avidin fed to A. pisum was found to bind to the stomach region of the gut 
after ingestion and was retained for at least 72 hours. Feeding conjugates of avidin 
with fluorescently labelled biotin, or a fluorescently labelled, biotinylated peptide, 
showed that the conjugated compound was also retained in the aphid gut after 
feeding. A conjugate between avidin and biotinylated leucomyosuppressin (LMS), a 
myoinhibitory peptide hormone that affects gut contractions in insects, was prepared 
and fed to aphids. The avidin : biotin-LMS conjugate had insecticidal activity 
towards A. pisum when fed in diet at levels which neither of the components (avidin 
or biotin-LMS) caused significant mortality. It was hypothesised that binding to the 
gut, through the avidin moiety, was responsible for the observed oral toxicity of the 
avidin : biotin-LMS conjugate. The same principle was applied to lepidopteran 
larvae. A conjugate between avidin and biotinylated allatostatin was prepared and 
fed to M. brassicae larvae. The avidin : biotin-allatostatin was non-toxic, most likely 
due to cleavage between the biotin molecule and allatostatin as a result of the high 
levels of gut proteolysis in lepidoptera. Avidin conjugates of peptides that have little 
or no oral toxicity to insects, as a result of restricted access to sites of action, could 
have the potential to form a novel class of insecticidal compounds. 
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Chapter 1 
 
Introduction 
 
Herbivorous Insect Pests – A Constraint on Agricultural Production 
 
 With the global population now reaching seven billion, there is an increased 
need to produce large amounts of food. However, a large constraint on meeting this 
requirement comes from crop spoilage by insects. The Global Crop Diversity Trust 
has recently estimated that as much as 30-40% of the world’s crop produce is 
destroyed by agricultural pests and associated crop diseases. In the UK alone, more 
than 370 tonnes of insecticides are applied annually, with a cost now exceeding 25 
million pounds (Garthwaite et al., 2008). 
 
 There are over one million insect species worldwide, many of which are 
herbivores. However, the number of species that are serious agricultural pests is 
comparatively limited. The major pest species belong to the orders coleoptera, 
diptera, lepidoptera, hemiptera and orthoptera. These include both mono- or 
oligophagous herbivores (feeding on one or a limited range of closely related host 
plant species) and polyphagous herbivores (opportunistic feeders that will attack a 
wide range of plant species). Lepidopteran larvae are considered to be the most 
economically significant insect pests; therefore, almost half of all chemical 
insecticides are directed against species within that order (Brooks and Hines, 1999). 
Hemipteran insects also cause significant crop damage, not only because of the 
damage they cause whilst sap sucking, but also due to their role as vectors of plant 
diseases (Chrispeels and Sadava, 2003). 
 
 The current agricultural pest control strategy involves using large amounts of 
chemical insecticides. These include carbamates, neonicotinoids, organophosphates, 
synthetic pyrethroids, insect growth regulators and metabolic disruptors (Garthwaite 
et al., 2008). However, there are significant problems and limitations associated with 
the widespread use of these conventional chemical insecticides. The most important 
of these problems, causing much public concern, is their broad-spectrum chemistry, 
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which gives a poor specificity to pest insect species and often causes toxicity to 
vertebrates. Over time, many insects that are beneficial to the environment have been 
harmed and ecosystems have been disrupted (Weisser and Siemann, 2004). This is 
why changes in European legislation (EU Directive 1991/414, EC 1107/2009) have 
led to the withdrawal of many chemical insecticides from commercial use. 
 
 With the loss of chemical insecticides, arable farmers have access to a 
reduced number of plant protection products. This, in turn, means that the extensive 
use of the fewer insecticides available rapidly increases the risk of insect resistance 
occurring. This is a crucial problem with similar chemical compounds such as 
pyrethroids for example, where resistance to one member of the pyrethroid family 
can mean a degree of resistance to others in that class (cross-resistance) (Beugnet 
and Chardonnet, 1995). Insect resistance to chemical pesticides has been common 
knowledge for many years. The occurrence has been steadily increasing and it is now 
reported that up to 1000 species of insects show resistance to one or more classes of 
insecticide (Miller, 2004). More importantly, for every class of chemical insecticide, 
there is at least one resistant insect (World Health Organisation, 1992). Beyond the 
extensive usage of these insecticides, the underlying reason for the increased 
development of insecticide resistance lies with the targets of the chemical 
insecticides. The majority of them aim to block or inhibit just one of five aspects of 
the central nervous system: voltage-gated sodium channels, !-aminobutyric acid 
(GABA) receptors, nicotinic acetylcholine receptors (nAChRs), glutamate receptors 
and acetylcholinesterase (AChE) (Raymond-Delpech et al., 2005). Insects have 
responded to this single target approach of crop protection by selecting for point-
mutations in the sodium channel, within the ion channel of the GABA receptor, in 
the active site of the AChE, in the amplification of esterase genes, and for further 
mutations causing the up-regulation of detoxification enzymes (Feyereisen, 1995; 
Brogdon and McAllister, 1998; Hemingway and Ranson, 2000). 
 
 The non-target toxicity of chemical pesticides, the development of insect 
resistance to these pesticides, and the prospect of additional insect pests spreading 
into the UK as a result of environmental change, are the reasons why a more 
sustainable and environmentally sensitive approach to insect pest management is 
required. 
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Insecticidal Proteins and Protein Biopesticides: Alternative Methods of Insect 
Pest Control 
 
 Investigations into alternative approaches to the chemical control of insect 
pests has led to the development of protein-based technologies, some of which are 
described here. 
 
Bacillus thuringiensis (Bt) 
 Bacillus thuringiensis (Bt) is a gram-positive, soil dwelling bacterium 
originally discovered by the Japanese biologist Ishiwata Shigetane in 1901. It was 
described as “a bacterium causing a disease affecting silkworms” (sudden-collapse). 
It was named Bt when Ernst Berliner encountered it in 1911 whilst studying its 
insecticidal activity towards Anagasta kuehniella (Mediterranean flour moth) 
(Lepidoptera: Pyralidae, Zeller 1879) (Berliner, 1911). Subsequent research showed 
that the insecticidal activity of Bt could be attributed to toxic proteins of the Cry, Cyt 
and Vip families (Angus, 1956). The Cry and Cyt proteins (!-endotoxins) are 
produced by the bacterium upon sporulation and form components of a crystalline 
matrix associated with the spores, whilst the Vip proteins are expressed during the 
bacterial vegetative growth. The genes that encode the proteins are located on 
transmissible plasmids (Gonzalez et al., 1982). 
 
 The three-domain Cry proteins have been extensively studied. They are 
named using a complex system based on similarities in their amino acid sequences 
(Crickmore et al., 1998). Analysis of six Cry toxins by X-Ray crystallography 
allowed their tertiary domain structure to be characterised (Li et al., 1991; 
Grochulski et al., 1995; Li et al., 1996; Galitsky et al., 2001; Morse et al., 2001; 
Boonserm et al., 2005). Generally, the N-terminal domain I consists of seven anti-
parallel "-helices, where helix five is hydrophobic and is therefore contained in the 
centre of the other six. Domain II contains three anti-parallel #-sheets arranged in a 
#-prism fold. The C-terminal domain III is a #-sandwich created from two twisted, 
anti-parallel #-sheets. Each domain plays a specific role in the toxins activity (see 
next page). 
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 The insecticidal activity of the three-domain Cry toxins occurs in a three-step 
process. First, the protoxins are activated by proteolysis. Following ingestion, the 
protoxins are solubilised and undergo proteolytic cleavage that removes fragments 
from both the C- and N-terminals (Milne and Kaplan, 1993). Domain III is believed 
to be involved in insect specificity (Aronson et al., 1995; Lee et al., 1995). Secondly, 
the activated toxin binds to receptors in the gut epithelium and a conformational 
change promotes its insertion into the cell membrane (Hoffman et al., 1988; Bravo et 
al., 1992; Knowles and Dow, 1993). Domain II is responsible for the specific 
receptor binding, as discovered by mutagenesis (Schnepf et al., 1998). Finally, the 
toxin is oligomerised. This then forms a pore causing osmotic cell lysis (Sacchi et 
al., 1986; Wolfersberger, 1989; Lorence et al., 1995; Bravo et al., 2004). Domain I 
shows similarity to other bacterial pore-forming toxins (Gazit et al., 1998) and is 
believed to form the oligomer that constitutes the open channel in this final step 
(Bravo et al., 2007). 
 
 The !-endotoxins (Cry and Cyt proteins) are considered safe for use as 
insecticides because the protoxins are highly insoluble in the gut conditions of 
humans and other vertebrates and there are no receptors for the toxins in mammalian 
gut cells. Thus, they have been used in biopesticides since 1920. However, Bt 
biopesticides account for less than 1% of the annual pesticide usage because, to 
prevent them from being washed off by rainfalls, they must be applied with extreme 
care. They are also susceptible to degradation in the presence of UV light (Pusztai et 
al., 1991). 
 
 As an alternative to Bt sprays, Bt transgenic tobacco, maize, corn, potato, 
tomato, cotton and rice crops have been produced (Delannay et al., 1989; Perlak et 
al., 1990; Tian et al., 1991; Koziel et al., 1993; Perlak et al., 1993; Datta et al., 
1998). Following their approval in the US by the Environmental Protection Agency 
in 1995, these commercialised plants have been some of the most successful 
genetically modified (GM) crop products: with the Bt toxins conferring protection 
from insect pests, insecticide usage on these crops has been reduced by 60% (Shelton 
et al., 2000; Huang et al., 2002; Ismael et al., 2002). 
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 Bt transgenic plants are not protected from sap-sucking hemipteran pests 
however. These possess the Bt receptors required for insecticidal activity, but it is 
believed that their low levels of digestive proteolysis only gives a small amount of 
active toxin build-up (Cristofoletti et al., 2006). There are also some other problems 
and limitations with Bt transgenic crops, namely, the potential impact of Bt toxins on 
non-target species containing Bt receptors within their gut, an increase in the Bt toxin 
levels in the soil which could affect soil organisms before the toxins degrade, the 
exchange of genetic material between plants, and the development of insect 
resistance (Kumar, 2002). Since their first use in Bt sprays, more than seven species 
of insect have developed resistance to Bt toxins (Marrone and Macintosh, 1993; 
Tabashnik et al., 2009). The first occurrence of insect resistance to Bt transgenic 
crops has recently been confirmed in India (Bagla, 2010). 
 
 Methods to delay the development of insect resistance have been researched 
and employed since the crops were introduced. These approaches include: 
(i) Gene pyramiding. Two or more Cry toxins are expressed in transgenic plants, 
so that insects would need to develop resistance to more than one toxin to 
survive. The odds of insects developing resistance to two toxins 
simultaneously are considerably lower than the odds of insects developing 
resistance to a single toxin. 
(ii) Targeted expression of the Bt toxins. Only allowing the plant to express the 
toxins when their presence is required reduces the time the insects are 
exposed to the toxin. 
(iii) A refuge strategy. This involves growing a small area of non-transgenic crops 
to maintain a refuge where insects without resistance mutations can reside 
and reproduce, therefore maintaining non-resistant genes within the insect 
gene pool and discouraging selection pressure in favour of resistant 
individuals. 
(iv) High dosage delivery of multiple Bt toxins. Using high dosages of !-
endotoxins in transgenic crops will ensure that virtually all pests are killed, 
reducing the chances of different Cry toxin resistant insects breeding with 
each other. 
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 Despite the success of Bt transgenic crops, their limitations in the range of 
pests targeted and the potential for the development of resistance has meant that 
other biopesticides still need to be developed for sustainable protection of crops. 
 
 More recently, a Bt toxin fusion protein with the galactose-binding domain of 
the ricin B-chain has been expressed successfully (Mehlo et al., 2005), highlighting 
the fact that combinations of different toxins can act synergistically and may be a 
further method to combat insect resistance developing. 
 
Other Bacterial Toxins 
1. Cholesterol Oxidase 
 Bacterial cholesterol oxidase is an enzyme that catalyses the oxidation of 
cholesterol. In terms of insect control, it has an insecticidal activity comparable to 
that of Bt toxins. Corbin et al. (2001) established that when the enzyme was 
expressed and localized in chloroplasts of tobacco, the leaf tissue was toxic to 
Anthonomus grandis (boll weevil) (Coleoptera: Curculionidae, Boheman 1843) 
larvae without any adverse effects on the phenotype of the plant. 
 
2. Photorhabdus luminescens Insecticidal Proteins 
 Photorhabdus luminescens is a symbiotic bacterium found in nematodes of 
Heterorhabditis species. When the nematodes enter a host insect, the bacterial cells 
are released from the nematode and enter the insect circulatory system. The bacteria 
secrete toxins that cause host cell death, leading to a lethal septicaemia. 
Photorhabdus luminescens bacteria contain multiple insecticidal toxins. Liu et al. 
(2003) isolated and expressed one of the toxins (toxin A) in leaves of Arabidopsis 
thaliana, which was found to confer almost complete protection against Manduca 
sexta (tobacco hornworm) (Lepidoptera: Sphingidae, Linnaeus 1763) and Diabrotica 
virgifera (corn rootworm) (Coleoptera: Chrysomelidae, LeConte 1868). 
 
Plant Defensive Proteins 
1. Protease Inhibitors (PIs) 
 Protease inhibitors (PIs) are small proteins, ubiquitous in nature, that vary in 
size from around 5kDa to 20kDa (Hung et al., 2003). Their function is to reversibly 
or irreversibly block or alter the active site of their target enzymes. They are believed 
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to be involved in the plant defence system; being produced in seeds and specific 
plant tissues upon wounding by insect herbivores (Koiwa et al., 1997). Once 
consumed by a herbivore, the plant PIs affect the activity of digestive enzymes 
within the insect gut, therefore altering the quantity of proteins that can be digested. 
Plant PIs include a number of different families of proteins, targeting all of the major 
types of digestive protease activity (serine, cysteine, aspartic and metallo-proteases). 
 
 Mickel and Standish (1947) originally described the role of PIs in plant 
defences after noticing how the development of various insect larvae was retarded 
following feeding on soybean products. Subsequently, soybean trypsin inhibitors 
were shown to cause retardation of development and toxicity towards Tribolium 
confusum (flour beetle) (Coleoptera: Tenebrionidae, Jacquelin du Val 1863) larvae 
(Lipke et al., 1954). Since then, over 500 PIs have been isolated, mostly from the 
Leguminosae, Poaceae and Solanaceae families (Brzin and Kidric, 1995) and are 
listed in the PLANT-PI database (De Leo et al., 2002). 
 
 The first transgenic plant expressing a foreign PI, the cowpea trypsin 
inhibitor (CpTI), was produced in 1987 (Hilder et al., 1987). The transgenic tobacco 
showed resistance to Heliothis virescens (tobacco budworm) (Lepidoptera: 
Noctuidae, Fabricius 1777) larvae, resulting in increased mortality and decreased 
feeding. Transgenic plants are relatively easy to produce, as only a single PI gene 
needs to be activated. A whole range of PI transgenic plants have therefore been 
produced, including transgenic rice, tomato, potato, cotton and wheat (Orozco-
Cardenas et al., 1993; Gatehouse et al., 1996; Li et al., 1998; Altpeter et al., 1999; 
Lee et al., 1999). Besides protection from herbivorous insects, PI transgenic plants 
have also been shown to be effective against nematodes, viruses and fungal 
infections (Lorito et al., 1994; Vain et al., 1998; Gutierrez-Campos et al., 1999; 
Urwin et al., 2000). 
 
 Although the successful production of PI transgenic plants is well 
documented, there have also been reports of transformed plants expressing PIs but 
showing little or no insect resistance (Johnson et al., 1989; McManus et al., 1994; 
Wu et al., 1997; Altpeter et al., 1999; Cloutier et al., 2000). Some insects overcome 
the effects of the expressed PIs by inducing alternative proteolytic enzymes (Bolter 
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and Jongsma, 1995; Jongsma et al., 1995), or by producing proteases that can 
themselves digest PIs (Girard et al., 1998). Despite these resistance issues and other 
concerns regarding the toxicity of PIs towards non-target organisms (Malone et al., 
1995), a cowpea trypsin inhibitor has recently been successfully employed 
commercially in cotton in China (Cui, 2003). 
 
2. Lectins 
 Lectins are a large and diverse group of proteins ubiquitous in nature that 
have been shown to bind carbohydrates and thereby agglutinate cells (agglutinins) 
(Pusztai, 1991). They contain a non-catalytic domain that can bind specifically but 
reversibly to mono- and oligosaccharides (Peumans and Van Damme, 1995). Some 
common examples are listed in Table 1.1. Many more lectins exist however. The true 
role of lectins in plants is still unknown, however, roles in growth regulation, legume 
nodulation and plant defence have been proposed (Roberts and Goldstein, 1983; 
Gatehouse et al., 1995; Hirsch, 1999). 
 
 
 
 Many lectins are insecticidal, with effects recorded in species of coleoptera, 
homoptera and lepidoptera (Czapla and Lang, 1990; Murdock et al., 1990; Powell et 
al., 1995; Rhabe et al., 1995; Gatehouse et al., 1999). However, some lectins such as 
Lectin Details 
Snowdrop Lectin (GNA) Mannose binding lectin purified from Galanthus nivalis 
Concanavalin A (Con A) Mannose binding lectin purified from Canavalia ensiformis 
Garlic Lectin (ASA) Mannose binding lectin purified from Allium sativum 
Phytohaemagglutinin (PHA) Mannose binding lectin purified from Legumes 
 
Ricin (RCA) 
Consists of a Galactose binding lectin purified from Ricinus 
communis 
Peanut Agglutinin (PNA) Galactose binding lectin purified from Arachis hypogaea 
 
Wheat Germ Agglutinin (WGA) 
N-acetylglucosamine binding lectin purified from Triticum 
vulgaris 
  
 
Table 1.1. 
Examples of plant lectins. 
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phytohaemagglutinin (PHA) have also been shown to be toxic to mammals (Pusztai 
et al., 1995). 
 
 Snowdrop lectin (Galanthus nivalis agglutinin; GNA) is an extensively 
studied lectin. It is a D-mannose-specific binding lectin isolated from the bulbs of 
snowdrops (Van Damme et al., 1987). Snowdrop lectin has a tetrameric structure 
with each identical subunit being 12.5kDa in size. The subunits can each bind three 
mannose sugar residues (Van Damme et al., 1998). Powell et al. (1993) first 
established the insecticidal activity of GNA in Nilaparvata lugens (rice brown plant 
hopper) (Homoptera: Delphacidae, Stål 1854). Since then, GNA transgenic tobacco, 
rice, wheat and potatoes have been produced and tested for herbivore resistance 
(Zhou et al., 1998; Rao et al., 1998; Bell et al., 2001; Liang et al., 2004). The 
transgenic plants were less susceptible to insect attack. 
 
3. Phaseolus vulgaris (bean) !-amylase Inhibitor 
 The !-amylase inhibitors isolated from legume seeds have been shown to 
confer resistance to coleopteran seed weevils. Phaseolus vulgaris (bean) !-amylase 
inhibitor was expressed in Pisum sativum (garden pea) seeds and their resistance to 
Bruchus pisorum (pea weevil) (Coleoptera: Bruchidae, Linnaeus 1758) and other 
bruchid beetle larvae was demonstrated (Shade et al., 1994; Morton et al., 2000). 
The use of !-amylase inhibitors for their insecticidal properties is restricted to 
insects, mostly coleopterans, which have a neutral or acidic gut pH to maintain the 
inhibitor in its active state. As with other plant defence proteins, widespread 
commercialisation has not taken place due to safety concerns within higher animals 
(Prescott et al., 2005). 
 
Insecticidal Toxins from Arthropods 
 Many arthropods feed on insects and use insecticidal toxins as a means of 
immobilising or killing their prey. These insecticidal toxins are commonly 
constituents of venom produced by the arthropod. Scientific research has shown that 
venoms can be reservoirs of insecticidal toxins, often containing complex mixtures 
of polypeptides that can induce paralysis, disrupt the development of the prey and 
interfere with its immune response, reproductive system or metabolic regulation 
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(Altstein, 2004: Gade, 2004; Tedford et al., 2004; Gade and Hoffmann, 2005). 
Because of these effects, venom-derived toxins have the potential to be used as 
insecticides. Whilst many arthropods also sting and bite humans and higher 
organisms, the small amounts of venom injected in comparison to their large size 
means that most are non-lethal. Insect-specific toxins can be selected, as can toxins 
that show specificity to a range of target species. 
 
 Below are two examples of toxins chosen for their documented specific 
activity against lepidopteran larvae (a major worldwide pest). Many more arthropod 
toxins exist. 
 
1. A Toxin from Mesobuthus tamulus (Indian Red Scorpion) 
 Wudayagiri et al. (2001) isolated an insecticidal toxin from the venom of 
Mesobuthus tamulus (Indian red scorpion) (Scorpiones: Buthidae, Fabricius 1798) 
and named it ButaIT. Mature ButaIT is a single-chain 37 amino acid polypeptide 
consisting of an !-helix and three "-strands with four disulphide bridges. It is 
classified as a short insect toxin (30-40 amino acids) due to its high sequence 
homology with other toxins that affect voltage dependent potassium channels and 
large conductance calcium activated potassium channels (Carbone et al., 1982). It 
was originally entered into databases (Genbank accession number AF481881, Swiss-
prot number P81761) as a novel lepidopteran-selective toxin, showing high 
specificity to Heliothis virescens (tobacco budworm) (Lepidoptera: Noctuidae, 
Fabricius 1777) larvae, inducing a progressive, irreversible flaccid paralysis leading 
to eventual larval mortality (at 1µg/100mg larvae). No toxic effects were observed in 
Sarcophaga falculata (blowfly) (Diptera: Calliphoridae, Pandelle 1896) larvae or 
mice (Wudayagiri et al., 2001). 
 
2. A Toxin from Hadronyche versuta (Australian Funnel Web Spider) 
 Fletcher et al. (1997) isolated the #-atracotoxin-Hv1a toxin from the venom 
of Hadronyche versuta (Australian funnel web spider) (Araneae: Hexathelidae, 
Rainbow 1914). The #-atracotoxin-Hv1a toxin, a member of the #-ACTX-1 family 
of insecticidal toxins, is a 37 amino acid polypeptide consisting of a "-turn core 
region containing three disulphide bridges and a "-hairpin that protrudes from this 
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core. It was shown to block neural transmission in cockroaches and was 
characterised as an insect-specific voltage-gated calcium channel agonist (Fletcher et 
al., 1997). 
 
Insecticidal Neuropeptides from Arthropods 
 Many vital processes in arthropods are specifically regulated by peptides and 
hormones produced internally. These can be stimulatory or inhibitory. Introducing or 
adjusting the amounts of these peptides and hormones therefore has a subsequent 
effect on the process, which can ultimately be fatal. Insect-specific neuropeptides can 
be selected, as can neuropeptides that show specificity to a range of target species. 
 
 Below are two examples of neuropeptides chosen for their documented 
specific activity against insect gut muscular contractions and motility (a vital process 
for crop insect pests). Many more arthropod neuropeptides exist. 
 
1. A Neuropeptide from Leucophaea maderae (Cockroach) 
 Holman et al. (1986) isolated an inhibitory neuropeptide from Leucophaea 
maderae (cockroach) (Orthoptera: Blaberidae, Fabricius 1781). Leucomyosuppressin 
(LMS) is a simple 10 amino acid FMRFamide-related peptide with the sequence 
pEDVDHVFLRFamide. The FMRFamide peptides occur quite widely in nature and 
are known to be involved in regulation of heart rate, blood pressure, gut motility, 
feeding behaviour and reproduction (Kingan et al., 1990; Kingan et al., 1996; Predel 
et al., 2001; Aguilar et al., 2004; Audsley and Weaver, 2006). The LMS peptide acts 
on gut muscular contractions (gut peristalsis). When LMS was injected into 
cockroaches, an accumulation of food within the foregut and a decrease in food 
consumption was observed as a result of inhibition of gut peristalsis (Aguilar et al., 
2004). Similar effects were seen in Lacanobia oleracea (tomato moth) (Lepidoptera: 
Noctuidae, Linnaeus 1758) and Spodoptera littoralis (cotton leafworm) 
(Lepidoptera: Noctuidae, Fabricius 1775) (Matthews et al., 2008). 
 
2. A Neuropeptide from Manduca sexta (Tobacco Hornworm) 
 Kramer et al. (1991) first identified a C-type neuropeptide from Manduca 
sexta (tobacco hornworm) (Lepidoptera: Sphingidae, Linnaeus 1763). This new type 
of allatostatin (Manse-AS) was structurally distinct from the A- and B-types isolated 
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in cockroaches and crickets (Woodhead et al., 1989; Pratt et al., 1989; Lorenz et al., 
1995). The Manse-AS neuropeptide is a relatively simple peptide with the sequence 
QVRFRQCYFNPISCF, which is known to inhibit gut contractions (Kramer et al., 
1991). 
 
 Recently, a teratocyte secretory protein gene from an endoparsite has been 
expressed in transgenic plants (Maiti et al., 2003), however, the main restriction 
around using insecticidal toxins and neuropeptides from arthropods as a method of 
insect pest control is the mode of delivery and the target location of the toxin or 
neuropeptide. Many species of insect have differing gut morphologies and pH 
conditions where orally delivered toxins and neuropeptides are susceptible to 
proteolytic degradation (Lehane and Billingsley, 1996). 
 
Avidin as an Insecticidal Protein 
 Avidin is a protein found in the egg white of birds, reptiles and amphibians 
that was originally discovered by Esmond Emerson Snell (Eakin et al., 1940). It is a 
basic glycoprotein, with an isoelectric point (pI) of 10.0 (Woolley and Longsworth, 
1942). It is thought to function as an antibacterial host-defence protein by virtue of 
its ability to bind biotin, an essential vitamin for most organisms (vitamin B7 or 
vitamin H). In nature, avidin exists as a homotetramer, comprised of four 128 amino 
acid subunits (16kDa), each singly glycosylated and able to bind one biotin molecule 
with extreme specificity and affinity (DeLange and Huang, 1971; Green, 1990). The 
avidin-biotin dissociation constant is 10
-15
 (Savage et al., 1992). 
 
 The insecticidal activity of avidin was first determined 50 years ago, when 
dietary avidin was found to have detrimental effects on the growth of Musca vicina 
(housefly) (Diptera: Calliphoridae, Macquart 1851) larvae (Levinson and Bergmann, 
1959). Avidin, and the related bacterial protein streptavidin, have since been shown 
to be toxic to a wide range of insects including representatives of lepidoptera 
(Morgan et al., 1993; Du and Nickerson, 1995; Markwick et al., 2001; Burgess et al., 
2002; Cheng Zhu et al., 2005), diptera (Levinson and Bergmann, 1959; Tsiropoulos, 
1985; Bruins et al., 1991), coleoptera (Levinson et al., 1967; Allsopp and McGhie, 
1996; Kramer et al., 2000; Yoza et al., 2005; Cooper et al., 2006; Murdock and 
Shade, 2008) and orthoptera (Christeller et al., 2000). 
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 Avidin is a normal component of human diet. It therefore has the potential to 
be adopted as an insect control agent because the dietary levels of the protein that are 
required to provide effective insecticidal activity against a wide range of pests are 
much lower than the levels present in normal human diet. Expression of avidin in 
transgenic plants has been put forward as a strategy to confer protection against 
insect pests, with engineering of maize, corn, tobacco, potato, apple and rice being 
reported (Kramer et al., 2000; Burgess et al., 2002; Murray et al., 2002; Markwick et 
al., 2003; Yoza et al., 2005). However, the initial report of expression of avidin in 
maize with the intention of producing protein that could be extracted for use as a 
biochemical reagent (Hood et al., 1997) remains the only example of large-scale 
expression in planta. 
 
 The insecticidal effects of avidin are mediated through its biotin-binding 
activity. In many cases, these effects were shown to be eliminated by feeding diets 
supplemented with biotin, supporting the hypothesis that avidin acts through the 
sequestration of biotin from ingested food, thereby preventing absorption from the 
gut and causing a biotin deficiency in the insect (Kramer et al., 2000). Biotin, as a 
cofactor of major carboxylases involved in key processes such as gluconeogenesis, 
lipogenesis, and fatty acid and amino acid catabolism, is essential for insect growth 
(Wood and Barden, 1977; Knowles, 1989). Insects fed on avidin-containing diets 
show retarded growth, eventually leading to mortality. Variability in susceptibility to 
the toxic effects of avidin is thought to depend on variations in levels of maternally-
derived biotin (Markwick et al., 2001). Perhaps a reason why transgenic avidin crops 
have not been commercialised is that insects could potentially increase the levels of 
maternally-derived biotin to overcome the effects of avidin expressed in crops. 
 
 
Protein Transport Across the Insect Gut 
 
 In order to be able to exploit many insecticidal proteins as biopesticides, a 
technical problem must be solved. Whetstone and Hammock (2007) note, 
“considering the total number of species that produce insect-specific toxins and the 
variety of toxins within each venom type, the potential for the development and 
application of novel biopesticides from these sources appears virtually limitless – 
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limitless, however, only if provided with suitable delivery systems.” Therefore, the 
problem with protein-based technologies is not in finding insecticidal proteins, but 
finding a suitable delivery method for these proteins. 
 
 Many insecticidal proteins that are active when directly injected into the 
insect are unlikely to pass through an insect cuticle by themselves. They are usually 
non-toxic even when administered orally, as they will not cross the gut wall to access 
their sites of action, which include for instance, ion channels in nervous tissue. For 
this reason, besides the insecticidal properties of lectins described earlier, their 
carbohydrate-binding specificity is of interest to scientists today. Many gut 
membrane proteins such as brush-border enzymes, receptors and transport proteins 
are glycosylated, producing potential lectin binding sites. It is the binding at these 
glycosylated sites that is thought to be at the centre of the ability of certain lectins to 
translocate across the gut epithelium into the haemolymph (Boyd and Reguera, 1949; 
Liener et al., 1986). The presence of intact snowdrop lectin (Galanthus nivalis 
agglutinin; GNA) and jackbean lectin (Canavalia ensiformis concanavalin A; Con A) 
within the haemolymph of Lacanobia oleracea (tomato moth) (Lepidoptera: 
Noctuidae, Linnaeus 1758) larvae following oral delivery has been demonstrated 
(Fitches et al., 2001). Similar behaviour has also been observed for other lectins 
(Fitches et al., 2008). 
 
 
Fusion Proteins 
 
 Creating fusion proteins by combining two or more proteins has recently 
become a widespread technique among researchers. The components of fusion 
proteins act together to produce effects that are not observed when they act 
independently. Fusion proteins could therefore be useful in addressing issues relating 
to protein delivery. 
 
Synthetic Fusion Proteins as Insecticides 
 The fusion protein approach has been used to develop a novel method of 
delivering insect-specific, biologically active peptides to the haemolymph of insect 
pests following oral ingestion. The technology utilizes recombinant DNA techniques 
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to fuse a coding sequence for an insect-derived, toxic peptide to that of a plant lectin. 
The resulting fusion protein is then produced by recombinant expression in the 
methylotrophic yeast Pichia pastoris. When fed to target insects via artificial diet, 
the plant lectin binds and subsequently translocates across the insect gut epithelium, 
acting as a ‘carrier,’ delivering the peptide to the haemolymph of the insect where it 
can exert a toxic effect (Figure 1.1). 
 
 
 
 To date, this synthetic fusion protein technology has been exploited to 
produce novel recombinant C- and N-terminal fusion proteins with snowdrop lectin 
(Galanthus nivalis agglutinin; GNA) using Manduca sexta (tobacco hornworm) 
(Lepidoptera: Sphingidae, Linnaeus 1763) allatostatin, Segestria florentina (tube-
web spider) (Araneae: Segestriidae, Rossi 1790) toxin and Mesobuthus tamulus 
(Indian red scorpion) (Scorpiones: Buthidae, Fabricius 1798) toxin. All three of the 
fusion proteins have demonstrated promising results, with oral toxicity to 
lepidopteran insect larvae demonstrated (Fitches et al., 2002; Fitches et al., 2004; 
Pham-Trung et al., 2006). 
 
 Employing a mannose-binding lectin as the ‘carrier’ ensures a fusion protein 
is instantly specific for organisms containing glycoproteins or lipopolysaccharides 
with high-mannose carbohydrate side chains within their guts. These are relatively 
 
 
Figure 1.1. 
Schematic representation of a lepidopteran larva. 
The fate of an orally delivered fusion protein. 
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uncommon in higher animals. The use of an insect-specific or insect order-specific 
toxic peptide also increases the specificity to a particular insect or to an insect order. 
Furthermore, it is thought unlikely that fusion proteins would be harmful to other 
non-target organisms, such as beneficial insects and mammals, as cleavage of fusion 
proteins may occur once they are transferred into the haemolymph of the target 
insect. This cleavage would allow the insecticidal protein to reach its site of action, 
but as it would no longer be associated with the lectin, it would mean that it would 
not be carried to the haemolymph of any other predator, should the target insect be 
consumed. 
 
 The main limitation of using GNA as the fusion protein ‘carrier’ is the public 
perception that it is toxic to higher animals following the Pusztai affair (Ewen and 
Pusztai, 1999; Rhodes, 1999). 
 
 Synthetic fusion protein technology offers great potential for the development 
of further insect-targeted, environmentally benign insecticides from peptides that are 
otherwise ineffective when administered alone due to either degradation by digestive 
enzymes within the insect gut or failure to permeate the gut membrane. With 
continued scientific and industrial research, the technology may provide, in part, an 
answer to some of the problems associated with current insecticides and with the 
threat of insect pest problems arising as a result of global environmental change. 
 
Conjugates as Insecticides 
 Besides fusing peptides together using recombinant DNA techniques, 
covalent linkage or non-covalent interactions between proteins and peptides can be 
used to produce conjugates. Conjugates are frequently used for purification in 
research and in medical treatments, but there are no published examples of using 
conjugates as insecticides. 
 
Advantages of Avidin as a Basis for Constructing Fusion Proteins and Conjugates 
 Like GNA, avidin has recently been shown to be translocated into the 
haemolymph of lepidopteran larvae following oral delivery (Hinchliffe, 2007). This 
property makes avidin a suitable candidate for use as a ‘carrier’ protein in synthetic 
fusion protein technology to produce recombinant insecticidal fusion proteins: the 
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avidin could be used in the same way as the GNA within the GNA fusions described 
earlier. Using avidin as a ‘carrier’ protein may resolve the public perception 
limitation with GNA fusion proteins. Avidin also has the advantage of having a 
biotin-binding site and it has previously been shown that biotin remains bound to 
avidin upon transfer to the haemolymph of lepidopteran larvae (Hinchliffe, 2007). 
This means that besides being a potential ‘carrier’ in synthetic fusion protein 
technology, avidin could also be utilised to attach biotinylated peptides to the biotin-
binding site and produce an insecticidal conjugate. Using avidin as a ‘carrier’ protein 
or as part of a conjugate would be advantageous over using it solely as a biopesticide 
to sequester dietary biotin, because it would eliminate the chance of resistance 
developing due to an increase in the levels of maternally-derived biotin in insects. 
 
 
Expression Systems for Recombinant Proteins Based on Pichia pastoris 
 
 Since Pichia Pastoris, a methylotrophic yeast, was established as an 
organism for heterologous protein expression (Ogata et al., 1969), numerous vectors, 
strains and manipulation protocols have been developed (Cereghino and Cregg, 
2000). It is now frequently used for the following reasons: 
(i) In spite of being a single-celled eukaryotic micro-organism, it is capable of 
many post-translational modifications performed by higher eukaryotic cells, 
such as proteolytic processing, folding, disulphide bond formation and 
glycosylation. 
(ii) It is fast and easy to manipulate. 
(iii) It can withstand the high cell densities involved in culturing therefore giving 
higher protein yields. 
Many proteins that express as insoluble inclusion bodies in Escherichia coli have 
been successfully expressed in yeast (Cereghino and Cregg, 2000). 
 
 A large range of expression vectors are available for P. pastoris, with the two 
main types being those containing inducible promoters, such as the alcohol oxidase 1 
gene (AOX1) promoter, and those containing constitutively expressed promoters, 
such as that from the glyceraldeyde-3-phosphate dehydrogenase gene (GAP) 
(Waterham et al., 1997). In addition, vectors can contain the Saccharomyces 
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cerevisiae alpha factor secretion signal prepropeptide to direct proteins to the 
secretory pathway (Duntze et al., 1970). This therefore allows the user to easily 
select between inducible or constitutive expression of heterologous protein and 
intracellular expression or secretion into the extracellular media. Extracellular 
secretion aids the protein purification process because P. pastoris itself secretes very 
low levels of endogenous proteins and the culture medium does not contain any 
added proteins either. Secreted heterologous protein therefore comprises the majority 
of the protein in the external medium and is already separated from cellular proteins. 
However, wild-type P. pastoris strains, for example X33, have a tendency to release 
aspartic proteases, and recombinant proteins can be undesirably cleaved by 
endogenous protease activity. This can be kept to a minimum by utilising protease 
deficient P. pastoris strains such as SMD1168, but secreted protein cleavage has yet 
to be eliminated completely (Jahic et al., 2006). The use of P. pastoris as an 
expression host has been found to be essential to produce functionally active 
insecticidal fusion proteins (Fitches et al., 2004) 
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Project Aims and Objectives 
 
 The aim of this project is to investigate the use of recombinant avidin for the 
protection of crops against insect pests. Specifically, the objectives are: 
 
1. To analyse recombinant avidin produced using Pichia pastoris. In particular, to 
study its in vitro activity in comparison to commercially available avidin and to test 
its activity in vivo towards hemipteran pests. 
 
2. To investigate the use of avidin as a ‘carrier’ for toxic peptides in synthetic fusion 
protein technology by producing recombinant avidin fusion proteins and analysing 
their insecticidal activity. 
 
3. To establish if recombinant avidin can be utilised to produce insecticidal 
conjugates with toxic peptides. 
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Chapter 2 
 
Materials and Methods 
 
Biological and Chemical Reagents 
 
All chemicals and reagents utilised were supplied by VWR (Radnor, USA) 
(BDH grades), Sigma (St. Louis, USA), or Merck (Whitehouse Station, USA) unless 
otherwise stated. These were of laboratory grade or higher. 
 For bacterial work, One Shot TOP10 Electrocomp Escherichia coli cells of 
the genotype F- mcrA !(mrr-hsdRMS-mcrBC) "80lacZ!M15 !lacX74 recA1 
araD139 !(araleu)7697 galU galK rpsL (Str
R
) endA1 nupG were used (supplied by 
Invitrogen, Carlsbad, USA). Aliquots of 50µl were stored at -80°C. 
 For yeast work, Easycomp protease-deficient SMD1168H of the genotype 
pep4 and X33 wild-type strains of Pichia pastoris were used (supplied by 
Invitrogen). Aliquots of 50µl were stored at -80°C. 
 
 
Frequently Used Solutions 
 
Bacterial Culture Media 
- Low Salt LB Media and Agar 
1% (w/v) trypticase peptone, 0.5% (w/v) yeast extract, 1% (w/v) sodium 
chloride. 
Low salt LB agar for petri dishes is identical to the above with the addition of 
1.5% (w/v) agar (supplied by Difco, Franklin Lakes, USA). 
 
Yeast Culture Media 
- YPG Media and Agar 
2% (w/v) trypticase peptone, 1% (w/v) yeast extract, 4% (v/v) glycerol. 
YPG agar for petri dishes is identical to the above with the addition of 2% 
(w/v) agar (supplied by Difco). 
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Fermentation Media 
26.7ml/L 85% phosphoric acid 
0.93g/L calcium sulphate 
18.2g/L potassium sulphate 
14.9g/L magnesium sulphate 7-hydrate 
4.13g/L potassium hydroxide 
40g/L glycerol 
 
- PTM1 Trace Salts 
6g/L Cupric sulphate 5-hydrate 
0.08g/L Sodium iodide 
3g/L Manganese sulphate hydrate 
0.2g/L Sodium molybdate 2-hydrate 
0.02g/L Boric acid 
0.5g/L Cobalt chloride 
20g/L Zinc chloride 
65g/L Iron(II) sulphate 7-hydrate 
0.2g/L Biotin 
5ml/L Sulphuric acid 
 
Agarose Gel Electrophoresis 
- 50x TAE 
2M tris-HCl, 2M glacial acetic acid, 50mM ethylenediaminetetra-acetic acid 
pH 8.0. 
 
- Orange G Loading Dye 
10mM tris-HCl pH 7.6, 0.15% (w/v) Orange G, 60% (v/v) glycerol, 60mM 
ethylenediaminetetra-acetic acid. 
 
- Lambda DNA/Eco47I Size Marker (supplied by Fermentas, Waltham, USA) 
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Protein Gel Electrophoresis 
- Resolving Gel 
15% (v/v) acrylamide, 0.2M tris-HCl pH 8.8, 0.1% sodium dodecyl sulphate, 
0.1% (w/v) ammonium persulphate, 0.5% (v/v) N, N, N!, N!-
tetramethylethylene-diamine. 
The percentage of acrylamide (supplied by National Diagnostics, Atlanta, 
USA) is varied as required (normally 12.5%, 15%, 17.5% or 20%). 
 
- Stacking Gel 
4% (v/v) acrylamide, 0.13M tris-HCl pH 6.8, 0.1% (w/v) sodium dodecyl 
sulphate, 0.1% (w/v) ammonium persulphate, 0.75% (v/v) N, N, N!, N!-
tetramethylethylene-diamine. 
 
- 10x Reservoir Buffer 
0.25M tris-HCl, 1.92M glycine, 1% (w/v) sodium dodecyl sulphate. 
 
- 5x SDS-PAGE Loading Dye  
312.5mM tris-HCl pH 6.8, 50% (v/v) glycerol, 10% (w/v) sodium dodecyl 
sulphate, 0.01% (w/v) Bromophenol Blue, 25% (v/v) 2-mercaptoethanol. 
 
- Coomassie Stain 
0.04% (w/v) Coomassie Brilliant Blue, 40% (v/v) methanol, 7% (v/v) glacial 
acetic acid. 
 
- Destain 
40% (v/v) methanol, 7% (v/v) glacial acetic acid. 
 
Silver Staining Reagents: 
- Fixative Solution 
40% (v/v) ethanol, 10% (v/v) glacial acetic acid. 
 
- Wash Solution 
30% (v/v) ethanol. 
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- Thiosulphate (Sensitizer) Solution 
0.02% (w/v) sodium thiosulphate. 
 
- Silver Nitrate Solution 
0.2% (w/v) silver nitrate, 0.02% (v/v) formaldehyde (37% solution). 
 
- Developing Solution 
3% (w/v) sodium carbonate, 0.05% (v/v) formaldehyde (37% solution), 
0.0005% (w/v) sodium thiosulphate. 
 
- Stop Solution 
0.5% (w/v) glycine. 
 
- SDS 7 Protein Size Marker (supplied by Sigma) 
66kDa Bovine albumin 
45kDa Egg albumin 
36kDa Glyceraldehyde-3-phosphate dehydrogenase (rabbit muscle) 
29kDa Bovine carbonic anhydrase 
24kDa Bovine pancreas trypsinogen 
20.1kDa Soybean trypsin inhibitor 
14.2kDa Bovine milk !-Lactalbumin 
 
Western Blotting 
- Bejerrum and Schafer-Nielsen Semi-Dry Transfer Buffer 
48mM tris-HCl, 39mM glycine, 20% (v/v) methanol. 
 
- Ponceau S Stain 
0.5% (w/v) Ponceau S, 1% (v/v) glacial acetic acid. 
 
- 10x Phosphate Buffered Saline 
0.2M phosphate, 1.5M sodium chloride. 
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- Antisera Solution (Block) 
5% (w/v) non-fat milk powder, 1x phosphate buffered saline, 0.05% (v/v) 
Tween-20. 
 
- Rinse Solution (PBS-Tween) 
1x phosphate buffered saline, 0.05% (v/v) Tween-20. 
 
- ECL Solution 
1M tris-HCl pH 8.5, 0.2mM coumaric acid, 1.25mM luminol + 3% (v/v) 
hydrogen peroxide. 
 
Column Chromatography 
- SP Sepharose Column Loading Buffer 
50mM sodium acetate, pH 4.0. 
 
- SP Sepharose Column Elution Buffer 
50mM sodium acetate, 1M sodium chloride, pH 4.0. 
 
- Nickel Column Binding Buffer 
50mM sodium acetate, 0.5M sodium chloride, pH 4.0. 
 
- Nickel Column Elution Buffer 
50mM sodium acetate, 300mM imidazole, 0.5M sodium chloride, pH 7.4. 
 
- Phenyl Sepharose Column Loading Solution 
2M sodium chloride. 
 
- Phenyl Sepharose Column Elution Solution 
Purified water. 
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Insect Cultures 
 
 Insect cultures originally obtained from the Food and Environment Research 
Agency (FERA), Sand Hutton, York, UK were subsequently maintained at Durham 
University. 
 Mamestra brassicae (cabbage moth) (Lepidoptera: Noctuidae, Linnaeus 
1758) were reared continuously on artificial diet (Bown et al., 1997, see below) 
under controlled environmental conditions of 23°C, 40% relative humidity and a 16 
hour light: 8 hour dark regime. 
 Sitobion avenae (cereal aphid) (Hemiptera: Aphididae, Fabricius 1775) were 
kept on two week old oat plants (Avena sativa) under controlled environmental 
conditions of 18°C, 30% relative humidity and a 16 hour light: 8 hour dark regime. 
 Acyrthosiphon pisum (pea aphid) (Hemiptera: Aphididae, Harris 1776) were 
maintained on established broad bean plants (Vicia fabae) under controlled 
environmental conditions of 18°C, 30% relative humidity and a 16 hour light: 8 hour 
dark regime. 
 
Insect Diet 
- Mamestra brassicae Artificial Diet 
74g/L Haricot bean flour 
59g/L Wheat germ 
30g/L Soyabean flour 
20g/L Casein 
33.4g/L Brewers yeast 
3.6g/L Ascorbic acid 
1.8g/L Sorbic acid 
3g/L Methyl 4-hydroxybenzoate 
8.4g/L Vanderzant vitamin mixture 
6.7g/L Wesson salt mixture 
0.12g/L Ampicillin sodium salt 
3.7ml/L Formaldehyde (37% solution) 
1.4ml/L Linseed oil 
13.4g/L Agar 
(Produced as described in Bown et al., 1997). 
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- Hemipteran Artificial Diet 
Amino Acid Stock (per 50ml) 
50.8mg Alanine 
213.9mg Asparagine 
189.7mg Aspartate / Aspartic acid 
42.5mg Cysteine 
123.6mg Glutamic acid 
241.1mg Glutamine 
9mg Glycine 
65.6mg Proline 
59.9mg Serine 
10.9mg Tyrosine 
300.2mg Arginine 
182.4mg Histidine 
114.1mg Isoleucine 
114.1mg Leucine 
158.9mg Lysine 
42.5mg Methionine 
47.1mg Phenylalanine 
103.6mg Threonine 
58.2mg Tryptophan 
101.9mg Valine 
 
Mineral Stock (per 10ml) 
11mg Ferric chloride 6-hydrate 
2mg Cupric chloride 4-hydrate 
4mg Manganese chloride 6-hydrate 
17mg Zinc sulphate 
 
Vitamin Stock (per 5ml) 
0.1mg Biotin 
5mg Pantothenate 
2mg Folic acid 
10mg Nicotinic acid 
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2.5mg Pyridoxine 
2.5mg Thiamine 
50mg Choline 
50mg Myo-inositol 
 
Sucrose Solution (per above stock mix) 
10mg Ascorbic acid 
1mg Citric acid 
20mg Magnesium sulphate 7-hydrate 
1.7g Sucrose 
 
Phosphate Solution (per 1ml) 
150mg di-Potassium hydrogen orthophosphate 3-hydrate 
(Produced as described in Prosser and Douglas, 1992). 
 
 
Laboratory Techniques 
 
 All procedures adopted for the routine molecular biology experimental work 
were based upon standard protocols that can be found in Molecular Cloning: A 
Laboratory Manual (Sambrook and Russell, 2001). 
 
Sterile Techniques 
 Agar was poured into sterile petri dishes (supplied by Sterilin, Waltham, 
USA) and allowed to cool within a 70% (v/v) ethanol treated laminar air-flow (LAF) 
cabinet. Set plates were spread with an ethanol flamed loop or glass rod within the 
proximity of a Bunsen burner. Liquefied cultures were inoculated with cells using 
sterile pipette tips, transferred to the media by flamed forceps within the proximity of 
a Bunsen burner. The necks of glass bottles and conical flasks were flamed prior to 
and following inoculation. 
 
Bacterial Cell Culture 
 Bacterial cells were cultured using low salt LB media (LSLB), a version of 
the media originally described by Luria and Bertani (Bertani, 1951) containing only 
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0.5% (w/v) sodium chloride to maintain Zeocin antibiotic (supplied by Invivogen, 
San Diego, USA) activity. Media was autoclave-sterilised before use and appropriate 
antibiotics were added, if necessary for selection, on cooling to 50°C. Where cell 
colonies were required, LSLB agar was used. Agar plates were prepared and spread 
as described above. For analysis, 5ml aliquots of LSLB media were prepared in 
McCartney bottles (minipreps). Following antibiotic addition (if required), minipreps 
were inoculated with either an aliquot of a glycerol stock or a bacterial cell colony 
transferred from an agar plate as described earlier. Bacterial plates and cultures, 
secured on an orbital shaker set at 200rpm, were incubated overnight at 37°C. 
Antibiotics used in bacterial cell culturing included Ampicillin, Carbenicillin, 
Kanamycin and Zeocin (50!g/ml, 50!g/ml, 50!g/ml and 100!g/ml respectively). 
 
DNA Technique 
 The use of nuclease-free water, sterile Eppendorf tubes and sterile pipette tips 
were fundamental during DNA work to ensure unwanted DNA digestion was 
prevented. 
 
Plasmid DNA Isolation 
 Plasmid DNA was extracted from propagated cells using Wizard Plus SV 
Miniprep DNA Purification Systems (supplied by Promega, Madison, USA). The 
manufacturers instructions supplied with the kit were followed. Purified plasmid 
DNA was stored at -20°C. 
 
Oligonucleotides 
 Oligonucleotides were synthesised and supplied by Sigma Genosys (St. 
Louis, USA). Primers were resuspended in nuclease-free water to a final 
concentration of 100µM as detailed in the manufacturer quality control sheet. 
Resuspended oligonucleotides were stored at -20°C. 
 
DNA Amplification by Polymerase Chain Reaction (PCR) 
 To amplify DNA, standard 50!l PCR reactions were prepared in thin walled 
PCR tubes. These consisted of final concentrations of 0.2!M primers, 0.2mM dNTPs 
(supplied by Promega), 1x PCR buffer (supplied by Promega), 1.5mM MgCl2, 1Unit 
Taq polymerase (supplied by Promega) and 1µl of DNA template. For high fidelity 
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PCR, proofreading Phusion polymerase (supplied by New England Biolabs, Ipswich, 
USA) was used. Thermo-cycling conditions were determined for each PCR to suit 
the type of polymerase used, the melting temperature (Tm) (as stated in the 
manufacturer quality control sheet) of the combination of primers and the predicted 
size of the PCR product (Table 2.1). Reactions were carried out using a GeneAmp 
PCR System 2400 thermocycler (supplied by Perkin Elmer, Waltham, USA). 
Amplified PCR products were visualised by DNA agarose gel electrophoresis (see 
page 30). 
 
 
 
Phosphorylation and Annealing of Oligonucleotides 
 Oligonucleotides were phosphorylated with ATP using T4 polynucleotide 
kinase (supplied by Fermentas) following the manufacturer protocol. Once 
phosphorylated, equal amounts of the 5! and 3! oligonucleotides were annealed by 
boiling for 10 minutes and allowing them to cool naturally to room temperature. 
 
Restriction Endonuclease Digestion of DNA 
 Restriction endonuclease digestion was carried out using commercially 
available enzymes (supplied by Fermentas, New England Biolabs and Promega). 
Compatible enzyme activity buffers were selected from those suggested by the 
manufacturers.  
 
Step Temperature Time   
0 94°C (98°C for Phusion) 30s   
1 - Melting 94°C (98°C for Phusion) 10s-30s   
2 - Annealing 5°C lower than primer Tm 30s  x Cycles 
3 - Extension 72°C 10s-3min   
4 72°C 5min   
5 4°C "   
 
Table 2.1. 
Standard PCR cycling conditions for Taq polymerase (Phusion in brackets). 
Sections highlighted in red are the variables depending on the primers used, the length of 
the DNA template and amount of DNA required. 
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A typical enzyme digest: 
 
- DNA for restriction   25µl 
- 10x Enzyme activity buffer  3µl 
- Required enzyme   1µl-2µl* (10Units) 
      (30µl Total) 
 
 *If restriction is with two enzymes, use 1µl (10Units) for each. 
 
Digests were placed in a heat block (supplied by Grant Instruments, Cambridge, UK) 
pre-set to 37°C and allowed to run to completion overnight. 
 
DNA Agarose Gel Electrophoresis 
 Submarine agarose gel electrophoresis was used to separate DNA. Agarose 
gel solutions were produced using 1x (v/v) tris-acetic acid-EDTA buffer (TAE) with 
the percentage (w/v) of agarose (supplied by Bioline, London, UK) varied between 
1% and 2% depending on the size of the DNA fragments to be separated. The 
solution was heated in the microwave until boiling clear and ethidium bromide 
(10mg/ml) was added at a concentration of 0.5!g/ml on cooling to 50°C, to allow 
visualisation on a UV transilluminator. Samples of DNA were mixed with 6x Orange 
G loading dye (to a final concentration of 1x) and " DNA digested with Eco471 
(supplied by Fermentas) was used as a marker of size. Gels were run at 100V, 0.05-
0.1A maximum current in buffer consisting of 1x (v/v) TAE and 0.5!g/ml ethidium 
bromide in purified water. Complete gels were observed using a Syngene UV cabinet 
with Pulnix camera (supplied by Syngene, Cambridge, UK) and photographed using 
a Video Graphic UP-895MD printer (supplied by Sony, Minato, Japan). 
 
Recovery of DNA from Agarose Gels 
 Where DNA needed to be recovered, agarose gels were visualised on a UV 
transilluminator (supplied by UVP inc., Upland, USA) and the required bands were 
cut from the gel using a sterile razor blade. Excised DNA was purified using a 
QIAquick Gel Extraction Kit (supplied by Qiagen, Hilden, Germany) following the 
manufacturer instructions. All DNA was eluted in 30µl of nuclease-free water. 
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Ligation of DNA 
 Fragments of DNA were ligated using T4 DNA ligase and ligase buffer 
(supplied by Promega). 
A typical vector and insert ligation reaction: 
 
- Vector DNA    4µl* 
- Insert DNA    4.5µl* 
- T4 Ligase reaction buffer  1µl 
- T4 DNA ligase   0.5µl (1.5Units) 
      (10µl Total) 
 
 *The ratio of vector DNA to insert DNA can be varied, but in the 
majority of cases, a slight excess (based on concentration and size) of 
insert DNA was used. 
 
Ligation reactions were incubated at 4°C overnight to ensure they were complete. 
 
Transformation of Competent Escherichia coli Bacterial Cells 
 One Shot TOP10 electro-competent Escherichia coli bacterial cells (supplied 
by Invitrogen, see page 20) were used for the expression of plasmid DNA. Cells 
were removed from -80°C storage, thawed upon ice and mixed with 0.5µl of the 
required plasmid DNA. To facilitate plasmid uptake, electroporation was carried out 
using a Gene Pulser system (supplied by Biorad, Hercules, USA), following 
recommendations by both Invitrogen (the cell provider) and Biorad (E. coli 
electroporation protocol). Once transformed, cells were mixed with 950µl LSLB 
media, placed on a shaker at 37°C for one hour and plated out and incubated as 
described on page 27. Transformants were analysed by colony PCR (see below). 
 
Colony PCR 
 Colony PCR was used as a rapid method of confirming successful E. coli 
plasmid DNA transformants. Individual colonies were suspended in 10!l of sterile 
water by vortex mixing and boiled in a water bath for five minutes to release DNA. 
Cell debris was pelleted through a 30 second pulse-spin in a microcentrifuge and 5µl 
of the supernatant was used as a template in a PCR reaction using vector specific or 
gene specific primers (see page 28). 
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DNA Sequence Analysis 
 DNA sequencing was used to check constructed gene products. Appropriate 
vector or gene specific primers were supplied and sequencing was carried out using 
ABI Prism 3730 automated DNA sequencers (supplied by Applied Biosystems, 
Carlsbad, USA) by the DNA sequencing service (DBS Genomics), School of 
Biological and Biomedical Sciences, Durham University. The sequence data 
obtained was analysed using Sequencher software version 4.5 (Gene Codes 
Corporation) running on Mac OS computers. 
 
Linearisation of Plasmid DNA 
 In preparation for yeast transformation, plasmid DNA was linearised. Unique 
restriction enzymes such as BlnI (supplied by Roche, Basel, Switzerland) were 
utilised to digest plasmid DNA from two minipreps (see page 28). 
A standard linearisation reaction: 
 
- Plasmid DNA for linearisation 80µl 
- 10x enzyme activity buffer  9µl 
- Unique cutting enzyme  1µl-2µl (10Units) 
      (90µl Total) 
 
Reactions were incubated similarly to standard restriction endonuclease reactions. 
 
Extraction and Precipitation of DNA 
 Solutions of DNA were cleaned up via a phenol-chloroform extraction. An 
equal volume of phenol-chloroform was added to the sample. The mixture was 
vortexed for two minutes and subjected to centrifugation in a microcentrifuge at 
maximum speed for 10 minutes. The top layer aqueous phase was carefully removed 
and put through another round of extraction with just chloroform. An equal volume 
of chloroform was added to the sample. Again, the mixture was vortexed for two 
minutes and subjected to centrifugation in a microcentrifuge at maximum speed for 
10 minutes. The top layer aqueous phase was carefully removed for ethanol 
precipitation. The volume of the extracted DNA solution was measured and one 
tenth volume of 3M sodium acetate, pH 5.2 was added. Two volumes of chilled 
ethanol was added and the mixture was briefly vortexed before incubation overnight 
at -20°C. Centrifugation at 11000x g (12500rpm), 4°C for 15 minutes (Beckman 
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rotor F2402) pelleted the precipitated DNA. The supernatant was carefully removed 
and 1ml of 75% (v/v) ethanol was added prior to vortexing to resuspend and wash 
the DNA pellet. Centrifugation at 11000x g (12500rpm), 4°C for 10 minutes 
(Beckman rotor F2402) again pelleted the DNA. With the supernatant carefully 
removed, the precipitated DNA pellet was vacuum dried in a dessicator (supplied by 
Jencons, Bridgeville, USA) and resuspended in 5!l of nuclease-free water. 
 
Transformation of Competent Pichia pastoris Yeast Cells 
 Easycomp SMD1168H Pichia pastoris yeast cells (supplied by Invitrogen, 
see page 20) were used for the expression of gene constructs. Cells were removed 
from -80°C storage and thawed on ice. Heat-shock transformation was carried out 
using the Easycomp Pichia pastoris kit following the manufacturer instructions 
(Invitrogen). Following four days growth, transformants were propagated and 
analysed by western blotting (see page 37). 
 
Yeast Cell Culture 
 Yeast cells were cultured using yeast extract-peptone-glycerol media (YPG). 
Similarly to bacterial cell culture, YPG media was autoclave-sterilised before use 
and appropriate antibiotics were added, if necessary for selection, on cooling to 
50°C. Where cell colonies were required, YPG agar was used. Agar plates were 
prepared and spread as described on page 27. For analysis, 10ml aliquots of YPG 
media were prepared in McCartney bottles. Following antibiotic addition (if 
required), YPG was inoculated with either an aliquot of a glycerol stock or a yeast 
cell colony transferred from an agar plate, as documented earlier. Yeast plates and 
cultures, secured on an orbital shaker set at 250rpm, were incubated for four days at 
30°C. The main antibiotic used in yeast cell culturing was Zeocin (100!g/ml). 
 
Bacterial and Yeast Glycerol Stocks 
 Glycerol stocks were prepared to maintain a supply of competent cells 
successfully transformed with modified DNA plasmids. Bacterial cells were 
propagated in LSLB media overnight and yeast cells were grown in YPG media over 
four days. A 750!l aliquot of the resultant cell culture was mixed with 250!l of 
sterile 60% (v/v) glycerol in sterile 1.5ml cryogenic tubes (supplied by Sarstedt, 
Germany). Cryogenic tubes were snap frozen in liquid nitrogen and stored at -80°C. 
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Large Scale Yeast Cell Culture (Fermentation) 
 BioFlo 110 7.5-litre autoclavable bench-top fermenters (supplied by New 
Brunswick Scientific, Enfield, USA) were used to produce cultures for protein 
purification. A basal three litres of autoclave-sterilised minimal media (Higgins and 
Cregg, 1998) supplemented with PTM1 trace salts (Cino, 1999) was inoculated with 
three 100ml YPG seed cultures (grown for three days). Cultivation limits were set at 
30°C, pH 4.0-5.0 and 30% dissolved oxygen with continuous agitation. A glycerol 
feed of 5-10ml/hour was maintained over three days. The pGAPZ! expression 
vectors used (supplied by Invitrogen) were specifically chosen as they contained the 
yeast alpha factor (extracellular secretion signal), hence, recombinant protein was 
secreted into the surrounding media. Cells were pelleted by centrifugation for 25 
minutes at 5500x g (7000rpm) and 4°C (Beckman rotor JLA10.500) so that the 
supernatant could be processed further (see below). 
 
Chromatography and Purification of Recombinant Proteins 
 Yeast culture supernatant containing recombinant protein, was filtered 
through 2.7"m GF/D and 0.7"m GF/F glass microfibre filter discs (supplied by 
Whatman Ltd., Little Chalfont, UK) in succession using a vacuum manifold. Based 
on the recombinant protein properties (pI and purification tags etc.), the supernatant 
was subject to ion-exchange chromatography (SP Sepharose or Phenyl Sepharose, 
supplied by GE Healthcare, Little Chalfont, UK) or metal affinity chromatography 
(Ni-NTA HisTrap FF, supplied by GE Healthcare). Chromatography columns 
(supplied by GE Healthcare) were sanitised and rinsed prior to use, following the 
manufacturer recommendations. Manufacturer recommended buffers were also used 
(listed on page 24). Loading supernatants (2ml/minute) were allowed to re-circulate 
overnight at 4°C to encourage maximum protein binding (room temperature for Ni-
NTA HisTrap FF columns). For hydrophobic interaction chromatography elution, 
increasing or decreasing linear gradients of sodium chloride concentration were 
generated using a fast protein liquid chromatography (FPLC) system (supplied by 
GE Healthcare). Throughout FPLC system purifications, 5ml fractions were 
collected via an attached fraction collector. The fractions showing an increased UV 
absorbance at a wavelength of 280nm were analysed using sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) (see next page) to establish which 
contained the recombinant protein. Nickel column elution peaks were collected as a 
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single fraction and analysed by SDS-PAGE. To maximise recombinant protein 
recovery from large volumes of supernatant, the column flow-through was 
reprocessed at least twice. Partially purified recombinant proteins were manually run 
through a gel filtration column (Sephacryl S-200 matrix, supplied by GE Healthcare) 
at 0.5ml/minute to size exclude high molecular weight yeast proteins. The column 
was sanitised and rinsed prior to use, following the manufacturer recommendations. 
Gel filtration was carried out in 20mM diaminopropane (DAP), 0.1M phosphate 
buffered saline (PBS), pH 9.0. Throughout the separation, 2.5ml fractions were 
collected and those showing an increased UV absorbance at a wavelength of 280nm 
were analysed using SDS-PAGE. 
 
Sodium Dodecyl Sulphate-PolyAcrylamide Gel Electrophoresis (SDS-PAGE) of 
Proteins 
 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis with the 
discontinuous pH system originally described by Laemmli (1970) was used to 
separate denatured proteins. Standard gels with 12 wells were cast using 1mm depth 
gel plate kits (supplied by ATTO Corporation, Tokyo, Japan) following the Qiagen 
SDS-PAGE protocol. The percentage (v/v) of acrylamide solution (supplied by 
National Diagnostics) contained within the resolving gel varied between 12.5% and 
20% depending on the size of the proteins to be separated. Protein samples were 
mixed with 5x SDS loading dye (to a final concentration of 1x) and boiled alongside 
SDS 7 molecular weight marker (supplied by Sigma) in a water bath for 10 minutes, 
to allow protein denaturation and reduction prior to loading. Gels were run at 100V, 
0.05-0.1A maximum current through the stacking gel and 200V, 0.05-0.1A 
maximum current through the resolving gel in gel tanks (supplied by ATTO 
Corporation) filled with 1x reservoir buffer. Complete gels were either Coomassie 
stained, silver stained or prepared for western blotting (see page 37). Coomassie 
staining was carried out for three hours followed by de-staining for analysis. Both 
staining and de-staining were carried out with gentle agitation at room temperature. 
Silver staining was carried out using a modified version of the protocol described by 
Blum et al. (1987). Gels underwent a one hour incubation in fixative solution, two 20 
minute washes in wash solution and a single wash in distilled water for 20 minutes. 
This was followed by a one minute incubation in sensitizer solution, three 20 second 
distilled water washes, a 20 minute incubation in silver nitrate solution and a further 
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three 20 second washes in distilled water. Gels were incubated in developing 
solution until proteins were resolved sufficiently. Finally, gels were washed for 20 
seconds in distilled water and incubated in stop solution for five minutes. All gels 
were scanned into a Mac OS computer and captured as JPEG files. 
 
Dialysis and Freeze Drying of Protein Samples 
 Chromatography column eluates and protein solutions were buffer exchanged 
into purified water via dialysis. Dialysis tubing (supplied by Medicell International 
Ltd., London, UK) with the correct molecular weight cut off for the protein was 
prepared by boiling for 20 minutes in purified water containing 5mM ammonium 
hydrogen carbonate and a trace of ethylenediaminetetra-acetic acid (EDTA). Rinsed 
tubing containing protein sample was double clamped and placed in at least 100x 
greater volume of purified water. Dialysis was carried out at 4°C with constant 
stirring and water replaced at least twice in 24 hours, ensuring initial buffer 
concentration was reduced to less than 50nM. Unless stated otherwise, dialysed 
protein samples were frozen on the walls of round-bottomed flasks by shelling under 
liquid nitrogen, lyophilised by an FTS System Flexi Dry MP freeze-drier and stored 
at 4°C. For solution volumes of less than 5ml, Slide-A-Lyzer dialysis cassettes were 
used (supplied by Thermo Scientific, Waltham, USA). Apart from being filled by 
using a syringe, the dialysis procedure was identical to that described above. 
 
Estimation of Protein Concentration 
 Where possible, recombinant protein concentration was estimated by SDS-
PAGE (see page 35). Protein samples were run alongside known concentrations of a 
suitable commercial protein standard and stained as described previously. However, 
for samples containing many different proteins, a bicinchoninic acid assay (BCA) 
(reagents supplied by Thermo Scientific) was carried out, using bovine serum 
albumin (BSA) in PBS as the standard protein, following the manufacturer 
instructions. Prepared 96 well microtitre plates were absorbance measured using a 
VersaMax microplate reader (supplied by Molecular Devices, Sunnyvale, USA) with 
BCA assay settings pre-programmed. 
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Western Blotting 
 Western blotting was used as a more sensitive approach for detecting 
proteins. The semi-dry electro-transfer method documented thoroughly by Kurien 
and Scofield (2006) was used in combination with chemilluminescent detection of 
proteins, carried out following the Qiagen protein analysis benchguide. Samples for 
analysis were run on SDS-PAGE gels (described on page 35), which were 
subsequently equilibrated for five minutes in Bjerrum and Schafer-Nielsen buffer 
(Bjerrum and Schafer-Nielsen, 1986). Optitran BA-S 85 reinforced nitrocelluose 
membrane and 3MM blotting papers (both supplied by Whatman Ltd.) were cut to 
match the dimensions of the gel and pre-soaked similarly in Bjerrum and Schafer-
Nielsen buffer. Blotting was carried out using HorizBlot electroblotting systems 
(supplied by ATTO Corporation) with a constant current of 0.15A (2mA/cm
2
) for a 
minimum of one hour as per the Qiagen protocol. Transfer was confirmed by using 
Ponceau S stain to stain the membrane and molecular weight markers prior to 
destaining with distilled water. Fresh solutions of antisera block and rinse were 
produced for every blot and membrane incubations were again carried out following 
the Qiagen protein analysis benchguide. Western blots were probed with appropriate 
specific primary antibodies, including monoclonal anti-avidin (supplied by Sigma, 
used at 1:10000 dilution), anti-His-tag (supplied by Novagen, Darmstadt, Germany, 
used at 1:1000 dilution) and monoclonal anti-GNA (raised in rabbit, used at 1:3000 
dilution) and were allowed to incubate overnight with gentle agitation. Peroxidase-
coupled secondary antibodies (anti-rabbit or anti-mouse) (supplied by Thermo 
Scientific, used at 1:5000 dilution) were left to bind for a minimum of one hour with 
gentle agitation. Enhanced chemilluminsecent (ECL) reagents (supplied by Sigma) 
were used to detect specifically bound secondary antibodies by adding 5ml of ECL 
solution to the membrane prior to exposure to X-Ray film (supplied by Fujifilm Ltd., 
Tokyo, Japan) in a lead-lined film cassette. Films were developed using an automatic 
Compact X4 developer (supplied by X-ograph Imaging systems, Stonehouse, UK). 
 
Protein Deglycosylation 
 Proteins were deglycosylated with Peptide: N-Glycosidase F (PNGase F) 
(supplied by New England Biolabs) as recommended by the manufacturer. Highly 
glycosylated yeast invertase was included as a positive control. Reaction products 
were analysed by SDS-PAGE (see page 35). 
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Avidin in vitro Functionality Assay 
 The functionality of avidin was assayed by its ability to bind biotin in vitro 
using biotin-agarose (supplied by Thermo Scientific). Following the manufacturer 
recommendations, matrix was incubated with 5µg of protein at room temperature for 
30 minutes with agitation. After microcentrifugation for one minute at 3000rpm, the 
pellet was washed twice with PBS. Avidin bound to the biotin of the matrix was 
eluted by boiling, and unbound, wash and elution fractions were analysed by SDS-
PAGE (see page 35). 
 
Fluorescent Labelling of Proteins 
 Recombinant proteins were fluorescently labelled with fluorescein 
isothiocyanate (FITC). This labels amine and sulphydryl groups of proteins. 
Dimethyl sulphoxide (DMSO) was used to dissolve FITC as recommended by the 
manufacturer (Sigma). Proteins were resuspended in 50mM carbonate, pH 9.0 and 
mixed with a 2:1 molar excess of FITC, to ensure complete saturation with the 
fluorescent label. The reaction was allowed to proceed for three hours at room 
temperature with gentle agitation, covered in foil to prevent photobleaching. 
Following incubation, the excess unbound FITC was removed by dialysis against 
purified water (see page 36), again covered in foil. Labelled proteins were stored at -
20°C. 
 
Microscopy 
 For all dissections, a Vision SX45 stereo zoom microscope (supplied by 
Vision Engineering, Woking, UK) was used with 10x eyepiece lenses. For 
fluorescence microscopy, a Nikon Eclipse TE300 fluorescent microscope was used. 
Images were captured using an attached Hamamatsu camera and Openlab software 
version 4 (Perkin Elmer) on a Mac OS computer. 
 
N-Terminal Protein Sequencing 
 Protein N-terminal sequencing was carried out by Cambridge Peptides, Philip 
Victor Road, Birmingham, West Midlands, UK. Samples were prepared following 
instructions supplied by Cambridge Peptides. 
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Protein Biotinylation 
 Biotinylation of proteins was carried out using the Protein Biotinylation 
Module (supplied by GE Healthcare) following the manufacturer instructions. 
Proteins were initially re-suspended in sodium bicarbonate as recommended. 
Following biotinylation, proteins were dialysed into PBS as described on page 36. 
Biotinylated proteins were stored at -20°C. More complex biotinylated peptides were 
synthesised by Cambridge Research Biochemicals, Billingham, Cleveland, UK. 
 
Conjugation of Biotinylated Peptides to Avidin 
 Conjugation was simply carried out by allowing avidin to mix with the 
biotinylated peptide. Avidin was resuspended in PBS and mixed with a 2:1 molar 
excess of biotinylated peptide (see above) to ensure complete saturation of the biotin 
binding sites. The conjugation was allowed to proceed for three hours at room 
temperature with constant agitation. Following incubation, the excess unbound 
biotinylated peptide was removed by dialysis against purified water (see page 36). 
Avidin conjugates were stored at -20°C. 
 
 
Insect Bioassays and Dissection Techniques 
 
Hemipteran Artificial Diet Feeding Bioassays 
 Adult aphids were selected from plants 48 hours before starting the feeding 
bioassay and placed in Perspex aphid feeding chamber rings (40mm diameter) 
covered by two sheets of parafilm between which, 100µl of artificial diet (Prosser 
and Douglas, 1992, see page 26) was sandwiched (Figure 2.1). Aphids were left to 
produce nymphs overnight. The following day, the adults were removed and the 
nymphs were maintained on the artificial diet for a further 24 hours. Aphid feeding 
chambers were prepared with treatment diets immediately before starting the 
bioassay. A total of 100µl of solution was used for each feeding chamber, 
comprising of 75µl of artificial diet and 25µl of test protein at the required 
concentration. Bioassays were carried out in duplicate, with 20 aphids transferred to 
each treatment (10 per chamber) and their survival and growth was monitored daily 
for 10 days, with the diet refreshed as required. After 10 days, if survival was high, 
aphids were imaged using an Olympus SZH10 stereo microscope with a QICAM 
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camera attached. Images were captured using Openlab software version 4 (Perkin 
Elmer) and analysed using ImageJ software version 1.41 (National Institutes of 
Health, USA), measuring the overall length and width of the aphids. 
 
 
 
 
Hemipteran Whole Insect Extracts 
 Forty whole aphids were frozen rapidly in liquid nitrogen, added to 200µl of 
50mM HEPES, 0.1% (v/v) Triton X100, pH 7.4 and hand-homogenised using an 
autoclave-sterilised pestle. Debris was pelleted by microcentrifugation at maximum 
speed and the supernatant extracted material removed for analysis or assay use. The 
total protein content of the aphid extracts was estimated by BCA assay and SDS-
PAGE (see pages 36 and 35). 
 
Hemipteran Haemolymph and Gut Extraction 
 Haemolymph was extracted from aphids by carefully removing a front leg 
and placing a glass capillary to the wound to collect extruded material. Collected 
haemolymph was added directly to 5x SDS loading dye in preparation for SDS-
PAGE and western blotting (see pages 35 and 37). Guts were removed under purified 
water by carefully pulling the head from the aphid using fine forceps and allowing 
the attached gut to follow. The head was removed once the gut was completely 
 
 
Artificial diet sandwiched between parafilm 
Space for!
aphids
Parafilm
Perspex ring
Figure 2.1. 
Schematic representation of an aphid feeding chamber. 
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pulled free of the body. Extracted guts were either observed by fluorescence 
microscopy (see page 38) or prepared for further analysis. For analysis, guts were 
collected in 100µl of purified water and homogenised manually using an autoclave-
sterilised pestle. Debris was pelleted by microcentrifugation at maximum speed and 
the supernatant gut material was removed for total protein quantitation and 
preparation in 5x SDS loading dye for SDS-PAGE and western blotting (see pages 
35 and 37). 
 
Amplification of Genomic Region Containing Biotin Synthesis Genes from 
Hemipteran Buchnera Genomic DNA 
 DNA was extracted from whole adult aphids using TRI reagent (supplied by 
Sigma) according to the manufacturer instructions. Oligonucleotide primers for PCR 
were designed based on the published A. pisum Buchnera genome sequence 
(http://buchnera.gsc.riken.go.jp), using sequences in flanking glyA and ybhE genes to 
amplify the region containing genes encoding biotin synthesis enzymes (primers 
listed in Table 2.2). Experiments using A. pisum DNA as a positive control showed 
that a product of the correct size was amplified. This was cloned into pJET (supplied 
by Clontech, Shiga, Japan) and DNA sequencing was used to confirm that it 
corresponded to the expected fragment. Amplification of DNA extracted from S. 
avenae gave a fragment of similar size to that obtained from A. pisum. This was 
cloned as detailed above and analysed by DNA sequencing, using a ‘primer walking’ 
method to obtain the complete sequence of the fragment. 
 
Primer Sequence (5´ ! 3´) 
glyA 5´ CAAGGTGGACCATTAATGCAT 
  
ybhE 3´ GGTCCGCGTCATATCATCTTTCATCC 
  
Round 2  5´ AATTTACTTAAGATATGAGGTGGAGC 
  
Round 2  3´ CAATATGACGTGAAGTTAGAGTTGC 
  
Round 3  5´ CGCCTAAACCTATGATTCCTCCAG 
  
 
Table 2.2. 
Oligonucleotide primers used to amplify and sequence the biotin operon. 
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Hemipteran Gut Pull-Down Assay 
 - Magnetic Bead Preparation 
 Magnabind amine-derivatized magnetic beads (supplied by Thermo 
Scientific) were cross-linked to recombinant avidin using a Bis[sulfosuccinimidyl] 
suberate (BS
3
) cross-linker (supplied by Thermo Scientific) following the 
manufacturer instructions. The coupling efficiency was determined from an initial 
UV absorbance at a wavelength of 280nm and a value for the supernatant after the 
cross-linking reaction had been stopped. It was calculated that 91% of the 
recombinant avidin had been cross-linked to the beads, giving a final bead solution 
concentration of 9.1mg/ml recombinant avidin. 
 
 - Gut Sample Preparation 
 Approximately one hundred adult A. pisum guts were dissected under 
purified water and placed in a chilled eppendorf tube containing 100µl of PBS. The 
guts were homogenised manually using an autoclave-sterilised pestle and debris was 
pelleted by microcentrifugation at 12000rpm, 4°C for 10 minutes. The supernatant 
gut protein solution was stored at -20°C until required. 
 
 -Pull-Down Assay 
 Gut samples were thawed, mixed with 50µl of recombinant avidin magnetic 
beads and made up to a final volume of 0.5ml with PBS. The mixture was placed on 
a roller at 4°C overnight. The beads were collected using a magnetic stand and the 
supernatant removed and kept as the unbound fraction. The beads were washed for 
five minutes with 0.5ml of PBS. This was repeated three times, each time collecting 
the beads and keeping the supernatant as wash fractions. After removal of the final 
wash fraction, the beads were resuspended in 1x SDS-PAGE loading dye and this 
was the elution fraction. Aliquots of 25µl of the starting gut sample preparation, the 
unbound fraction, the wash fractions and a sample of the magnetic beads were 
prepared for SDS-PAGE alongside the elution fraction. Prior to loading, samples 
were spun briefly in a microcentrifuge to pellet and prevent the magnetic beads being 
loaded into the wells of the gel. Due to the small amounts of protein, the gel was 
silver stained. 
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Lepidopteran Haemolymph, Gut Contents, Gut and Nerve cord Extraction 
 Haemolymph, gut contents, gut and nerve cord samples from lepidopteran 
larvae were extracted and processed as described in Fitches et al. (2001) with the 
exceptions that intact guts were flushed with purified water and the extraction buffer 
was PBS containing 1mM dithiothreitol (DTT) (Figure 2.2). The total protein 
concentration of the gut contents and gut-processed supernatants were estimated by 
BCA assay (see page 36). Haemolymph, nerve cord and equal amounts of quantified 
gut samples were analysed for the presence of the required proteins by western 
blotting (see page 37). 
 
 
 
 
Figure 2.2. 
Micrographs of M. brassicae larvae dissection. 
(a) Gut dissection. (b) Nerve cord dissection. Labels define the dissected components. 
 
(a) Gut Dissection
(b) Nervecord Dissection
Gut
Extracted Gut
Extracted Nervecord
Fat Bodies
Malphigian Tubules
Nervecord 
(underneath fat bodies)
Foregut
Midgut
Hindgut
Scale:1cm = 0.5cm
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Lepidopteran Injection Bioassays 
 Purified recombinant proteins were tested for their biological activity by 
injecting day one, fifth stadium M. brassicae larvae of similar size with a maximum 
of 100µg of protein (quantified by SDS-PAGE) re-suspended in 5µl of PBS. Larvae 
were anaesthetised with carbon dioxide for 30 seconds and injected behind the head 
capsule using a 10µl Hamilton syringe (supplied by Scientific Laboratory Supplies, 
Hessle, UK). Unless otherwise stated, batches of 10 larvae were injected for each 
treatment concentration, alongside 10 others injected with equivalent amounts of 
PBS as a negative control (previously shown to have no effect). Following injection, 
the larvae were maintained on artificial diet in clear plastic pots (five larvae per pot) 
and monitored over the following days until pupation (if required). Fresh artificial 
diet was added to the pots as necessary. For in vivo analysis of protein transport, 
larvae were dissected after the required amount of time had passed, as described on 
page 43. 
 
Lepidopteran Droplet Feeding Bioassays 
 Purified recombinant proteins were tested for their oral activity by feeding a 
5µl droplet containing a maximum of 50µg of protein with 0.5% (w/v) sucrose (as a 
‘sweetener’) to newly moulted fifth stadium M. brassicae larvae. Larvae had been 
starved for 24 hours prior to the bioassay. Unless otherwise stated, batches of 10 
larvae were droplet fed for each treatment concentration, alongside 10 others droplet 
fed with equivalent amounts of PBS as a negative control (previously shown to have 
no effect). Larvae were also maintained, monitored or dissected. 
 
Lepidopteran Artificial Diet Feeding Bioassays 
 Conjugates were tested for their oral activity by inclusion in a powdered 
optimal artificial diet (supplied by Bio-Serv, Frenchtown, USA). Protein was added 
to 5g wet weight of diet at the required concentration and set with 1% (w/v) agar. 
Neonate M. brassicae larvae were carefully placed on the diet in clear plastic pots 
(10 larvae per pot) and monitored over the following days. Unless otherwise stated, 
batches of 10 larvae were fed for each treatment concentration, alongside 10 others 
fed with optimal artificial diet as a negative control. For in vivo analysis of conjugate 
transport, haemolymph was extracted after the required amount of time had passed, 
as described on page 43. 
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Production of Recombinant Fusion Proteins 
 
ButaIT-Avidin 1 (pGAPZ!B) 
 The ButaIT toxin coding sequence was PCR-amplified with 5" PstI and 3" 
SalI restriction end sites (primers listed in Table 2.3) using the ButaIT-GNA 
pGAPZ!B expression construct (Pham-Trung, 2006) as a template (Phusion 
polymerase, PCR thermocycling conditions: 98°C 10 seconds, 60°C 30 seconds, 
72°C 10 seconds, 25 cycles). After purification by agarose gel electrophoresis and 
extraction, the PCR product was restricted with PstI and SalI. The product was 
subsequently ligated into the recombinant avidin pGAPZ!B expression construct 
(Hinchliffe et al., 2010), which had also been restricted with PstI and SalI. The 
ligation mixture was transformed into E. coli and the resultant clones were screened 
by colony PCR. Recombinant plasmid was extracted from positive clones and 
purified DNA was sequenced to confirm the presence and correct assembly of the 
expression construct. 
 
ButaIT-Avidin 2 (pGAPZ!B) 
 The Avidin coding sequence was PCR-amplified with 5" NotI and 3" XbaI 
restriction end sites (primers listed in Table 2.3) using the recombinant avidin 
pGAPZ!B expression construct (Hinchliffe et al., 2010) as a template (Phusion 
polymerase, PCR thermocycling conditions: 98°C 15 seconds, 57°C 30 seconds, 
72°C 20 seconds, 25 cycles). The GNA lectin coding sequence was restricted from 
the ButaIT-GNA pGAPZ!B expression construct (Pham-Trung, 2006) using NotI 
and XbaI. Following purification by agarose gel electrophoresis and extraction, the 
avidin PCR product was restricted with NotI and XbaI. The product was 
subsequently ligated in place of the removed GNA lectin coding sequence described 
above. The ligation mixture was transformed into E. coli and the resultant clones 
were screened by colony PCR. Recombinant plasmid was extracted from positive 
clones and purified DNA was sequenced to confirm the presence and correct 
assembly of the expression construct. 
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Avidin-ButaIT 3 (pGAPZ!B) 
 In a similar manner to ButaIT-Avidin 2, the avidin coding sequence was 
PCR-amplified with 5" PstI and 3" NotI restriction end sites (primers listed in Table 
2.3) using the recombinant avidin pGAPZ!B expression construct (Hinchliffe et al., 
2010) as a template (Phusion polymerase, PCR thermocycling conditions: 98°C 15 
seconds, 65°C 30 seconds, 72°C 20 seconds, 25 cycles). The GNA lectin coding 
sequence was restricted from the GNA-ButaIT pGAPZ!B expression construct 
(Fitches et al., 2010) using PstI and NotI. After purification by agarose gel 
electrophoresis and extraction, the avidin PCR product was restricted with PstI and 
NotI. The product was subsequently ligated in place of the removed GNA lectin 
coding sequence described above. The ligation mixture was transformed into E. coli 
and the resultant clones were screened by colony PCR. Recombinant plasmid was 
extracted from positive clones and purified DNA was sequenced to confirm the 
presence and correct assembly of the expression construct. 
 
ButaIT-IgG Hinge-Avidin and Avidin-IgG Hinge-ButaIT (pGAPZ!B) 
 Oligonucleotide primers with NotI restriction end sites were designed to 
incorporate the Immunoglobulin G (IgG) hinge coding sequence (Airenne and 
Kulomaa, 1995) (primers listed in Table 2.3). The IgG hinge primers were 
phosphorylated, annealed and ligated into both the ButaIT-Avidin 2 and Avidin-
ButaIT 3 pGAPZ!B expression constructs (produced as described above), which had 
been restricted with NotI. As both restriction end sites were NotI (due to the absence 
of alternative restriction sites), it was expected that a proportion of the hinge insert 
would ligate in the correct orientation, while the remainder would ligate in the 
reverse direction. The ligation mixture was transformed into E. coli and the resultant 
clones were screened by colony PCR. Recombinant plasmid was extracted from 
positive clones and purified DNA was sequenced to confirm the presence and correct 
assembly of the expression construct. 
 
#ACTXHv1a-Avidin (Omega Atracotoxin) (pGAPZ!B) 
 The #ACTXHv1a-Avidin fusion protein expression construct was produced 
utilising the existing ButaIT-Avidin 2 pGAPZ!B (produced as described on page 45) 
and #ACTXHv1a-GNA pGAPZ!B (supplied by Dr Elaine Fitches) expression 
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constructs. The ButaIT toxin coding sequence was restricted from the ButaIT-Avidin 
2 pGAPZ!B expression construct using PstI and NotI and the "ACTXHv1a toxin 
coding sequence was restricted from the "ACTXHv1a-GNA pGAPZ!B expression 
construct similarly with PstI and NotI. Following purification by agarose gel 
electrophoresis and extraction, the "ACTXHv1a toxin coding sequence was ligated 
in place of the removed ButaIT toxin coding sequence described above. The ligation 
mixture was transformed into E. coli and the resultant clones were screened by 
colony PCR. Recombinant plasmid was extracted from positive clones and purified 
DNA was sequenced to confirm the presence and correct assembly of the expression 
construct. 
 
eGFP-Avidin (enhanced Green Fluorescent Protein) (pGAPZ!B) 
 The eGFP chromophore coding sequence was PCR-amplified with 5# PstI 
and 3# NotI restriction end sites (primers listed in Table 2.3) using the eGFP 
pGAPZ!B expression construct (supplied by Dr Daniel Price, Accession Number 
HQ259114.1) as a template (Phusion polymerase, PCR thermocycling conditions: 
98°C 30 seconds, 55°C 30 seconds, 72°C 30 seconds, 25 cycles). The ButaIT toxin 
coding sequence was restricted from the ButaIT-Avidin 2 pGAPZ!B expression 
construct (produced as described on page 45) using PstI and NotI. After purification 
by agarose gel electrophoresis and extraction, the eGFP PCR product was restricted 
with PstI and NotI. The product was subsequently ligated in place of the removed 
ButaIT toxin coding sequence described above. The ligation mixture was 
transformed into E. coli and the resultant clones were screened by colony PCR. 
Recombinant plasmid was extracted from positive clones and purified DNA was 
sequenced to confirm the presence and correct assembly of the expression construct. 
 
ButaIT-GNA Fragment-Avidin (ButaIT-Gavidin) (pGAPZ!B) 
 The ButaIT-GNA Fragment coding sequence was PCR-amplified with 5# PstI 
and 3# SalI restriction end sites (primers listed in Table 2.3) using the ButaIT-GNA 
pGAPZ!B expression construct (Pham-Trung, 2006) as a template (Phusion 
polymerase, PCR thermocycling conditions: 98°C 15 seconds, 66°C 30 seconds, 
72°C 15 seconds, 25 cycles). The ButaIT toxin coding sequence was restricted from 
the ButaIT-Avidin 1 pGAPZ!B expression construct (produced as described on page 
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45) using PstI and SalI. Following purification by agarose gel electrophoresis and 
extraction, the ButaIT-GNA Fragment PCR product was restricted with PstI and 
SalI. The product was subsequently ligated in place of the removed ButaIT toxin 
coding sequence described above. The ligation mixture was transformed into E. coli 
and the resultant clones were screened by colony PCR. Recombinant plasmid was 
extracted from positive clones and purified DNA was sequenced to confirm the 
presence and correct assembly of the expression construct. 
 
ButaIT-Gavidin (1 Mutation) (pGAPZ!B) 
 End-to-end oligonucleotide primers were designed to allow PCR 
amplification around the complete plasmid of the ButaIT-Gavidin pGAPZ!B 
expression construct (produced as described above) (primers listed in Table 2.3) 
(Phusion polymerase, PCR thermocycling conditions: 98°C 30 seconds, 59°C 30 
seconds, 72°C 2 minutes 40 seconds, 25 cycles). The 5" primer incorporated a double 
nucleotide base change mutation (underlined in Table 2.3). Following amplification 
around the plasmid, the blunt ends were phosphorylated and ligated as described on 
page 29. The ligation mixture was transformed into E. coli and the resultant clones 
were screened by colony PCR. Recombinant plasmid was extracted from positive 
clones and purified DNA was sequenced to confirm the presence and correct 
mutation of the expression construct. 
 
ButaIT-Gavidin (3 Mutations) (pGAPZ!B) 
 Similarly to ButaIT-Gavidin 1 Mutation, end-to-end oligonucleotide primers 
were designed to allow PCR amplification around the complete plasmid of the 
ButaIT-Gavidin pGAPZ!B expression construct (produced as described on page 47) 
(primers listed in Table 2.3) (Phusion polymerase, PCR thermocycling conditions: 
98°C 30 seconds, 68°C 30 seconds, 72°C 2 minutes 40 seconds, 25 cycles). Both the 
5" primer and the 3" primer incorporated two double nucleotide base change 
mutations (underlined in Table 2.3). Following amplification around the plasmid, the 
blunt ends were phosphorylated and ligated as described on page 29. The ligation 
mixture was transformed into E. coli and the resultant clones were screened by 
colony PCR. Recombinant plasmid was extracted from positive clones and purified 
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DNA was sequenced to confirm the presence and correct mutations of the expression 
construct. 
 
ButaIT-GNA Fragment (pGAPZ!B) 
 The ButaIT-GNA Fragment fusion protein expression construct was 
produced utilising the existing ButaIT-Gavidin pGAPZ!B expression construct 
(produced as described on page 47). The ButaIT-GNA Fragment coding sequence 
was restricted from the ButaIT-Gavidin pGAPZ!B expression construct using PstI 
and SalI. After purification by agarose gel electrophoresis and extraction, the 
ButaIT-GNA Fragment coding sequence was ligated into pGAPZ!B vector that had 
also been restricted with PstI and SalI. The ligation mixture was transformed into E. 
coli and the resultant clones were screened by colony PCR. Recombinant plasmid 
was extracted from positive clones and purified DNA was sequenced to confirm the 
presence and correct assembly of the expression construct. 
 
GNA Fragment-Avidin (pGAPZ!B) 
 The GNA Fragment-Avidin coding sequence was PCR-amplified with 5" PstI 
and 3" NotI restriction end sites (primers listed in Table 2.3) using the ButaIT-
Gavidin pGAPZ!B expression construct (produced as described on page 47) as a 
template (Phusion polymerase, PCR thermocycling conditions: 98°C 20 seconds, 
62°C 30 seconds, 72°C 20 seconds, 25 cycles). Following purification by agarose gel 
electrophoresis and extraction, the PCR product was restricted with PstI and NotI. 
The product was subsequently ligated into pGAPZ!B vector that had also been 
restricted with PstI and NotI. The ligation mixture was transformed into E. coli and 
the resultant clones were screened by colony PCR. Recombinant plasmid was 
extracted from positive clones and purified DNA was sequenced to confirm the 
presence and correct assembly of the expression construct. 
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Primer Sequence (5´ ! 3´) Enzyme site 
ButaIT-Avidin 1  5´ TAACTGCAGCAAGGTGTGGTCCTTGCTTT PstI 
   
ButaIT-Avidin 1  3´ TTAGTCGACTTGTATACCACAGATACATTG SalI 
   
ButaIT-Avidin 2  5´ TAAGCGGCCGCCGCTAGAAAATGCTCG NotI 
   
ButaIT-Avidin 2  3´ TTATCTAGATCATTCCTTTTGAGTTCTC XbaI 
   
Avidin-ButaIT 3  5´ TAACTGCAGCTAGAAAATGCTCGCTG PstI 
   
Avidin-ButaIT 3  3´ TTAGCGGCCGCTTCCTTTTGAGTTCTCAA NotI 
   
IgG Hinge 5´ GGCCGCACCAAAGCCAAGTACTCCACCAGGTAGTAGTGC NotI 
   
IgG Hinge 3´     CGTGGTTTCGGTTCATGAGGTGGTCCATCATCACGCCGG NotI 
   
eGFP-Avidin 5´ TAACTGCAGCAATGGTGAGCAAGGGC PstI 
   
eGFP-Avidin 3´ GCGGCGGCCGCCTTGTACAGCTCGTC NotI 
   
ButaIT-Gavidin 5´ TAACTGCAGCAAGGTGTGGTCCTTGCTTT PstI 
   
ButaIT-Gavidin 3´ TTAGTCGACGTTGAGAAATTCCCCTGTAGAGAG SalI 
   
1 Mutation 5´ ACTGCCTCTACAGGGGAATTTCTC - 
   
1 Mutation 3´ CTCACCGGAGTACAAAATATTGTC - 
   
3 Mutations 5´ ACTGCCTCTACAGGGGAATTTGCCAACGTCGACGCT - 
   
3 Mutations 3´ CTCACCGGAGGTCGCAATATTGTCGGCGGCCGC - 
   
GNA Frag-Avidin 5´ TTACTGCAGCCGACAATATTTTGTAC PstI 
   
GNA Frag-Avidin 3´ TAAGCGGCCGCTCAATGATGATGATGATGATGGTCGAT NotI 
   
 
Table 2.3. 
Oligonucleotide primers used to produce avidin fusion proteins. 
Enzyme or mutation sites are underlined. 
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Statistical Analysis 
 
 All data analysis was conducted using the statistical functions of Prism 
version 5.0 software (GraphPad Software, Inc.). Kaplan-Meier insect survival curves 
were compared using Mantel-Cox log-rank tests, again using Prism software. 
 
Chapter 3                     Comparison of Recombinant Avidin with Commercially Available Avidin 
 - 52 - 
Chapter 3 
 
Comparison of Recombinant Avidin with Commercially 
Available Avidin 
 
Introduction 
 
 A previous study with recombinant avidin produced in Pichia pastoris was 
directed towards analysing its transport from the gut to the haemolymph in vivo and 
its toxicity towards lepidopteran insects (Hinchliffe, 2007). The insecticidal activity 
of recombinant avidin was demonstrated in Mamestra brassicae (cabbage moth) 
(Lepidoptera: Noctuidae, Linnaeus 1758) larvae together with its transport to the 
haemolymph following ingestion. However, little consideration was given to the 
scientific basis of how recombinant avidin compared to the Sigma commercial 
alternative (product number: A9275-25MG from accession number: CAC34569). 
The initial experiments of this chapter therefore focus on the characterisation of 
recombinant avidin. 
 
 The difference between recombinant avidin and the commercial avidin is a 
nine amino acid N-terminal extension and a C-terminal (His)6 tag (Appendix 1). The 
P. pastoris yeast expression host is documented to carry out glycosylation and 
sometimes hyperglycosylation (Cregg et al., 1993). The difference in the amount of 
glycosylation will be evident by the change in size observed on sodium dodecyl 
sulphate-poly acrylamide gel electrophoresis (SDS-PAGE) gel following 
deglycosylation with PNGase F. 
 
 From the amino acid sequence (Appendix 1), it is predicted that recombinant 
avidin will form tetramers similar to commercial avidin. To see if this is correct, gel 
filtration of a sample of both will be carried out. Finally, to ensure that recombinant 
avidin is functional, immobilised biotin will be bound, rinsed and analysed on SDS-
PAGE gel. 
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 The scientific literature contains no published reports of the insecticidal 
effects of avidin towards hemiptera. Aphids are important globally as pests of crops, 
not only for the direct damage they cause by infestation, but also through their role as 
vectors of plant diseases (Chrispeels and Sadava, 2003). The later experiments of this 
chapter therefore focus around the effects and differences of recombinant avidin 
upon two species of aphid: Acyrthosiphon pisum (pea aphid) (Hemiptera: Aphididae, 
Harris 1776) and Sitobion avenae (cereal aphid) (Hemiptera: Aphididae, Fabricius 
1775). 
 
 The final experiments of this chapter look again at the in vivo transport of 
recombinant avidin from the gut to the haemolymph of insects, making comparisons 
between hemiptera and lepidoptera, which form the basis of the experimental design 
later in this study (Chapters 4 and 5). 
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Results 
 
 For these experiments, commercial egg-white avidin was supplied by Sigma 
(St. Louis, USA) (product number: A9275-25MG). Recombinant avidin was 
previously produced in P. pastoris and purified by nickel affinity chromatography, as 
described in Hinchliffe (2007). The nucleotide and amino acid sequence of 
recombinant avidin can be found in Appendix 1, or Hinchliffe et al., 2010 (Appendix 
2). 
 
Characterisation of Recombinant Avidin 
1. Deglycosylation 
 Deglycosylation in vitro showed that recombinant avidin contained 
covalently linked carbohydrate, indicating glycosylation by the P. pastoris yeast 
expression host. Treatment of 10µg of recombinant avidin with 500 units of PNGase 
F overnight at 37°C to remove N-glycan chains resulted in a reduction of the 
intensity of the 20kDa recombinant avidin band seen on sodium dodecyl sulphate-
poly acrylamide gel electrophoresis (SDS-PAGE) gels and the appearance of a band 
at 16kDa (Figure 3.1). The presence of some remaining 20kDa recombinant avidin 
indicates that the reaction had not run to completion. Yeast invertase is known to be 
highly glycosylated; hence it was included as a positive control. The appearance of 
one band at 64kDa indicates the yeast invertase was completely converted to a 
deglycosylated form. 
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2. Gel Filtration 
 Gel filtration of 2mg of recombinant avidin and commercial egg-white avidin 
was carried out through a sephacryl S-200 column using phosphate buffered saline 
(PBS). The two proteins gave identical elution profiles, with both samples running at 
a molecular weight of approximately 60kDa when compared to a standard protein 
calibration (Figure 3.2). This suggests that recombinant avidin forms tetrameric 
molecules similar to egg-white avidin. 
 
 
 
Figure 3.1. 
15% SDS-PAGE analysis following in vitro deglycosylation of recombinant avidin by 
PNGase F. 
M is SDS7 molecular weight marker. Lane 1 is recombinant avidin (20kDa). Lane 2 is 
deglycosylated recombinant avidin (16kDa). The presence of a band at 20kDa and 16kDa 
indicates the reaction had not run to completion. Lane 3 is yeast invertase (135kDa). Lane 4 
is deglycosylated yeast invertase (64kDa). (20µl loaded for each sample). The arrows 
indicate the PNGase F enzyme. 
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3. Binding to Biotin 
 The ability of recombinant avidin to bind biotin was confirmed in vitro by 
incubation with a molar excess of immobilised biotin (agarose-biotin). The 
immobilised biotin matrix was mixed with 5µg of recombinant avidin for 30 minutes 
at room temperature to ensure complete binding. Following microcentrifugation, the 
matrix pellet was washed twice with PBS. Finally, any bound recombinant avidin 
was eluted from the matrix by boiling. Analysis by SDS-PAGE (Figure 3.3) showed 
the absence of recombinant avidin in the unbound fraction, an absence of protein in 
the wash fractions and 100% recombinant avidin eluted upon boiling. This shows 
that all of the recombinant avidin was bound to the biotin matrix and suggests that it 
was fully functional. 
 
 
Figure 3.2. 
Sephacryl S-200 gel filtration profile of avidin. 
The dashed line represents commercial egg-white avidin. The solid line represents 
recombinant avidin. The labelled arrow-heads indicate the elution points of standard 
proteins used for calibration: (a) bovine serum albumin dimer (134kDa), (b) bovine serum 
albumin (67kDa), (c) ovalbumin (45kDa), (d) soya bean Kunitz trypsin inhibitor (20kDa). 
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Figure 3.3. 
15% SDS-PAGE analysis following in vitro binding of recombinant avidin to 
immobilised biotin (agarose-biotin). 
M is SDS 7 molecular weight marker. Lane 1 is the unbound fraction. Lanes 2 and 3 are the 
PBS wash fractions. Lane 4 is the elution fraction, showing recombinant avidin (20kDa). 
(25µl loaded for each sample). Lane 5 is 5µg of recombinant avidin (20kDa). 
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Insecticidal Activity of Orally Delivered Recombinant Avidin Towards Two 
Hemipteran Species 
 The oral toxicity of avidin towards two hemipteran pest species was 
evaluated by allowing Acyrthosiphon pisum (pea aphid) (Hemiptera: Aphididae, 
Harris 1776) and Sitobion avenae (cereal aphid) (Hemiptera: Aphididae, Fabricius 
1775) to feed on artificial diets containing recombinant avidin at concentrations in 
the range 0.05mg/ml-2mg/ml (50ppm-2000ppm, 0.75µM-30µM). Artificial diet was 
used as a negative control for the feeding bioassay. The standard aphid diet contained 
a background level of biotin of 0.001mg/ml (4µM). 
 
 Recombinant avidin showed a dose-dependent insecticidal activity towards A. 
pisum, causing a reduction in aphid survival (Figure 3.4). Acute toxicity was 
observed on diets containing 1mg/ml, 0.5mg/ml and 0.25mg/ml recombinant avidin, 
with 100% mortality recorded for all three treatments in four days (Mantel-Cox log-
rank statistical analysis, compared to artificial diet control, P<0.0001). Aphid 
survival was also reduced in treatments containing 0.2mg/ml, 0.1mg/ml and 
0.05mg/ml recombinant avidin, with respective values of 20%, 70% and 80% 
recorded at the end of the 10-day bioassay, compared to 95% control aphid survival. 
Differences in survival were statistically significant for the 0.2mg/ml and 0.1mg/ml 
treatments (Mantel-Cox log-rank statistical analysis, P<0.0001 and P<0.0087 
respectively), but not for the 0.05mg/ml treatment (Mantel-Cox log-rank statistical 
analysis, P=0.1527) when compared to controls. For these lower doses, aphid 
mortality was observed in the first six days of the bioassay, after which, no further 
decrease in survival was recorded. Fitting data from the mid-point of the bioassay 
(day 5) to a dose-response curve equation allowed a median lethal concentration 
(LC50) of 0.14mg/ml (140ppm, 2.1µM) for recombinant avidin toxicity to pea aphid 
to be estimated (Figure 3.5). This LC50 was also similar for data from the end of the 
bioassay (day 10). 
 
 Supplementation of the aphid diet with biotin alleviated the insecticidal 
effects of recombinant avidin. Pea aphids fed diets containing recombinant avidin 
and biotin at concentrations of 2mg/ml and 0.1mg/ml respectively (2000ppm and 
100ppm, 30µM and 410µM respectively), showed no reduction in survival when 
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compared to controls. This suggests that the insecticidal activity of recombinant 
avidin towards A. pisum was attributable to a biotin deficiency caused by the 
sequestering of biotin by avidin. 
 
 
 
 
Figure 3.4. 
Survival of A. pisum (pea aphid) fed on artificial diet containing varying 
concentrations of recombinant avidin. 
(n = 20 for each concentration - Two separate treatments with 10 individuals). 
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 In contrast to the effects on A. pisum, when recombinant avidin was fed to S. 
avenae, no significant differences on aphid survival were observed at concentrations 
up to 1mg/ml (1000ppm, 15µM). Even when recombinant avidin was incorporated 
into diet at a concentration of 2mg/ml (2000ppm, 30µM), aphid survival after 10 
days of feeding was only reduced to 75%, compared to 95% for control insects 
(Figure 3.6). However, avidin did have an effect on the growth of S. avenae, since all 
of the aphids exposed to diets containing recombinant avidin at 2mg/ml (2000ppm, 
30µM) were observed to be around 40% of the size of the control aphids at the end 
of the 10-day bioassay (Figure 3.7). 
 
 
 
Figure 3.5. 
Dose response curve for A. pisum at day 5 of recombinant avidin feeding assay. 
The data are fitted to a standard dose-response curve using non-linear regression. 
(n = 20 for each concentration - Two separate treatments with 10 individuals). 
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Figure 3.6. 
Survival of S. avenae (cereal aphid) fed on artificial diet containing varying 
concentrations of recombinant avidin. 
(n = 20 for each concentration - Two separate treatments with 10 individuals). 
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(a) 
 
 
 
 
(b) 
 
 
Figure 3.7. 
Size difference of S. avenae fed on control diet or on artificial diet containing 2mg/ml 
recombinant avidin. 
(a) Photographic comparison of S. avenae in aphid feeding chambers. (b) Graphic 
representation of the average size of the aphids measured using ImageJ (L = Length, W = 
Width) (n = 20 for each treatment - Two separate treatments with 10 individuals). 
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Mechanism of Toxicity of Recombinant Avidin Towards A. pisum 
1. Difference in Stability of Recombinant Avidin in the Gut of A. pisum and S. 
avenae 
 Whole insect protein extracts prepared from aphids exposed to dietary 
recombinant avidin showed no differences in proteolytic degradation between A. 
pisum and S. avenae. Protein extracts produced directly from aphids fed diets 
containing recombinant avidin at 0.5mg/ml (500ppm, 7.5µM) for 48 hours and also 
from aphids that had been chase-fed with control diet for 48 hours post recombinant 
avidin feeding, were analysed by western blotting (anti-avidin antibodies) (Figure 
3.8). 
 
 The blot suggests that the contrast in insecticidal activity is not attributable to 
differences in the susceptibility of the protein to gut proteolytic degradation in vivo 
in the different aphid species, as the same bands on the blot are present in both. 
However, in contrast to the recombinant avidin added to the diet (20kDa), the avidin 
in both aphids extracts shows signs of proteolytic degradation (19kDa, 15kDa and to 
a lesser extent, 10kDa), with all three products still being immunoreactive with the 
avidin antibody. Although the levels of degraded recombinant avidin detected in 
extracts from aphids that had been chase-fed with control diet were lower than in 
aphids without the chase, the protein was still present in readily detectable amounts, 
suggesting that ingested avidin had bound to the gut or had been sequestered, and 
that not all of the ingested protein had been excreted in honeydew within 24 hours. 
No avidin was detected in aphids fed artificial diet as a control. The blot also shows 
the presence of an immunoreactive, higher molecular weight protein (36kDa), 
suggesting the formation of a recombinant avidin dimer as it is not present in protein 
extracts obtained from aphids fed with control diet (Figure 3.8). 
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2. Difference in Susceptibility to Biotin Depletion in A. pisum and S. avenae 
 As avidin is known to sequester biotin, an investigation into the effect of 
dietary biotin was conducted. When A. pisum and S. avenae were fed on diets 
containing varying amounts of biotin, from 0µM up to 4µM biotin (4ppm, 
0.004mg/ml) (normal artificial diet concentration), mortality was observed in both 
species at biotin levels of 3µM or less (Figure 3.9). Pea aphids fed diet containing the 
normal 4µM amount of biotin grew normally with no mortality, whereas aphids fed 
levels of 3µM or less of biotin showed similar mortality to aphids fed no biotin at all, 
with 100% mortality observed by day nine for all three treatments. Cereal aphids 
were less sensitive to reduced biotin levels in diet, with 100% mortality at day nine 
 
 
Figure 3.8. 
Western analysis of whole S. avenae and A. pisum protein extracts prepared directly 
after feeding on 0.5mg/ml recombinant avidin for 48 hours, or after chasing 
recombinant avidin with control diet for 48 hours. 
A one second exposure of the membrane transferred from a 15% SDS-PAGE gel, probed 
with anti-avidin antibodies (1:10000) is shown. M is SDS 7 molecular weight marker. Lane 
1 is protein extract from S. avenae fed with control diet for 48 hours. Lane 2 is protein 
extract from S. avenae fed with recombinant avidin for 48 hours. Lane 3 is protein extract 
from S. avenae fed with recombinant avidin for 48 hours followed by control diet for 48 
hours. The avidin in the aphid extracts shows signs of proteolytic degradation (19kDa, 
15kDa and 10kDa). There is also a higher molecular weight protein (36kDa), suggesting 
the formation of a recombinant avidin dimer. Lanes 4-6 are the equivalent protein extracts 
from A. pisum. (25µl loaded for each sample). Lane 7 is 10ng of recombinant avidin 
(20kDa). 
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and similar survival curves for treatments in the range 0µM-2µM, but only partial 
mortality (55%) for the 3µM biotin treatment (Mantel-Cox log-rank statistical 
analysis, P=0.0001, significant difference between both the 3µM treatment and the 
control and, P=0.0291, for the 3µM and 0µM-2µM biotin treatments). Survival and 
growth of the aphids fed the normal 4µM diet was similar to that for A. pisum. 
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 (a) 
 
 (b) 
 
 
Figure 3.9. 
Survival of aphids fed on artificial diet containing varying concentrations of biotin. 
(a) A. pisum. (b) S. avenae. (n = 20 for each concentration - Two separate treatments with 
10 individuals). 
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 The two aphid species also showed differing responses when fed diet 
containing no biotin and a sub-lethal level of recombinant avidin (0.2mg/ml for A. 
pisum and 2mg/ml for S. avenae) (Figure 3.10). In this assay, 100% mortality was 
observed for both aphid species in 9-10 days for the diets with an absence of biotin. 
Adding 0.2mg/ml recombinant avidin to the biotin-free diet accelerated the complete 
mortality of A. pisum to seven days. In contrast, the addition of 2mg/ml recombinant 
avidin to the S. avenae biotin-free diet promoted a statistically significant 75% 
survival outcome at day 10 (Mantel-Cox log-rank statistical analysis, compared to no 
biotin control, P<0.0001). This suggests that supplying the recombinant avidin to S. 
avenae compensates largely for the absence of biotin. 
 
 
 
 
Figure 3.10. 
Survival of aphids fed on biotin-free artificial diet containing recombinant avidin. 
(n = 20 for each treatment - Two separate treatments with 10 individuals). 
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3. Difference in Biotin Synthesis by Bacterial Symbionts in A. pisum and S. avenae 
 To investigate one other possibility that S. avenae survived better on reduced 
biotin diets because the Buchnera symbionts contain a functional operon for biotin 
synthesis, the sequence of the region of Buchnera genome containing the biotin 
operon was determined. A fragment of approximately 4.5kbp was amplified from 
DNA isolated from S. avenae, using primers based on the published A. pisum 
Buchnera genome sequence (Chapter 2). This fragment was fully sequenced (Figure 
3.11). 
 
 The determined sequence was very similar to the published genome sequence 
for Buchnera aphidicola from A. pisum, containing parts of the glyA and ybhE genes 
which flank the bio operon and open reading frames for the polypeptides encoded by 
the bioA, bioB and bioD genes (Figure 3.11). This result shows that the S. avenae 
symbionts, like the A. pisum symbionts, lack the full complement of genes necessary 
for biotin synthesis (bioW and bioF missing). 
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bp 318674 - 323153 
 
    Q  G  G  P  L  M  H  V  I  A  A  K  A  I  A  F  K  E  A  L  E  P  K  F  K 
5!--CAAGGTGGACCATTAATGCATGTAATTGCAGCAAAAGCTATTGCATTTAAAGAGGCTTTAGAACCAAAGTTTAAA 
3!--GTTCCACCTGGTAATTACGTACATTAACGTCGTTTTCGATAACGTAAATTTCTCCGAAATCTTGGTTTCAAATTT 
 
 T  Y  Q  K  Q  I  V  K  N  S  K  V  M  V  E  R  F  L  E  K  G  Y  K  I  I 
ACATATCAAAAACAAATAGTAAAAAACTCTAAAGTTATGGTTGAAAGATTTTTAGAAAAAGGATATAAAATCATA 
TGTATAGTTTTTGTTTATCATTTTTTGAGATTTCAATACCAACTTTCTAAAAATCTTTTTCCTATATTTTAGTAT 
 
 S  G  H  T  F  N  H  L  F  L  I  D  L  T  N  K  K  I  T  G  K  D  A  D  I 
TCTGGACATACTTTTAATCATTTGTTTCTAATTGATTTAACCAATAAAAAAATAACAGGAAAAGATGCTGATATT 
AGACCTGTATGAAAATTAGTAAACAAAGATTAACTAAATTGGTTATTTTTTTATTGTCCTTTTCTACGACTATAA 
 
 I  L  S  K  A  N  I  T  V  N  K  N  T  I  P  N  D  L  K  S  P  F  I  T  S 
ATTTTAAGTAAAGCAAATATAACTGTTAATAAAAATACGATACCTAATGATTTAAAAAGTCCTTTTATTACTTCA 
TAAAATTCATTTCGTTTATATTGACAATTATTTTTATGCTATGGATTACTAAATTTTTCAGGAAAATAATGAAGT 
 
 G  I  R  I  G  T  A  A  V  T  R  R  G  F  K  E  N  E  V  S  K  I  S  D  W 
GGCATACGTATTGGTACTGCCGCTGTTACTAGAAGAGGATTCAAAGAAAATGAGGTCTCTAAAATATCAGATTGG 
CCGTATGCATAACCATGACGGCGACAATGATCTTCTCCTAAGTTTCTTTTACTCCAGAGATTTTATAGTCTAACC 
 
 I  T  S  I  L  N  N  V  D  D  H  N  N  V  L  Q  I  K  K  K  V  L  E  M  C 
ATAACTAGTATTTTAAATAATGTTGATGATCATAATAATGTTCTTCAAATAAAAAAGAAAGTATTAGAAATGTGT 
TATTGATCATAAAATTTATTACAACTACTAGTATTATTACAAGAAGTTTATTTTTTCTTTCATAATCTTTACACA 
 
 L  K  Y  P  V  Y  I  . 
TTAAAATATCCCGTGTACATTTGATCAAAAATGTTGAATATGTCCATCTTTGTTAATCATTATATTAATAATGAT 
AATTTTATAGGGCACATGTAAACTAGTTTTTACAACTTATACAGGTAGAAACAATTAGTAATATAATTATTACTA 
 
AAAAATCATACTTTCTAAAACTATTTTTTAAACTTTTTATTTAGGTAGTTTGATTTTTATTTTTTTAAAATTAAT 
TTTTTAGTATGAAAGATTTTGATAAAAAATTTGAAAAATAAATCCATCAAACTAAAAATAAAAAAATTTTAATTA 
                                     .  K  P  L  K  I  K  I  K  K  F  N  I 
 
TCTATTTTTATTTTTAAAATAAGGAACTACGCCCAAAAATGGAGATTTAATATAATTTAACAAAGTTTGGATGTA 
AGATAAAAATAAAAATTTTATTCCTTGATGCGGGTTTTTACCTCTAAATTATATTAAATTGTTTCAAACCTACAT 
 R  N  K  N  K  F  Y  P  V  V  G  L  F  P  S  K  I  Y  N  L  L  T  Q  I  Y 
 
ATGCATATTATATTTGTCTTTTGGAAAAATATTATTAGCAATCCAGCCTCCACATTTTATTTGATCTGAAATAAT 
TACGTATAATATAAACAGAAAACCTTTTTATAATAATCGTTAGGTCGGAGGTGTAAAATAAACTAGACTTTATTA 
 H  M  N  Y  K  D  K  P  F  I  N  N  A  I  W  G  G  C  K  I  Q  D  S  I  I 
 
AGCTTTTTCTGTTAAAATTGCATGGTTAATACATCCCAATTTGATTGCAATTATTATAATAACAGTTAATTTTTC 
TCGAAAAAGACAATTTTAACGTACCAATTATGTAGGGTTAAACTAACGTTAATAATATTATTGTCAATTAAAAAG 
 A  K  E  T  L  I  A  H  N  I  C  G  L  K  I  A  I  I  I  I  V  T  L  K  E 
 
TTGTTTCACCCAACTTGAAAAAGTATCTTTACAAGATAGTGGTGTATACCATCCACCAGCACCTTCTACTAAAAT 
AACAAAGTGGGTTGAACTTTTTCATAGAAATGTTCTATCACCACATATGGTAGGTGGTCGTGGAAGATGATTTTA 
 Q  K  V  W  S  S  F  T  D  K  C  S  L  P  T  Y  W  G  G  A  G  E  V  L  I 
 
CCAATTGCTTTTTTTTGTAATATTGCTTAAACCTAAAGACAATTCTTCTTTTTTAATACTCCTTTTTTGAAATTT 
GGTTAACGAAAAAAAACATTATAACGAATTTGGATTTCTGTTAAGAAGAAAAAATTATGAGGAAAAAACTTTAAA 
 W  N  S  K  K  T  I  N  S  L  G  L  S  L  E  E  K  K  I  S  R  K  Q  F  K 
 
ACTTAAGATATGAGGTGGAGCATTTTCAAAAAATGCAATCGGATTAACTTCTCTATCACTTAATATTATAGAGCT 
TGAATTCTATACTCCACCTCGTAAAAGTTTTTTACGTTAGCCTAATTGAAGAGATAGTGAATTATAATATCTCGA 
 S  L  I  H  P  P  A  N  E  F  F  A  I  P  N  V  E  R  D  S  L  I  I  S  S 
 
ACTTTTCTTAAGAAGAATCGCGTCTTGATTAAAAAAACCAGATGATTTTTTTTGGCCTCCAGAAGAGACAGGTTT 
TGAAAAGAATTCTTCTTAGCGCAGAACTAATTTTTTTGGTCTACTAAAAAAAACCGGAGGTCTTCTCTGTCCAAA 
 S  K  K  L  L  I  A  D  Q  N  F  F  G  S  S  K  K  Q  G  G  S  S  V  P  K 
 
GTATCCTGCTGTCTGATATCCAGACATAGTGGCTTTTTTTAGCAAAATACTGCTTACTATTGTTTTTCCTACATT 
CATAGGACGACAGACTATAGGTCTGTATCACCGAAAAAAATCGTTTTATGACGAATGATAACAAAAAGGATGTAA 
 Y  G  A  T  Q  Y  G  S  M  T  A  K  K  L  L  I  S  S  V  I  T  K  G  V  N 
 
TGTATCAGTTCCAGTAATGAAAAATTTTTTTATCATAATAAAATCTTTTTTTTAAATCTGACGTAGTATTAAAGA 
ACATAGTCAAGGTCATTACTTTTTAAAAAAATAGTATTATTTTAGAAAAAAAATTTAGACTGCATCATAATTTCT 
 T  D  T  G  T  I  F  F  K  K  I  M 
 
ATTATATTGTTTTAATATCGTAATTAACATGTTTAATATATTTTTATATTATTATTTTAAATATAAAAAAGTTTC 
TAATATAACAAAATTATAGCATTAATTGTACAAATTATATAAAAATATAATAATAAAATTTATATTTTTTCAAAG 
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TTTATTAACAATCATATTCATATTAATTGCCCTCCAAATCGAGTAACTCAATATTAGTTATTATGTCTATTTGAT 
AAATAATTGTTAGTATAAGTATAATTAACGGGAGGTTTAGCTCATTGAGTTATAATCAATAATACAGATAAACTA 
 
ACAATAACATATAACTATAATATTGAGTTACTCCTAAAATAAAAAAGATAATATTATTCTTATTTAGAAGAATTT 
TGTTATTGTATATTGATATTATAACTCAATGAGGATTTTATTTTTTCTATTATAATAAGAATAAATCTTCTTAAA 
 
TCCAATATTTTATTTGAAGAAAATAAAATATTTTTATGATTAATAGATTCAAAAATTTCTATAATTTTTATTTCT 
AGGTTATAAAATAAACTTCTTTTATTTTATAAAAATACTAATTATCTAAGTTTTTAAAGATATTAAAAATAAAGA 
 
TCAAGGATATTTTTTTAAATAAATTATATTATAGCTGCATTATAATATTGATCTTTTTTAATTTTTGACGATTTT 
AGTTCCTATAAAAAAATTTATTTAATATAATATCGACGTAATATTATAACTAGAAAAAATTAAAAACTGCTAAAA 
                        .  I  I  A  A  N  Y  Y  Q  D  K  K  I  K  S  S  K 
 
ATAATATTTTTATATTCATCTTCTTTTAATAAAGTTTGTGTTTTATTTTCAGGAATTAAATCTAATTTCTTAAAT 
TATTATAAAAATATAAGTAGAAGAAAATTATTTCAAACACAAAATAAAAGTCCTTAATTTAGATTAAAGAATTTA 
I  I  N  K  Y  E  D  E  K  L  L  T  Q  T  K  N  E  P  I  L  D  L  K  K  F 
 
AATTCTAAATCATGTTTTTCTTCTGGATTATCTGAAGTAAGTAATTTACATCCATAAAAAATAGAATTTGCTCCA 
TTAAGATTTAGTACAAAAAGAAGACCTAATAGACTTCATTCATTAAATGTAGGTATTTTTTATCTTAAACGAGGT 
L  E  L  D  H  K  E  E  P  N  D  S  T  L  L  K  C  G  Y  F  I  S  N  A  G 
 
GCCATAAAACACATTGCTTGAGTTTGATCGTTCATTTTATGACGTCCGGCTGACAATCTAATATAAGATTTTGGC 
CGGTATTTTGTGTAACGAACTCAAACTAGCAAGTAAAATACTGCAGGCCGACTGTTAGATTATATTCTAAAACCG 
A  M  F  C  M  A  Q  T  Q  D  N  M  K  H  R  G  A  S  L  R  I  Y  S  K  P 
 
ATCATAATGCGAGCTACAGCAATAATACGAATAAAATCAAATGGTTCTACATCTTTATTATCTGCCATTGGAGTA 
TAGTATTACGCTCGATGTCGTTATTATGCTTATTTTAGTTTACCAAGATGTAGAAATAATAGACGGTAACCTCAT 
M  M  I  R  A  V  A  I  I  R  I  F  D  F  P  E  V  D  K  N  D  A  M  P  T 
 
CCTGGAATTTTTACTAACATATTAATAGGTACACTTTCTGGTTGAATAGATAAATTAGATAATTCCATTAATAAT 
GGACCTTAAAAATGATTGTATAATTATCCATGTGAAAGACCAACTTATCTATTTAATCTATTAAGGTAATTATTA 
G  P  I  K  V  L  M  N  I  P  V  S  E  P  Q  I  S  L  N  S  L  E  M  L  L 
 
TCAATACGATCTTGTTTTTTTTCGCCTAAACCTATGATTCCTCCAGAACAAACTTTCATTCCCGAACTACGAACT 
AGTTATGCTAGAACAAAAAAAAGCGGATTTGGATACTAAGGAGGTCTTGTTTGAAAGTAAGGGCTTGATGCTTGA 
E  I  R  D  Q  K  K  E  G  L  G  I  I  G  G  S  C  V  K  M  G  S  S  R  V 
 
GCATGCAATGTATGAAGTCGTTCTTGATATGTACGAGTAGTAATAATATTACTGTAAAAATTTTTAGATGTATCT 
CGTACGTTACATACTTCAGCAAGAACTATACATGCTCATCATTATTATAATGACATTTTTAAAAATCTACATAGA 
A  H  L  T  H  L  R  E  Q  Y  T  R  T  T  I  I  N  S  Y  F  N  K  S  T  D 
 
AAATTATGATTATAAAAATCTAAACCGGCATCAGCTAGTTTTTTTGCTTGTGTGCTATTTAATGTACCCAGAGTC 
TTTAATACTAATATTTTTAGATTTGGCCGTAGTCGATCAAAAAAACGAACACACGATAAATTACATGGGTCTCAG 
L  N  H  N  Y  F  D  L  G  A  D  A  L  K  K  A  Q  T  S  N  L  T  G  L  T 
 
ATACAGGTTTCCATACCCATTTCTTTTATTTTTTTAATAATTTTTTCTAAATAAGGCATATCTTTTTCTTTTGGG 
TATGTCCAAAGGTATGGGTAAAGAAAATAAAAAAATTATTAAAAAAGATTTATTCCGTATAGAAAAAGAAAACCC 
M  C  T  E  M  G  M  E  K  I  K  K  I  I  K  E  L  Y  P  M  D  K  E  K  P 
 
TTTTTCCATGCAGCACCCATACAGAATCGACTAGATCCTGAATCTTTCGCTTTTTTTGCAGCACTTAGGATTTGT 
AAAAAGGTACGTCGTGGGTATGTCTTAGCTGATCTAGGACTTAGAAAGCGAAAAAAACGTCGTGAATCCTAAACA 
N  K  W  A  A  G  M  C  F  R  S  S  G  S  D  K  A  K  K  A  A  S  L  I  Q 
 
TCTATTTCTAATAAAGGTTCTTTTTTCAAACCTGTTTTATATCTAGAACTTTGCGGACAATATTTACAATCTTCT 
AGATAAAGATTATTTCCAAGAAAAAAGTTTGGACAAAATATAGATCTTGAAACGCCTGTTATAAATGTTAGAAGA 
E  I  E  L  L  P  E  K  K  L  G  T  K  Y  R  S  S  Q  P  C  Y  K  C  D  E 
 
GGACACGATCCTGTTTTTATAGAAAGCAAAGTGCTTATTTGTATTGTATTAGGATCAAAGTTTTTTCTATGTTCT 
CCTGTGCTAGGACAAAAATATCTTTCGTTTCACGAATAAACATAACATAATCCTAGTTTCAAAAAAGATACAAGA 
P  C  S  G  T  K  I  S  L  L  T  S  I  Q  I  T  N  P  D  F  N  K  R  H  E 
 
TCTTGAGCTTGAAACATAAGATTAAAAAATGGTTTTTTAAAAAGCATTTTTGTTTCTTCTAAAGTCCATTTTTTT 
AGAACTCGAACTTTGTATTCTAATTTTTTACCAAAAAATTTTTCGTAAAAACAAAGAAGATTTCAGGTAAAAAAA 
E  Q  A  Q  F  M  L  N  F  F  P  K  K  F  L  M  K  T  E  E  L  T  W  K  K 
 
TTCATATTATCTCCAAAAAAATTGTGATTTTATTTAAGTTAACGTTTATACTGAATTATTTAATATTTTATATAT 
AAGTATAATAGAGGTTTTTTTAACACTAAAATAAATTCAATTGCAAATATGACTTAATAAATTATAAAATATATA 
K  M 
         M  S  Q  S  D  T  I  F  D  Y  K  H  I  W  H  P  Y  S  S  M  N  N 
AAATTATTATGAGTCAATCTGATACTATTTTTGATTACAAGCATATTTGGCATCCTTATTCATCTATGAATAATC 
TTTAATAATACTCAGTTAGACTATGATAAAAACTAATGTTCGTATAAACCGTAGGAATAAGTAGATACTTATTAG 
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P  H  P  C  Y  T  V  I  S  A  K  G  V  Y  L  K  L  K  N  R  K  Y  M  I  D 
CTCATCCTTGTTATACTGTTATATCAGCTAAGGGAGTATATTTAAAATTAAAAAATAGGAAATATATGATAGATG 
GAGTAGGAACAATATGACAATATAGTCGATTCCCTCATATAAATTTTAATTTTTTATCCTTTATATACTATCTAC 
 
G  M  S  S  W  W  A  A  I  H  G  Y  N  H  P  V  L  N  K  A  L  K  K  Q  I 
GAATGTCTTCATGGTGGGCTGCAATACATGGTTATAATCATCCTGTTTTAAATAAAGCATTAAAAAAACAGATAA 
CTTACAGAAGTACCACCCGACGTTATGTACCAATATTAGTAGGACAAAATTTATTTCGTAATTTTTTTGTCTATT 
 
R  K  M  S  H  V  M  F  G  G  I  T  H  P  P  A  I  S  L  C  R  K  L  I  S 
GAAAAATGTCTCATGTAATGTTTGGCGGAATTACACATCCTCCAGCCATTTCACTGTGTCGAAAATTAATTTCAC 
CTTTTTACAGAGTACATTACAAACCGCCTTAATGTGTAGGAGGTCGGTAAAGTGACACAGCTTTTAATTAAAGTG 
 
L  T  P  E  K  L  D  C  V  F  L  S  D  S  G  S  V  A  I  E  V  A  I  K  M 
TAACGCCAGAAAAATTAGATTGTGTTTTTCTTTCTGATTCTGGTTCAGTTGCTATTGAAGTAGCAATAAAAATGT 
ATTGCGGTCTTTTTAATCTAACACAAAAAGAAAGACTAAGACCAAGTCAACGATAACTTCATCGTTATTTTTACA 
 
L  I  Q  Y  W  Q  A  L  G  Q  K  R  K  L  F  L  T  I  R  N  G  Y  H  G  D 
TAATACAGTATTGGCAAGCATTAGGGCAAAAGAGAAAATTATTTTTGACTATTCGTAATGGTTATCATGGTGATA 
ATTATGTCATAACCGTTCGTAATCCCGTTTTCTCTTTTAATAAAAACTGATAAGCATTACCAATAGTACCACTAT 
 
T  F  S  A  M  S  V  S  D  P  K  N  S  F  H  Q  I  Y  H  N  L  L  P  K  H 
CTTTTTCTGCAATGTCAGTATCGGACCCAAAAAATTCATTCCATCAAATATATCATAACTTATTACCAAAACACT 
GAAAAAGACGTTACAGTCATAGCCTGGGTTTTTTAAGTAAGGTAGTTTATATAGTATTGAATAATGGTTTTGTGA 
 
L  F  A  D  A  P  V  S  S  F  Y  K  N  W  D  N  E  D  I  L  S  F  K  K  I 
TATTTGCAGACGCACCAGTTTCTTCTTTTTATAAAAACTGGGACAACGAAGATATTTTATCTTTTAAAAAAATAA 
ATAAACGTCTGCGTGGTCAAAGAAGAAAAATATTTTTGACCCTGTTGCTTCTATAAAATAGAAAATTTTTTTATT 
 
I  E  K  N  S  F  K  I  A  G  V  I  L  E  P  I  V  Q  G  V  G  G  M  N  F 
TAGAAAAAAATTCATTTAAAATAGCAGGGGTCATATTAGAACCTATCGTGCAAGGAGTCGGAGGGATGAATTTTT 
ATCTTTTTTTAAGTAAATTTTATCGTCCCCAGTATAATCTTGGATAGCACGTTCCTCAGCCTCCCTACTTAAAAA 
 
Y  H  P  M  Y  L  K  Q  I  K  I  L  C  N  H  Y  S  I  P  V  I  F  D  E  I 
ATCATCCTATGTATTTGAAGCAAATAAAAATTTTATGTAATCATTATTCTATTCCAGTTATTTTTGATGAAATTG 
TAGTAGGATACATAAACTTCGTTTATTTTTAAAATACATTAGTAATAAGATAAGGTCAATAAAAACTACTTTAAC 
 
A  T  G  F  G  R  T  G  K  M  F  A  F  E  H  A  N  V  V  P  D  I  L  C  L 
CAACTGGATTCGGTCGAACTGGAAAAATGTTTGCTTTTGAACATGCGAATGTTGTGCCAGATATACTATGTTTAG 
GTTGACCTAAGCCAGCTTGACCTTTTTACAAACGAAAACTTGTACGCTTACAACACGGTCTATATGATACAAATC 
 
G  K  S  I  T  G  G  T  I  T  L  A  A  T  L  T  S  R  H  I  A  D  T  I  S 
GAAAATCAATTACAGGTGGTACAATAACTTTGGCCGCAACTCTAACTTCACGTCATATTGCTGATACAATTAGTA 
CTTTTAGTTAATGTCCACCATGTTATTGAAACCGGCGTTGAGATTGAAGTGCAGTATAACGACTATGTTAATCAT 
 
K  G  K  V  G  C  F  M  H  G  P  T  Y  M  G  N  P  L  A  C  A  V  A  N  A 
AAGGTAAAGTCGGTTGTTTTATGCATGGTCCGACTTATATGGGAAATCCATTAGCATGTGCAGTTGCTAATGCTA 
TTCCATTTCAGCCAACAAAATACGTACCAGGCTGAATATACCCTTTAGGTAATCGTACACGTCAACGATTACGAT 
 
N  I  K  I  L  K  T  N  Q  W  K  I  Q  V  L  N  I  E  K  Q  L  F  K  S  L 
ATATCAAAATATTAAAAACTAATCAATGGAAAATACAAGTATTGAATATTGAAAAGCAATTATTTAAAAGTTTAA 
TATAGTTTTATAATTTTTGATTAGTTACCTTTTATGTTCATAACTTATAACTTTTCGTTAATAAATTTTCAAATT 
 
M  P  L  I  N  H  P  Y  V  A  D  V  R  V  L  G  A  I  G  V  V  E  C  S  R 
TGCCGTTAATTAATCATCCTTATGTTGCTGATGTACGTGTATTAGGAGCCATTGGTGTAGTTGAATGTTCTCGTT 
ACGGCAATTAATTAGTAGGAATACAACGACTACATGCACATAATCCTCGGTAACCACATCAACTTACAAGAGCAA 
 
S  I  N  M  I  S  I  Q  K  F  F  V  E  N  G  V  W  I  R  P  F  K  K  L  I 
CAATTAATATGATTTCAATACAAAAATTTTTTGTTGAAAATGGTGTTTGGATTAGACCATTTAAAAAATTAATTT 
GTTAATTATACTAAAGTTATGTTTTTAAAAAACAACTTTTACCACAAACCTAATCTGGTAAATTTTTTAATTAAA 
 
Y  I  V  P  P  Y  I  I  S  P  H  T  L  K  K  L  T  N  V  I  S  N  A  L  N 
ATATTGTCCCACCTTATATTATTAGCCCTCACACATTAAAAAAATTAACGAACGTAATTTCGAATGCTTTAAATA 
TATAACAGGGTGGAATATAATAATCGGGAGTGTGTAATTTTTTTAATTGCTTGCATTAAAGCTTACGAAATTTAT 
 
K  T  E  L  F  I  . 
AAACTGAATTATTTATATAATTTTAATTTCAACACAATGCATGTATAAGTATCCATACAGGTCTTTGACCAGTAC 
TTTGACTTAATAAATATATTAAAATTAAAGTTGTGTTACGTACATATTCATAGGTATGTCCAGAAACTGGTCATG 
                             .  C  L  A  H  I  L  I  W  V  P  R  Q  G  T  S 
 
TATATACATTTATTTTTTTTAATTCACCAGTGCTATTAGAAATGCCATATATAATGAATGTATTAGATTTTTCTC 
ATATATGTAAATAAAAAAAATTAAGTGGTCACGATAATCTTTACGGTATATATTACTTACATAATCTAAAAAGAG 
  Y  V  N  I  K  K  L  E  G  T  S  N  S  I  G  Y  I  I  F  T  N  S  K  E  G 
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CAGCAACGATCAAATGTGTATTATGAGAATTTATATTAAATGATCGAGGTTGTTCTTCTGTATCATAACTTTTAA 
GTCGTTGCTAGTTTACACATAATACTCTTAAATATAATTTACTAGCTCCAACAAGAAGACATAGTATTGAAAATT 
  A  V  I  L  H  T  N  H  S  N  I  N  F  S  R  P  Q  E  E  T  D  Y  S  K  F 
 
AAAAAACAAGTTTATTGTCATTTTGATTGATATGAAATAATGAAATAATATTAAAAAAGCGATCGCAAGCATACA 
TTTTTTGTTCAAATAACAGTAAAACTAACTATACTTTATTACTTTATTATAATTTTTTCGCTAGCGTTCGTATGT 
  F  V  L  K  N  D  N  Q  N  I  H  F  L  S  I  I  N  F  F  R  D  C  A  Y  L 
 
AAAAACGACCACACGATGTTATATGAATGTCAGAACACCAATAATCTTTTAGAAATCTATTTTTCAATACATGTA 
TTTTTGCTGGTGTGCTACAATATACTTACAGTCTTGTGGTTATTAGAAAATCTTTAGATAAAAAGTTATGTACAT 
  F  R  G  C  S  T  I  H  I  D  S  C  W  Y  D  K  L  F  R  N  K  L  V  H  I 
 
TATTTTGTATATTTTTTACTTTTATCACGTTGTTCTTTTTGTATATTTTCCATACATCTATAGTTCCATTTAATT 
ATAAAACATATAAAAAATGAAAATAGTGCAACAAGAAAAACATATAAAAGGTATGTAGATATCAAGGTAAATTAA 
  N  Q  I  N  K  V  K  I  V  N  N  K  K  Y  I  K  W  V  D  I  T  G  N  L  E 
 
CATTTATAGTATAGATAAAATCTTGATTAGGATGAAAGATGATATGACGCGGACC--3! 
GTAAATATCATATCTATTTTAGAACTAATCCTACTTTCTACTATACTGCGCCTGG--5! 
  N  I  T  Y  I  F  D  Q  N  P  H  F  I  I  H  R  P  G 
 
 
 
 
 
 
 
 
Figure 3.11. 
Nucleotide sequence, deduced amino acid sequence and schematic representation 
of the region of genome sequenced in Buchnera from S. avenae. 
(From Buchnera aphidicola; accession CP001158). 
(5!-3!) The glyA gene flanking the bio operon is highlighted in grey (bp 318674-319147 
truncated). The bioA gene is highlighted in purple (bp 321382-322668). 
(3!-5!) The ybhE gene flanking the bio operon is highlighted in green (bp 323153-
322677 truncated). The bioB gene is highlighted in yellow (bp 321303-320272). The 
bioD gene is highlighted in blue (bp 319909-319235). Diagram not to scale. 
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Transport of Recombinant Avidin in Insects 
1. Hemipteran In vivo Transport of Recombinant Avidin 
 Analysis of guts and haemolymph extracted from A. pisum following 
ingestion of recombinant avidin revealed it was likely that recombinant avidin was 
not transported throughout the aphid body and haemolymph in vivo. Extractions were 
carried out on aphids fed on diet containing 1mg/ml (1000ppm, 15µM) recombinant 
avidin for 24 and 48 hours and also from aphids that had been chase-fed with control 
diet for 24 hours post recombinant avidin feeding. 
 
 Avidin was readily detected in the dissected guts after a chase of 24 hours 
(Figure 3.12). On the other hand however, no avidin could be detected in the 
haemolymph extracted from the aphids. These results suggest that recombinant 
avidin is being retained in the gut, but is not transported to the haemolymph. As 
observed previously, in contrast to the recombinant avidin added to the diet (20kDa), 
the avidin in the aphid gut shows signs of proteolytic degradation (19kDa) and 
dimerisation (36kDa) (Figure 3.12). 
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 To identify the site of avidin binding, A. pisum were fed diet containing 
fluorescently-labelled recombinant avidin (fluorescein isothiocyanate-recombinant 
avidin; FITC-recombinant avidin). Fluorescein isothiocyanate (FITC) was used as a 
control. The labelled proteins were included in artificial diet at a concentration of 
0.2mg/ml (200ppm) and fed for 48 hours. Half of the aphids were also chase-fed 
with control diet for 24 hours. Following the feeding treatments, whole aphids or 
dissected guts were observed directly under the fluorescence microscope and images 
were captured in Openlab (Chapter 2) (Figure 3.13). 
 
 After feeding, FITC was observed throughout the gut, but all of the 
fluorescence was eliminated from the aphid after 24 hours chase with label-free diet, 
 
 
Figure 3.12. 
Western analysis of A. pisum haemolymph and extracted guts after feeding on 1mg/ml 
recombinant avidin for 24 hours, 48 hours or after chasing recombinant avidin with 
control diet for 24 hours. 
A one second exposure of the membrane transferred from a 15% SDS-PAGE gel, probed 
with anti-avidin antibodies (1:10000) is shown. M is SDS 7 molecular weight marker. Lane 
1 is haemolymph from aphids fed with control diet for 24 hours. Lane 2 is haemolymph 
from aphids fed with recombinant avidin for 24 hours. Lane 3 is haemolymph from aphids 
fed with control diet for 48 hours. Lane 4 is haemolymph from aphids fed with recombinant 
avidin for 48 hours. Lane 5 is haemolymph from aphids fed with recombinant avidin for 48 
hours followed by control diet for 24 hours. Lane 6 is guts from aphids fed with control diet 
for 48 hours. Lane 7 is guts from aphids fed with recombinant avidin for 48 hours followed 
by control diet for 24 hours. The avidin in the aphid gut shows signs of proteolytic 
degradation (19kDa) and dimerisation (36kDa). (25µl loaded for each sample). Lane 8 is 
10ng of recombinant avidin (20kDa). 
 
M 1 2 3 4 5
66kDa
45kDa
36kDa
29kDa
20kDa
24kDa
14kDa
6 7 8
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showing that the label itself was not subject to non-specific binding. The FITC-
recombinant avidin was strongly bound by the anterior region (foregut) of the aphid 
gut when fed and could be detected readily in vivo even after 24 hours chase with 
diet containing no labelled components (Figure 3.13). 
 
 As shown in Figure 3.14, when guts were dissected from aphids fed FITC-
recombinant avidin, all of the fluorescence observed was present in the stomach 
region (foregut) of the aphid gut and no fluorescence was observed in the midgut 
region. The fluorescence appeared to be associated with the gut cell surface, although 
attempts to visualise this directly were unsuccessful. These results strongly suggest 
that avidin is being retained in the aphid stomach. The retention of avidin in the 
aphid was also observed when the recombinant avidin was saturated with biotin pre-
feeding, showing that the binding to the gut is not dependent on avidin’s biotin-
binding capacity. 
 
 Similar results were also observed in S. avenae, suggesting that the avidin 
binding to the stomach may be common throughout the hemipteran order. 
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Figure 3.13. 
Fluorescence micrographs of A. pisum after feeding on 0.2mg/ml FITC or FITC-
labelled recombinant avidin. 
(Left hand side) After feeding for 48 hours. (Right hand side) After chasing fluorescent 
label with control diet for 24 hours. 
 
Control (Artificial Diet)
48 HOUR FEEDING
FOLLOWING 24 HOUR  
ARTIFICIAL DIET  
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FITC fed
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 Further analysis of A. pisum gut protein extracts from a recombinant avidin 
feeding timecourse experiment with an extended chase period showed that 
recombinant avidin is retained in the gut for at least 72 hours. As with the initial 
transport experiment, 1mg/ml (1000ppm, 15µM) recombinant avidin was fed to 
aphids for 24 hours and guts were extracted following a chase with control diet for 
either 24, 48 or 72 hours. 
 
 As observed previously, in contrast to the recombinant avidin added to the 
diet (20kDa), the avidin in the aphid gut shows signs of proteolytic degradation 
(19kDa, 15kDa and 10kDa) and dimerisation (36kDa) (Figure 3.15). However, the 
avidin was still observed after 72 hours, with only a limited decrease in the amount, 
confirming the binding in the gut and supporting the likelihood of it remaining 
present post 72 hours (Figure 3.15). 
 
 
Figure 3.14. 
Micrographs showing binding of FITC-labelled recombinant avidin to aphid gut. 
(a) Fluorescence micrograph of a whole aphid after feeding on FITC-labelled recombinant 
avidin for 48 hours followed by control diet for 24 hours. (b) Micrograph of a dissected 
aphid gut. (c) Fluorescence micrograph of a dissected aphid gut after feeding on FITC-
labelled recombinant avidin for 48 hours followed by control diet for 24 hours. 
 
(a) (b)
(c)
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 To identify the type of avidin interaction within the aphid gut, a pull-down 
assay of A. pisum gut tissue was carried out. Approximately 100 adult A. pisum guts 
were dissected and homogenised in PBS containing Triton X-100. Supernatant 
containing the extracted gut proteins was incubated with recombinant avidin labelled 
magnetic beads overnight at 4°C. Following incubation, the beads were washed three 
times with PBS and analysed by silver stained SDS-PAGE (Figure 3.16). 
 
 After incubation with recombinant avidin labelled magnetic beads, it is clear 
that extracted A. pisum gut proteins do not interact with avidin in vitro. The complex 
mix of proteins in the gut tissue preparation can be seen in the unbound and wash 
 
 
Figure 3.15. 
Western analysis of A. pisum extracted guts after feeding on 1mg/ml recombinant 
avidin for 24 hours and chasing recombinant avidin with control diet for 24 hours, 48 
hours and 72 hours. 
A one second exposure of the membrane transferred from a 15% SDS-PAGE gel, probed 
with anti-avidin antibodies (1:10000) is shown. M is SDS 7 molecular weight marker. Lane 
1 is guts from aphids fed with control diet for 72 hours. Lane 2 is guts from aphids fed with 
recombinant avidin for 24 hours. Lane 3 is guts from aphids fed with recombinant avidin for 
24 hours followed by control diet for 24 hours. Lane 4 is guts from aphids fed with 
recombinant avidin for 24 hours followed by control diet for 48 hours. Lane 5 is guts from 
aphids fed with recombinant avidin for 24 hours followed by control diet for 72 hours. 
(25µl loaded for each sample). The avidin in all of the samples shows signs of proteolytic 
degradation (19kDa, 15kDa and 10kDa). There is also a higher molecular weight protein 
(36kDa), suggesting the formation of a recombinant avidin dimer. Lane 6 is 10ng of 
recombinant avidin (20kDa). 
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fractions whilst the elution fraction is identical to the starting magnetic beads (Figure 
3.16). 
 
 
 
 Far western blotting was used to confirm that avidin would not bind to gut 
proteins in vitro. Extracted gut proteins from approximately 40 A. pisum were 
transferred to nitrocellulose membrane prior to blocking of the non-specific binding 
sites with bovine serum albumin (BSA). The membrane was then incubated with 
recombinant avidin and following extensive washing, was probed with anti-avidin 
antibodies to detect any bound avidin. As a positive control, a similar blot was also 
conducted with Galanthus nivalis agglutinin (GNA), which is known to bind to 
mannose residues within the aphid gut. 
 
 The result (Figure 3.17) further supports the gut pull-down assay finding that 
extracted gut proteins do not bind to avidin in vitro. No extra bands are visible when 
 
 
Figure 3.16. 
15% SDS-PAGE analysis following an A. pisum gut tissue pull-down assay with 
recombinant avidin labelled magnetic beads. 
(silver stained). 
M is SDS 7 molecular weight marker. Lane 1 is recombinant avidin labelled magnetic 
beads. Recombinant avidin is 20kDa. There is also a higher molecular weight protein 
(36kDa), suggesting the formation of a recombinant avidin dimer during the labelling. Lane 
2 is applied extracted gut proteins. Lane 3 is the unbound fraction. Lanes 4 and 5 are the 
PBS wash fractions. Lane 6 is the elution fraction, showing both recombinant avidin 
(20kDa) and the recombinant avidin dimer (36kDa). (25µl loaded for each sample). 
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compared to the negative control. However, the GNA positive control clearly shows 
a different banding pattern, indicating the occurrence of protein interactions. 
 
 
 
2. Lepidopteran In vivo Transport of Recombinant Avidin 
 The analysis of dissected lepidopteran larvae components following feeding 
on diet containing recombinant avidin suggests that avidin is readily transported 
throughout the whole insect. Dissections were carried out on fifth stadium M. 
brassicae larvae fed on diet containing 1000ppm (5mg in 5g diet) recombinant 
avidin for 48 hours (see Figure 2.2 for photographs of the dissected components). 
 
 Avidin was readily detected in all of the components of the M. brassicae 
larvae (Figure 3.18), even after extensive washing with distilled water. As observed 
in aphids, in contrast to the recombinant avidin added to the diet (20kDa), the avidin 
in the lepidopteran components shows signs of proteolytic degradation (19kDa) and 
 
 
Figure 3.17. 
Far western analysis of A. pisum extracted guts. 
A one second exposure of the membrane transferred from a 15% SDS-PAGE gel is shown. 
M is SDS 7 molecular weight marker. (a) Control (no probe). Lane 1 is control guts. (b) 
Probed with recombinant avidin (1:2000) followed by anti-avidin antibodies (1:10000). 
Lane 2 is avidin probed guts. Lane 3 is 10ng of recombinant avidin (20kDa). (c) Probed 
with recombinant GNA (1:2000) followed by anti-GNA antibodies (1:3000). Lane 4 is 
GNA probed guts. (25µl loaded for each gut sample). Lane 5 is 50ng of recombinant GNA 
(15kDa). 
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dimerisation (36kDa). These results suggest that recombinant avidin travels 
throughout lepidopteran larvae, including parts of the insect only accessible via the 
haemolymph. 
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(a) 
 
 (b) 
 
 
Figure 3.18. 
Western analysis of dissected M. brassicae larvae after feeding on 1000ppm 
recombinant avidin for 48 hours. 
One second exposures of the membranes transferred from 15% SDS-PAGE gels, probed 
with anti-avidin antibodies (1:10000) are shown. M is SDS 7 molecular weight marker. (a) 
Lane 1 is foregut from larvae fed with control diet. Lane 2 is foregut from larvae fed with 
recombinant avidin. Lane 3 is midgut from larvae fed with control diet. Lane 4 is midgut 
from larvae fed with recombinant avidin. Lane 5 is hindgut from larvae fed with control 
diet. Lane 6 is hindgut from larvae fed with recombinant avidin. Lane 7 is nerve cord from 
larvae fed with control diet. Lane 8 is nerve cord from larvae fed with recombinant avidin. 
Lane 9 is malphigian tubules from larvae fed with control diet. Lane 10 is malphigian 
tubules from larvae fed with recombinant avidin. (25µl loaded for each sample). All 
recombinant avidin samples show a slightly degraded avidin (19kDa) and some 
recombinant avidin dimerisation (36kDa). Lane 11 is 10ng of recombinant avidin (20kDa). 
(b) Lane 1 is fat bodies from larvae fed with control diet. Lane 2 is fat bodies from larvae 
fed with recombinant avidin. Lane 3 is gut contents from larvae fed with control diet. Lane 
4 is gut contents from larvae fed with recombinant avidin. Lane 5 is faeces from larvae fed 
with recombinant avidin. (25µl loaded for each sample). All recombinant avidin samples 
show a slightly degraded avidin (19kDa) and some recombinant avidin dimerisation 
(36kDa). Lane 6 is 10ng of recombinant avidin (20kDa). 
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 A recombinant avidin feeding timecourse experiment was carried out in 
lepidopteran larvae to establish how long avidin persists in the haemolymph 
(transport previously demonstrated in Hinchliffe, 2007). As in the previous 
experiment, 1000ppm (5mg in 5g diet) recombinant avidin was fed to fifth stadium 
M. brassicae larvae for 24 hours and then the larvae were chase-fed with control diet 
containing no avidin. Haemolymph samples were extracted at regular intervals 
throughout the feeding. 
 
 Avidin, showing signs of proteolytic degradation (19kDa), was detected in 
the haemolymph by western blotting (anti-avidin antibodies) after 20 minutes (Figure 
3.19), suggesting that the transport process is relatively rapid. The levels of avidin 
remained fairly constant for the 24 hours feeding period, but once chase-fed, the 
avidin within the haemolymph was completely removed within 24 hours, suggesting 
that avidin reaches its final destination within the larvae in 24 hours. 
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Figure 3.19. 
Western analysis of M. brassicae haemolymph samples taken whilst feeding on 
1000ppm recombinant avidin for 24 hours and chasing recombinant avidin with 
control diet for 48 hours. 
A one second exposure of the membrane transferred from a 15% SDS-PAGE gel, probed 
with anti-avidin antibodies (1:10000) is shown. M is SDS 7 molecular weight marker. Lane 
1 is haemolymph from larvae fed on recombinant avidin for 20 minutes. Lane 2 is 
haemolymph from larvae fed on recombinant avidin for 1 hour. Lane 3 is haemolymph 
from larvae fed on recombinant avidin for 2 hours. Lane 4 is haemolymph from larvae fed 
on recombinant avidin for 6 hours. Lane 5 is haemolymph from larvae fed on recombinant 
avidin for 24 hours (* denotes the removal of recombinant avidin diet). Lane 6 is 
haemolymph from larvae fed on recombinant avidin for 24 hours followed by control diet 
for 6 hours (30 hours total). All of the haemolymph samples containing recombinant avidin 
show a slightly degraded avidin (19kDa). Lane 7 is haemolymph from larvae fed on 
recombinant avidin for 24 hours followed by control diet for 24 hours (48 hours total). Lane 
8 is haemolymph from larvae fed on recombinant avidin for 24 hours followed by control 
diet for 48 hours (72 hours total). (10µl loaded for each sample). Lane 9 is 10ng of 
recombinant avidin (20kDa). 
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Discussion 
 
 This chapter presents the experiments carried out with recombinant avidin 
produced in Pichia pastoris that were required to gain a greater understanding of its 
structure and functionality both in vitro and in vivo. 
 
 The indicated molecular weight of recombinant avidin on SDS-PAGE gels 
(20kDa) is significantly larger (approximately 4kDa) than that of commercially 
available egg-white avidin (16kDa), to a greater extent than would be accounted for 
by the presence of the nine amino acid N-terminal extension and the (His)6 tag 
sequence added at the C-terminus (Appendix 1). The single N-glycosylation site in 
the amino acid sequence is utilised in egg-white avidin (Green, 1990) and the results 
here confirm it is used in recombinant avidin. Deglycosylation of recombinant avidin 
gives a polypeptide whose estimated molecular weight is in good agreement with the 
predicted value from the nucleotide sequence alone (16kDa, Figure 3.1). Core 
glycosylation plus the addition of extra mannose residues (hyperglycosylation) is 
carried out by P. pastoris, normally adding approximately 2kDa or more to the 
molecular weight of a polypeptide (Cregg et al., 1993). In agreement with the present 
results, glycosylation of recombinant avidin expressed in P. pastoris has been 
reported previously (Schenk et al., 2008), however, the glycosylation in P. pastoris 
differs from that observed in egg-white avidin (Green, 1990), but the carbohydrate 
side chain does not affect the functional properties of the protein (Nardone et al., 
1998). 
 
 The gel filtration profile (Figure 3.2) shows that recombinant avidin forms 
tetrameric molecules similar to egg-white avidin, as both samples ran at an indicated 
molecular weight of approximately 60kDa compared to standard proteins. 
Recombinant avidin is very slightly larger, due to the hyperglycosylation described 
above. The listed tetrameric size of commercial avidin is 66kDa (Budavari et al., 
1996), therefore, the results here are within the experimental error of the gel filtration 
Sephacryl S-200 matrix (±10kDa) (5kDa-250kDa separation). 
 
 The interaction with immobilised biotin (Figure 3.3) shows that recombinant 
avidin is biologically fully functional in terms of biotin binding. 
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 Toxicity of avidin to insects from a wide range of orders has been 
demonstrated (Chapter 1), however, no studies have reported the effects on 
hemipteran insects. Here, recombinant avidin shows a dose-dependent toxicity to A. 
pisum (Figure 3.4). The dose response curve for recombinant avidin in these 
bioassays shows a sharp transition between no significant effect on survival and 
complete mortality, similar to the threshold effect described previously (Hinchliffe, 
2007), with an estimated LC50 value of 0.14mg/ml (140ppm, 2.1µM) (Figure 3.5). 
This value is comparable to the level of biotin in the standard artificial diet (4µM, 
0.001mg/ml; one molecule of avidin binds four molecules of biotin and thus the LC50 
is a two-fold molar excess of avidin binding sites over biotin) and suggests that these 
insects are highly biotin dependent. 
 
 In contrast, recombinant avidin has no significant effects on the survival of S. 
avenae, even when incorporated at 2mg/ml (2000ppm, 30µM) in artificial diet 
(Figure 3.6). However, the aphids show signs of retarded growth, being 40% smaller 
than the controls (Figure 3.7). Both insect cultures were maintained on plants and 
thus have a similar biotin ‘background.’ Reports of immunity to the effects of avidin 
are rare. Kramer et al. (2000) reported that of 11 coleopteran species tested, only 
one, Prostephanus truncates (larger grain borer) (Coleoptera: Bostrichidae, Horn 
1878), exhibited a tolerance for avidin, where 17% mortality was recorded at a 
dietary level of 1000ppm (1mg/ml, 15µM). Malone et al. (2002) reported that whilst 
avidin had detrimental effects on larvae of Sitona Lepidus (clover root weevil) 
(Coleoptera: Curculionidae, Gyllenhal 1834), it was ineffective against adults. 
Similarly, Markwick et al. (2001) found that avidin had a limited toxicity to larvae of 
Planotortrix octo (green-headed leaf roller) (Lepidoptera: Tortricidae, Dugdale 
1990) at concentrations up to 100µg/ml (100ppm, 0.15µM). The failure of avidin to 
show insecticidal effects on some species has been ascribed to the availability of 
biotin sequestered into eggs and/or embryos by parental generations, a view 
supported by experiments in which the LC50 of avidin towards Epiphyas postvittana 
(light brown apple moth) (Lepidoptera: Tortricidae, Walker 1863) larvae was 
decreased over 10-fold as a result of feeding for five generations on biotin-free diet 
(Markwick et al., 2001). 
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 Some evidence for the degradation of avidin by aphids in vivo has been 
presented here (Figure 3.8). Proteolytic degradation was considered to explain the 
difference in insecticidal activity between A. pisum and S. avenae, as the gut pH of S. 
avenae is lower than that of A. pisum and, results have shown that Aphis gossypii 
(cotton-melon aphid) (Hemiptera: Aphididae, Glover 1877) contain cathepsin L-like 
cysteine protease activity in their gut (Deraison et al., 2004) and a gut-expressed 
family of cathepsin B-like proteases have been identified in A. pisum (Rispe et al., 
2008). However, in this case, there was no difference in the amount of proteolytic 
degradation between A. pisum and S. avenae (Figure 3.8). Beyond the scope of the 
stability experiment, a little analysis was carried out on the recombinant avidin 
degradation products (19kDa and 15kDa). Samples of A. pisum and S. avenae protein 
extract from the stability experiment were analysed by western blotting using anti-his 
tag antibodies (1:1000). The recombinant avidin degradation products were not 
immunoreactive, suggesting that the C-terminal (His)6 tag is cleaved (blank blot not 
shown). This would most likely account for the 19kDa degradation product (Figure 
3.8), as the two added C-terminal amino acid residues and the (His)6 tag are 1kDa in 
size (Appendix 1). Experiments in this study also demonstrate that recombinant 
avidin is glycosylated by the P. pastoris yeast expression host (see page 54). The 
observed size difference of recombinant avidin compared to deglycosylated 
recombinant avidin is approximately 4kDa (Figure 3.1). A speculation can therefore 
be made that it is likely that the 15kDa degradation product (a difference of 4kDa) is 
due to deglycosylation of the recombinant avidin. However, further experimentation 
would be required to confirm these. 
 
 The absence of toxicity of avidin towards S. avenae cannot be due to a lack of 
dependence on exogenous biotin because these aphids do not survive on diets 
containing no biotin or low levels of biotin (Figure 3.9), although they appear to be 
slightly less sensitive than A. pisum to sub-optimal biotin concentrations, as 100% 
mortality was recorded in A. pisum at all but the standard artificial diet concentration 
of 4µM and there was 45% survival of S. avenae fed artificial diet containing 3µM 
biotin. This 4µM biotin threshold is no surprise as the artificial diet has been 
developed to specifically contain all of the nutrients required to support the aphid 
through its lifecycle. 
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 The symbiotic Buchnera bacteria in aphids have varying complements of the 
genes involved in the biotin biosynthesis pathway, depending on the aphid host 
species (BuchneraBase, http://www.buchnera.org). However, B. aphidicola APS in 
A. pisum has lost the capacity to synthesise biotin, having only three (bioA, bioD and 
bioB) of the five genes involved in biotin biosynthesis (bioW, bioF, bioA, bioD and 
bioB) (Figure 3.20). The requirement of A. pisum for dietary biotin is thus not 
surprising. Based on the bioassays carried out, the Buchnera symbiont in S. avenae 
(genome not available) cannot complement a biotin deficiency either. Amplification 
of the biotin synthesis operon from S. avenae provided confirmation that the 
Buchnera symbiont in this aphid species similarly lacks the full complement of genes 
necessary for ‘de novo’ synthesis of biotin (Figure 3.11). 
 
 
 
 The most surprising and significant result of the set of recombinant avidin 
toxicity experiments is the ability of S. avenae, but not A. pisum, to survive on 
biotin-free diets supplemented with recombinant avidin (Figure 3.10). The only 
plausible explanation for this is that biotin bound to the recombinant avidin can be 
recovered from the protein in a scavenging system. Recombinant avidin contains 
 
 
Figure 3.20. 
Schematic representation of the biotin synthesis pathway. 
(Adapted from KEGG database, http://www.genome.jp/kegg/kegg2.html). 
The biotin synthesis genes present in B. aphidicola APS are highlighted in red. 
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biotin, as the culture medium in which the P. pastoris yeast is grown is supplemented 
with this vitamin (see Chapter 2, PTM1 trace salts). However, the biotin-binding 
sites on recombinant avidin cannot be saturated because the protein binds to 
immobilised biotin (Figure 3.3), but since tetrameric molecules are formed (Figure 
3.2, discussed on page 85), if a small proportion of the binding sites contain biotin, 
the protein will show both functional activity and contain biotin. This is further 
supported by the aphid in vivo transport of recombinant avidin where, in both species 
of aphid (S. avenae and A. pisum), the protein is retained in the foregut (Figures 3.13, 
3.14 and 3.15) and is detected in the insect even after a chase with non avidin-
containing diet (Figure 3.15), showing that rapid elimination of avidin, which might 
prevent sequestration of ingested biotin, does not occur. So, in the present case, the 
data suggest that a combination of lower sensitivity to sub-optimal levels of biotin 
and a more effective system for scavenging biotin from recombinant avidin in the 
diet makes S. avenae relatively insensitive to the insecticidal effects of this protein 
when compared to A. pisum. 
 
 The attempts made here to isolate exactly what recombinant avidin is binding 
to in the gut were unsuccessful (Figures 3.17 and 3.18). This is perhaps no surprise 
as in vitro conditions will never fully represent the in vivo environment. It does 
however show that the avidin interaction is highly specific. The binding could be as a 
result of a direct interaction with the avidin or as an indirect interaction with biotin 
associated with the avidin. The saturation of recombinant avidin with biotin does not 
alleviate the binding in the gut, showing that the interaction is independent of 
avidin’s biotin-binding capacity but this still does not exclude the possibility the 
binding is mediated through the associated biotin. One suggestion here may be that 
the avidin retention may arise as a result of binding to a complex of proteins be that 
directly, or indirectly via biotin. Any complex of proteins will have been separated 
during the gut protein extraction process and thus the specific binding site formed by 
the complex would be destroyed leading to the negative result seen in these 
experiments. One such protein complex would be the biotin transport system that is 
present in humans (Said, 2009). It is likely that aphids also have a biotin transport 
mechanism be it similar to that of humans or otherwise, but further investigation 
would be required to establish this. 
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 The in vivo transport of recombinant avidin in lepidopteran larvae is a 
completely different scenario however. The protein is readily transported into the 
haemolymph and distributed around the insect following ingestion (Figures 3.19 and 
3.20). The process of peptides crossing the lepidopteran gut epithelium is a common 
occurrence (Casartelli et al., 2005; Fiandra et al., 2009), although there is little data 
available as to the mechanism that the peptides use. However, in the present case, 
there appears to be different mechanisms for dealing with ingested avidin in 
hemiptera and lepidoptera. 
 
 In conclusion, the recombinant avidin produced in P. pastoris shows similar 
characteristics to the Sigma commercial alternative. The knowledge of the difference 
in avidin transport between hemiptera and lepidoptera will prove helpful and 
significant for the designing of insecticidal recombinant avidin fusion proteins and 
recombinant avidin conjugates (Chapters 4 and 5). 
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Chapter 4 
 
Expression of Recombinant Avidin Fusion Proteins 
 
Introduction 
 
 Results previously obtained as part of research towards an MSc thesis have 
shown that like snowdrop lectin (Galanthus nivalis agglutinin; GNA), avidin is 
transported from the gut contents to the haemolymph of lepidopteran larvae 
following oral delivery (Hinchliffe, 2007). Avidin therefore has the potential to act as 
a protein ‘carrier’ for the production of insecticidal fusion proteins, transporting 
fused toxins to their sites of action, thus playing a role similar to that of GNA in 
fusion proteins described previously (Fitches et al., 2002, 2004; Pham-Trung et al., 
2006). 
 
 The production of synthetic avidin fusion proteins in Escherichia coli using 
glutathione S-transferase (GST) and hevein has been documented previously 
(Airenne and Kulomaa, 1995; Airenne et al., 1999). However, there have not yet 
been any reports of synthetic avidin fusion proteins produced in Pichia pastoris. As 
functional avidin expresses with high yields in P. pastoris and purifies well 
(Hinchliffe, 2007), it is expected that an avidin fusion protein may behave similarly. 
The GNA fusion proteins expressed in P. pastoris (Fitches et al., 2002, 2004; Pham-
Trung et al., 2006) provide an ideal starting point for the production of avidin fusion 
proteins: directly replacing the GNA with avidin. 
 
 The experiments in this chapter describe attempts to produce a fully 
functional, insecticidal avidin fusion protein in P. pastoris. Beginning with a fusion 
between avidin and the insecticidal ButaIT toxin from Mesobuthus tamulus (Indian 
red scorpion) (Scorpiones: Buthidae, Fabricius 1798), N-terminal and C-terminal 
variants will be produced. Peptide linker regions incorporating different restriction 
enzyme sites, an IgG Hinge successfully demonstrated by Airenne and Kulomaa 
(1995), and a fragment of GNA will also be investigated. Fusion proteins produced 
with the insecticidal Omega Atracotoxin (!ACTXHv1a) from Hadronyche versuta 
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(Australian Funnel Web Spider) (Araneae: Hexathelidae, Rainbow 1914) and the 
non-toxin alternative of enhanced Green Fluorescent Protein (eGFP) will also be 
analysed. Finally, following computational and sequence analysis, structural 
mutations will be used to gain a greater understanding of the fusion proteins and 
synthetic fusion protein technology as a whole. 
 
 Using the evidence that avidin transports to the haemolymph of Mamestra 
brassicae (cabbage moth) (Lepidoptera: Noctuidae, Linnaeus 1758) larvae from 
Hinchliffe (2007), the initial focus of the fusion protein testing will be on 
lepidopteran larvae (a major worldwide pest). 
 
 A successfully active fusion protein would have the potential to be developed 
as a commercial biopesticide pellet or spray, or eventually produced in a transgenic 
plant. 
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Results 
 
 Due to the number of fusion proteins produced and the large amount of data 
generated, Table 4.1 sumarises the main results of this chapter. 
 
Fusion Protein Linker Details 
ButaIT-Avidin 1 VDA (SalI) 
No activity upon injection. 
Degraded in gut following oral delivery. 
   
ButaIT-Avidin 2 AAAA (NotI) 
No activity upon injection. 
Degraded in gut following oral delivery. 
   
Avidin-ButaIT 3 AAA (NotI) 
No activity upon injection. 
Degraded in gut following oral delivery. 
 
ButaIT-IgG Hinge-Avidin IgG Hinge 
No activity upon injection. 
Stable in haemolymph following injection. 
   
Avidin-IgG Hinge-ButaIT IgG Hinge 
No activity upon injection. 
Stable in haemolymph following injection. 
 
!ACTXHv1a-Avidin AAAA (NotI) No activity upon injection. 
 
eGFP-Avidin AAAA (NotI) 
Degraded during purification. 
Appeared not active. 
 
ButaIT-Gavidin GNA Fragment 
Appeared active upon injection and oral 
delivery. 
Degraded in vivo following oral delivery. 
(No activity upon injection following 
reassessment) 
   
ButaIT-Gavidin 1 Mutation GNA Fragment 
Appeared less active upon injection. 
No activity following oral delivery. 
Degraded in vivo following oral delivery. 
   
ButaIT-Gavidin 3 Mutations GNA Fragment No activity upon injection and oral delivery. 
   
ButaIT-GNA Fragment AAA (NotI) 
Active upon injection. 
No activity following oral delivery. 
   
GNA Fragment-Avidin VDA (SalI) 
Active upon injection. 
No activity following oral delivery. 
   
 
Table 4.1. 
Summary of the fusion proteins produced. 
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Avidin-ButaIT Fusion Proteins 
 
 To assess the suitability of avidin for use as a ‘carrier’ in synthetic fusion 
protein technology, recombinant fusion proteins containing the insecticidal ButaIT 
toxin from Mesobuthus tamulus (Indian red scorpion) (Scorpiones: Buthidae, 
Fabricius 1798) (Chapter 1) and avidin were produced. 
 
1. Production of the Avidin-ButaIT Fusion Protein Expression Constructs 
 Expression constructs for three ButaIT fusion proteins (designated ButaIT-
Avidin 1, ButaIT-Avidin 2 and Avidin-ButaIT 3) were designed and produced by the 
cloning strategy described in Chapter 2. The ButaIT-Avidin 1 construct contained 
ButaIT toxin fused N-terminally to avidin using a SalI restriction site linker (amino 
acid sequence: VDA). The expression construct also had a C-terminal extension 
encoding a (His)6 tag. The ButaIT-Avidin 2 construct contained ButaIT toxin fused 
N-terminally to avidin using a NotI restriction site linker (amino acid sequence: 
AAAA). The Avidin-ButaIT 3 construct contained ButaIT toxin fused C-terminally 
to avidin using a NotI restriction site linker (amino acid sequence: AAA). The 
expression construct also had a C-terminal extension encoding a (His)6 tag. The 
complete expression constructs of the three fusion proteins were cloned in-frame 
with the yeast N-terminal !-mating factor pre-pro secretory signal within the 
pGAPZ!B expression vector. The nucleotide sequences, deduced amino acid 
sequences and schematic diagrams of the expression constructs are shown in Figures 
4.1, 4.2 and 4.3. 
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ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACA    +75 
 M  R  F  P  S  I  F  T  A  V  L  F  A  A  S  S  A  L  A  A  P  V  N  T  T      25 
 
ACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTT    +150 
 T  E  D  E  T  A  Q  I  P  A  E  A  V  I  G  Y  S  D  L  E  G  D  F  D  V      50 
 
GCTGTTTTGCCATTTTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCT    +225 
 A  V  L  P  F  S  N  S  T  N  N  G  L  L  F  I  N  T  T  I  A  S  I  A  A      75 
 
AAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGCAAGGTGTGGTCCTTGCTTTACAACTGAT    +300 
 K  E  E  G  V  S  L  E  K  R  E  A  E  A  A  A  R  C  G  P  C  F  T  T  D      100 
 
CCTCAAACACAAGCCAAGTGTAGTGAGTGTTGTGGGCGAAAGGGTGGAGTATGCAAGGGCCCACAATGTATCTGT    +375 
 P  Q  T  Q  A  K  C  S  E  C  C  G  R  K  G  G  V  C  K  G  P  Q  C  I  C      125 
 
GGTATACAAGTCGACGCTAGAAAATGCTCGCTGACTGGGAAATGGACCAACGATCTGGGCTCCAACATGACCATC    +450 
 G  I  Q  V  D  A  R  K  C  S  L  T  G  K  W  T  N  D  L  G  S  N  M  T  I      150 
 
GGGGCTGTGAACAGCAAAGGTGAATTCACAGGCACCTACACCACAGCCGTAACAGCCACATCAAATGAGATCAAA    +525 
 G  A  V  N  S  K  G  E  F  T  G  T  Y  T  T  A  V  T  A  T  S  N  E  I  K      175 
 
GAGTCACCACTGCATGGGACACAAAACACCATCAACAAGAGGACCCAGCCCACCTTTGGCTTCACCGTCAATTGG    +600 
 E  S  P  L  H  G  T  Q  N  T  I  N  K  R  T  Q  P  T  F  G  F  T  V  N  W      200 
 
AAGTTTTCAGAAAGTACTACTGTCTTCACGGGCCAGTGCTTCATAGACAGGAACGGGAAGGAGGTCCTGAAGACC    +675 
 K  F  S  E  S  T  T  V  F  T  G  Q  C  F  I  D  R  N  G  K  E  V  L  K  T      225 
 
ATGTGGCTGCTGCGGTCAAGTGTTAATGACATTGGTGATGACTGGAAAGCTACGCGTGTTGGTATCAACATCTTC    +750 
 M  W  L  L  R  S  S  V  N  D  I  G  D  D  W  K  A  T  R  V  G  I  N  I  F      250 
 
ACTAGATTGAGAACTCAAAAGGAAATCGACCATCATCATCATCATCATTGA                            +801 
 T  R  L  R  T  Q  K  E  I  D  H  H  H  H  H  H  .                              266 
 
 
 
 
 
 
 
 
ButaIT (111bp) (His)6 
SalI
Avidin (381bp)
PstI
Figure 4.1. 
Nucleotide sequence, deduced amino acid sequence and schematic representation 
of the ButaIT-Avidin 1 fusion protein - ‘ButaIT (VDA) Avidin (His)6.’ 
The yeast alpha factor sequence of pGAPZ!B is highlighted in grey. The ButaIT toxin 
sequence is highlighted in red. The avidin sequence is highlighted in yellow. The (His)6 
tag is underlined in black. Diagram not to scale. 
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ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACA    +75 
 M  R  F  P  S  I  F  T  A  V  L  F  A  A  S  S  A  L  A  A  P  V  N  T  T      25 
 
ACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTT    +150 
 T  E  D  E  T  A  Q  I  P  A  E  A  V  I  G  Y  S  D  L  E  G  D  F  D  V      50 
 
GCTGTTTTGCCATTTTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCT    +225 
 A  V  L  P  F  S  N  S  T  N  N  G  L  L  F  I  N  T  T  I  A  S  I  A  A      75 
 
AAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGCAAGGTGTGGTCCTTGCTTTACAACTGAT    +300 
 K  E  E  G  V  S  L  E  K  R  E  A  E  A  A  A  R  C  G  P  C  F  T  T  D      100 
 
CCTCAAACACAAGCCAAGTGTAGTGAGTGTTGTGGGCGAAAGGGTGGAGTATGCAAGGGCCCACAATGTATCTGT    +375 
 P  Q  T  Q  A  K  C  S  E  C  C  G  R  K  G  G  V  C  K  G  P  Q  C  I  C      125 
 
GGTATACAAGCGGCCGCCGCTAGAAAATGCTCGCTGACTGGGAAATGGACCAACGATCTGGGCTCCAACATGACC    +450 
 G  I  Q  A  A  A  A  R  K  C  S  L  T  G  K  W  T  N  D  L  G  S  N  M  T      150 
 
ATCGGGGCTGTGAACAGCAAAGGTGAATTCACAGGCACCTACACCACAGCCGTAACAGCCACATCAAATGAGATC    +525 
 I  G  A  V  N  S  K  G  E  F  T  G  T  Y  T  T  A  V  T  A  T  S  N  E  I      175 
 
AAAGAGTCACCACTGCATGGGACACAAAACACCATCAACAAGAGGACCCAGCCCACCTTTGGCTTCACCGTCAAT    +600 
 K  E  S  P  L  H  G  T  Q  N  T  I  N  K  R  T  Q  P  T  F  G  F  T  V  N      200 
 
TGGAAGTTTTCAGAAAGTACTACTGTCTTCACGGGCCAGTGCTTCATAGACAGGAACGGGAAGGAGGTCCTGAAG    +675 
 W  K  F  S  E  S  T  T  V  F  T  G  Q  C  F  I  D  R  N  G  K  E  V  L  K      225 
 
ACCATGTGGCTGCTGCGGTCAAGTGTTAATGACATTGGTGATGACTGGAAAGCTACGCGTGTTGGTATCAACATC    +750 
 T  M  W  L  L  R  S  S  V  N  D  I  G  D  D  W  K  A  T  R  V  G  I  N  I      250 
 
TTCACTAGATTGAGAACTCAAAAGGAATGA                                                 +780 
 F  T  R  L  R  T  Q  K  E  .                                                   259 
 
 
 
 
 
 
 
 
ButaIT (111bp) Avidin (381bp)
PstI NotI
Figure 4.2. 
Nucleotide sequence, deduced amino acid sequence and schematic representation 
of the ButaIT-Avidin 2 fusion protein - ‘ButaIT (AAAA) Avidin.’ 
The yeast alpha factor sequence of pGAPZ!B is highlighted in grey. The ButaIT toxin 
sequence is highlighted in red. The avidin sequence is highlighted in yellow. Diagram 
not to scale. 
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ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACA    +75 
 M  R  F  P  S  I  F  T  A  V  L  F  A  A  S  S  A  L  A  A  P  V  N  T  T      25 
 
ACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTT    +150 
 T  E  D  E  T  A  Q  I  P  A  E  A  V  I  G  Y  S  D  L  E  G  D  F  D  V      50 
 
GCTGTTTTGCCATTTTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCT    +225 
 A  V  L  P  F  S  N  S  T  N  N  G  L  L  F  I  N  T  T  I  A  S  I  A  A      75 
 
AAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGCTAGAAAATGCTCGCTGACTGGGAAATGG    +300 
 K  E  E  G  V  S  L  E  K  R  E  A  E  A  A  A  R  K  C  S  L  T  G  K  W      100 
 
ACCAACGATCTGGGCTCCAACATGACCATCGGGGCTGTGAACAGCAAAGGTGAATTCACAGGCACCTACACCACA    +375 
 T  N  D  L  G  S  N  M  T  I  G  A  V  N  S  K  G  E  F  T  G  T  Y  T  T      125 
 
GCCGTAACAGCCACATCAAATGAGATCAAAGAGTCACCACTGCATGGGACACAAAACACCATCAACAAGAGGACC    +450 
 A  V  T  A  T  S  N  E  I  K  E  S  P  L  H  G  T  Q  N  T  I  N  K  R  T      150 
 
CAGCCCACCTTTGGCTTCACCGTCAATTGGAAGTTTTCAGAAAGTACTACTGTCTTCACGGGCCAGTGCTTCATA    +525 
 Q  P  T  F  G  F  T  V  N  W  K  F  S  E  S  T  T  V  F  T  G  Q  C  F  I      175 
 
GACAGGAACGGGAAGGAGGTCCTGAAGACCATGTGGCTGCTGCGGTCAAGTGTTAATGACATTGGTGATGACTGG    +600 
 D  R  N  G  K  E  V  L  K  T  M  W  L  L  R  S  S  V  N  D  I  G  D  D  W      200 
 
AAAGCTACGCGTGTTGGTATCAACATCTTCACTAGATTGAGAACTCAAAAGGAAGCGGCCGCAAGGTGTGGTCCT    +675 
 K  A  T  R  V  G  I  N  I  F  T  R  L  R  T  Q  K  E  A  A  A  R  C  G  P      225 
 
TGCTTTACAACTGATCCTCAAACACAAGCCAAGTGTAGTGAGTGTTGTGGGCGAAAGGGTGGAGTATGCAAGGGC    +750 
 C  F  T  T  D  P  Q  T  Q  A  K  C  S  E  C  C  G  R  K  G  G  V  C  K  G      250 
 
CCACAATGTATCTGTGGTATACAAGTCGACCATCATCATCATCATCATTGA                            +801 
 P  Q  C  I  C  G  I  Q  V  D  H  H  H  H  H  H  .                              266 
 
 
 
 
 
 
 
 
Avidin (381bp)
PstI NotI
ButaIT (111bp)
SalI
(His)6 
Figure 4.3. 
Nucleotide sequence, deduced amino acid sequence and schematic representation 
of the Avidin-ButaIT 3 fusion protein - ‘Avidin (AAA) ButaIT (His)6.’ 
The yeast alpha factor sequence of pGAPZ!B is highlighted in grey. The avidin 
sequence is highlighted in yellow. The ButaIT toxin sequence is highlighted in red. The 
(His)6 tag is underlined in black. Diagram not to scale. 
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2. Recombinant Expression of the Avidin-ButaIT Fusion Proteins 
 The fusion protein expression construct vectors were transformed into 
protease-deficient Pichia pastoris. Clones expressing the fusion proteins were 
identified by western blotting analysis (anti-avidin antibodies) of culture supernatant 
from 10ml cultures. High expressers were cultured separately in bench-top 
fermenters. 
 
 Recombinant ButaIT-Avidin 1 and Avidin-ButaIT 3 were both purified from 
culture supernatant by nickel affinity chromatography utilising the added (His)6 tag. 
Recombinant ButaIT-Avidin 2 was purified from culture supernatant by SP-
Sepharose ion exchange chromatography as no (His)6 tag was present. Typical 
elution profiles of purifications by nickel affinity and SP-Sepharose column 
chromatography are shown in Figures 4.4 and 4.5. 
 
 From the amino acid sequences, the predicted sizes of ButaIT-Avidin 1, 
ButaIT-Avidin 2 and Avidin-ButaIT 3 are 19.4kDa, 18.4kDa and 19.4kDa 
respectively. The presence of ButaIT-Avidin 1, ButaIT-Avidin 2 and Avidin-ButaIT 
3 was confirmed by western blotting (anti-avidin antibodies) of culture supernatant 
from the fermentation, and column eluates were also analysed by sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) (Figure 4.6). 
 
 Recombinant ButaIT-Avidin 1, ButaIT-Avidin 2 and Avidin-ButaIT 3 were 
present and reacted with anti-avidin antibodies, but ran at an indicated molecular 
weight slightly larger than that predicted from the nucleotide sequences (23kDa, 
22kDa and 23kDa respectively) (Figure 4.6(a)(ii), (b)(ii) and (c)(ii)). This was most 
likely due to glycosylation by the P. pastoris host (see Chapter 3). The SDS-PAGE 
analysis showed that there was a small amount of proteolytic degradation of all three 
of the purified fusion proteins (21kDa, 20kDa and 19kDa), with Avidin-ButaIT 3 
showing the most evidence of proteolysis (Figure 4.6(a)(i), (b)(i) and (c)(i)). 
However, the column eluates contained a majority of the intact fusion protein. 
 
 Once analysed, column eluates were dialysed to remove salts and lyophilised 
by freeze-drying. Lyophilised proteins were quantified by SDS-PAGE. A typical 
quantification gel is shown in Figure 4.7. Yields of approximately 10mg of fusion 
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protein per litre of culture supernatant were obtained for all three recombinant fusion 
proteins. 
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Figure 4.4. 
Nickel column purification. 
(a) Typical purification profile. One elution 
peak (E) was collected (10ml-15ml). 
(b) Typical 15% SDS-PAGE analysis of a 
nickel column purification. M is SDS7 
molecular weight marker. Lane 1 is nickel 
column load (L). Lane 2 is nickel column 
wash (W). Lane 3 is nickel column elution 
(E). (25µl loaded for each sample). Lane 4 is 
5µg of recombinant avidin (20kDa). 
(In this case, the fusion protein was Avidin-
ButaIT 3). 
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Figure 4.5. 
SP-Sepharose column purification. 
(a) Typical purification profile. As 
indicated by the red NaCl 
concentration line, the NaCl gradient 
was held at 0.35M to allow elution of 
protein through the complete column 
volume. Typically, the 0.35M NaCl 
elution peak contained the majority 
of the larger molecular weight 
proteins associated with P. pastoris 
yeast. Fusion proteins were present 
in the 1M NaCl elution peak. 
(b) Typical 15% SDS-PAGE 
analysis of an SP-Sepharose column 
purification. M is SDS7 molecular 
weight marker. Lane 1 is 0.35M 
NaCl elution peak. Lane 2 is 1M 
NaCl elution peak. (25µl loaded for 
each sample). Lane 3 is 5µg of 
recombinant avidin (20kDa). 
(In this case, the fusion protein was 
ButaIT-Avidin 2). 
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(a) ButaIT-Avidin 1                                                          (b) ButaIT-Avidin 2 
 
          
 
 (c) Avidin-ButaIT 3 
 
 
Figure 4.6. 
SDS-PAGE and western analysis of the recombinant Avidin-ButaIT fusion proteins 
produced in P. pastoris. 
M is SDS7 molecular weight marker. (a) ButaIT-Avidin 1: (i) 15% SDS-PAGE analysis. 
Lane 1 is 15µl of nickel column elution, showing ButaIT-Avidin 1 (23kDa) with slight 
proteolytic degradation (21kDa). Lane 2 is 2µg of recombinant avidin (20kDa). (ii) 
Western analysis (anti-avidin antibodies [1:10000], one second exposure). Lane 1 is 1µl 
of fermenter supernatant, showing unpurified ButaIT-Avidin 1 (23kDa) with high 
molecular weight yeast proteins. Lane 2 is 20ng of recombinant avidin (20kDa). (b) 
ButaIT-Avidin 2: (i) 15% SDS-PAGE analysis. Lane 1 is 25µl of SP-Sepharose column 
elution, showing ButaIT-Avidin 2 (22kDa) with slight proteolytic degradation (20kDa 
and 19kDa). Lane 2 is 5µg of recombinant avidin (20kDa). (ii) Western analysis (anti-
avidin antibodies [1:10000], one second exposure). Lane 1 is 1µl of fermenter 
supernatant, showing unpurified ButaIT-Avidin 2 (22kDa) with high molecular weight 
yeast proteins and proteolytic degradation products (20kDa and 19kDa). Lane 2 is 20ng 
of recombinant avidin (20kDa). (c) Avidin-ButaIT 3: (i) 15% SDS-PAGE analysis. Lane 
1 is 20µl of nickel column elution, showing Avidin-ButaIT 3(23kDa) with proteolytic 
degradation (19kDa). Lane 2 is 5µg of recombinant avidin (20kDa). (ii) Western 
analysis (anti-avidin antibodies [1:10000], one second exposure). Lane 1 is 1µl of 
fermenter supernatant, showing unpurified Avidin-ButaIT 3 (23kDa) with high 
molecular weight yeast proteins. Lane 2 is 20ng of recombinant avidin (20kDa). 
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3. Insecticidal Activity of the Recombinant Avidin-ButaIT Fusion Proteins 
 The recombinant Avidin-ButaIT fusion proteins were tested for insecticidal 
activity by injection into newly moulted fifth stadium Mamestra brassicae (cabbage 
moth) (Lepidoptera: Noctuidae, Linnaeus 1758) larvae. Initially, to establish the 
amounts of fusion protein to include and for a comparison of activity, 10µg-150µg 
amounts of recombinant ButaIT toxin and recombinant ButaIT-GNA were injected. 
Recombinant ButaIT toxin had been prepared in P. pastoris by Dr Nanasaheb 
Chougule. Dr Elaine Fitches supplied both recombinant ButaIT and recombinant 
ButaIT-GNA proteins. 
 
 When injected into fifth stadium M. brassicae larvae, the recombinant ButaIT 
toxin showed a dose-dependent insecticidal activity over 24 hours, with complete 
mortality observed at a dose of 150µg, 50% mortality at a dose of 100µg and no 
 
 
Figure 4.7. 
15% SDS-PAGE Quantification Gel. 
M is SDS7 molecular weight marker. Lanes 1-5 are 0.5µg, 1µg, 2.5µg, 5µg, and 10µg of 
sample protein respectively (in this case, ButaIT-Avidin 1). Lanes 6-8 are 1µg, 2.5µg and 
5µg of protein standard respectively (in this case, recombinant avidin). Protein samples are 
quantified based on the content of the required protein, excluding any degradation products. 
In this case, the sample protein was deemed to contain 40% fusion protein. 
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mortality at a dose of 50µg (Figure 4.8). Recombinant ButaIT-GNA also had a dose-
dependent insecticidal activity, with 100% mortality observed at a dose of 50µg, 
80% mortality at a dose of 25µg, 20% mortality at a dose of 20µg and no mortality at 
a dose of 10µg (Figure 4.8). 
 
 Based on these results, each 5µl injection contained a total of either 50µg or 
100µg of recombinant Avidin-ButaIT fusion protein (quantified by SDS-PAGE) re-
suspended in PBS. At those amounts, if the fusion protein activity was comparable to 
ButaIT-GNA, or if the toxin component of the fusion protein was active, mortality 
should be observed. Injections of PBS were also carried out as a negative control. 
 
 None of the recombinant Avidin-ButaIT fusion proteins were found to have 
any insecticidal activity in M. brassicae larvae (Figure 4.8). Injected larvae were 
completely unaffected by the fusion proteins, with 100% survival and no obvious 
visual or developmental effects being observed. Similar survival was observed in the 
PBS negative control injections (Figure 4.8). Even when the recombinant Avidin-
ButaIT fusion proteins were injected at a dose of 100µg, no mortality was observed, 
suggesting that the ButaIT toxin component of the fusion protein is not active, most 
likely due to incorrect folding. 
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4. Analysis of the Recombinant Avidin-ButaIT Fusion Proteins 
 To investigate the in vivo transport of the recombinant Avidin-ButaIT fusion 
proteins, starved fifth stadium M. brassicae larvae were fed 5µl droplets containing 
50µg of the fusion protein. Control larvae were fed droplets of phosphate buffered 
saline (PBS). Guts and haemolymph were extracted from five similarly fed larvae 
after three and 24 hours, pooled together and analysed by western blotting (anti-
avidin antibodies) (Figure 4.9). 
 
 The results show that the fusion proteins were degraded in the gut of M. 
brassicae larvae. There was therefore no in vivo transport of the intact fusion 
proteins however, the remaining avidin (19kDa) was transported and readily detected 
in the haemolymph. The blots also show some recombinant avidin dimerisation 
(36kDa) (Figure 4.9). 
 
  
 
Figure 4.8. 
Mortality of M. brassicae (cabbage moth) larvae following injection with varying amounts 
of recombinant ButaIT, ButaIT-GNA or the Avidin-ButaIT fusion proteins. 
(n = 20 for each treatment - Two separate treatments with 10 individuals). 
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 The activity of avidin within the recombinant ButaIT fusion proteins was 
confirmed in vitro by incubation with a molar excess of immobilised biotin (agarose-
biotin). The immobilised biotin matrix was mixed with 2.5µg of recombinant 
Avidin-ButaIT 3 for 30 minutes at room temperature. Following microcentrifugation, 
the pellet was washed twice with PBS. Finally, any bound recombinant avidin was 
eluted from the matrix by boiling. Analysis by SDS-PAGE (Figure 4.10) showed the 
absence of the fusion protein in the unbound fraction, an absence of protein in the 
wash fractions and 100% fusion protein eluted upon boiling. This shows that the 
avidin within the fusion protein was bound to the biotin matrix and suggests that it 
was fully functional. 
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(a) Guts 
 
 
 
(b) Haemolymph 
 
 
 
Figure 4.9. 
Western analysis of M. brassicae larvae extracted guts and haemolymph, three hours 
and 24 hours after feeding on a 50µg recombinant Avidin-ButaIT fusion protein 
droplet. 
Five second exposures of the membranes transferred from 15% SDS-PAGE gels, probed 
with anti-avidin antibodies (1:10000) are shown. M is SDS 7 molecular weight marker. (a) 
Guts. Lane 1 is guts from larvae fed with PBS (control). Lanes 2-4 are guts from larvae fed 
with ButaIT-Avidin 1, ButaIT-Avidin 2 and Avidin-ButaIT 3 for three hours respectively. 
All three samples contain avidin showing signs of proteolytic degradation (19kDa) and 
some recombinant avidin dimerisation (36kDa). Lanes 5-7 are guts from larvae fed with 
ButaIT-Avidin 1, ButaIT-Avidin 2 and Avidin-ButaIT 3 for 24 hours respectively. The 
amount of degraded avidin (19kDa) has decreased. (20µl loaded for each sample). Lane 8 
is 10ng of Avidin-ButaIT 3 (23kDa), showing signs of proteolytic degradation (19kDa). 
Lane 9 is 10ng of recombinant avidin (20kDa). (b) Haemolymph. Lanes 1-9 are the 
equivalent haemolymph loadings. The avidin antibody shows some reactivity with other 
haemolymph proteins (Lane 1). 
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Figure 4.10. 
15% SDS-PAGE analysis following in vitro binding of recombinant Avidin-ButaIT 3 to 
immobilised biotin (agarose-biotin). 
M is SDS 7 molecular weight marker. Lane 1 is the unbound fraction. Lanes 2 and 3 are the 
PBS wash fractions. Lane 4 is the elution fraction, showing recombinant Avidin-ButaIT 3 
(23kDa) with slight proteolytic degradation (19kDa). (25µl loaded for each sample). Lane 5 
is 5µg of Avidin-ButaIT 3 (23kDa), showing signs of proteolytic degradation (19kDa). 
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IgG Hinge Avidin-ButaIT Fusion Proteins 
 
 To address the suggestion that the ButaIT toxin may have folded incorrectly, 
a linker region was incorporated into the fusion proteins to allow more space 
between the components. 
 
1. Production of the IgG Hinge Avidin-ButaIT Fusion Protein Expression Constructs 
 Expression constructs for two further fusion proteins containing an 
Immunoglobulin G (IgG) hinge linker region were developed from the existing 
ButaIT-Avidin 2 and Avidin-ButaIT 3 fusion proteins (designated ButaIT-IgG 
Hinge-Avidin and Avidin-IgG Hinge-ButaIT) using the cloning strategy described in 
Chapter 2. The IgG hinge region (amino acid sequence: PKPSTPPGSS, optimised 
with yeast codons) was included to increase the spatial distribution between the 
ButaIT toxin and the avidin, hopefully giving less hindrance and thus allowing the 
ButaIT toxin to fold correctly. The successful use of the IgG hinge as a spacer in 
peptide fusions was previously demonstrated by Airenne and Kulomaa (1995). The 
complete expression constructs of the two fusion proteins were cloned in-frame with 
the yeast N-terminal !-mating factor pre-pro secretory signal within the pGAPZ!B 
expression vector. The nucleotide sequences, deduced amino acid sequences and 
schematic diagrams of the expression constructs are shown in Figures 4.11 and 4.12. 
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ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACA    +75 
 M  R  F  P  S  I  F  T  A  V  L  F  A  A  S  S  A  L  A  A  P  V  N  T  T      25 
 
ACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTT    +150 
 T  E  D  E  T  A  Q  I  P  A  E  A  V  I  G  Y  S  D  L  E  G  D  F  D  V      50 
 
GCTGTTTTGCCATTTTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCT    +225 
 A  V  L  P  F  S  N  S  T  N  N  G  L  L  F  I  N  T  T  I  A  S  I  A  A      75 
 
AAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGCAAGGTGTGGTCCTTGCTTTACAACTGAT    +300 
 K  E  E  G  V  S  L  E  K  R  E  A  E  A  A  A  R  C  G  P  C  F  T  T  D      100 
 
CCTCAAACACAAGCCAAGTGTAGTGAGTGTTGTGGGCGAAAGGGTGGAGTATGCAAGGGCCCACAATGTATCTGT    +375 
 P  Q  T  Q  A  K  C  S  E  C  C  G  R  K  G  G  V  C  K  G  P  Q  C  I  C      125 
 
GGTATACAAGCGGCCGCACCAAAGCCAAGTACTCCACCAGGTAGTAGTGCGGCCGCCGCTAGAAAATGCTCGCTG    +450 
 G  I  Q  A  A  A  P  K  P  S  T  P  P  G  S  S  A  A  A  A  R  K  C  S  L      150 
 
ACTGGGAAATGGACCAACGATCTGGGCTCCAACATGACCATCGGGGCTGTGAACAGCAAAGGTGAATTCACAGGC    +525 
 T  G  K  W  T  N  D  L  G  S  N  M  T  I  G  A  V  N  S  K  G  E  F  T  G      175 
 
ACCTACACCACAGCCGTAACAGCCACATCAAATGAGATCAAAGAGTCACCACTGCATGGGACACAAAACACCATC    +600 
 T  Y  T  T  A  V  T  A  T  S  N  E  I  K  E  S  P  L  H  G  T  Q  N  T  I      200 
 
AACAAGAGGACCCAGCCCACCTTTGGCTTCACCGTCAATTGGAAGTTTTCAGAAAGTACTACTGTCTTCACGGGC    +675 
 N  K  R  T  Q  P  T  F  G  F  T  V  N  W  K  F  S  E  S  T  T  V  F  T  G      225 
 
CAGTGCTTCATAGACAGGAACGGGAAGGAGGTCCTGAAGACCATGTGGCTGCTGCGGTCAAGTGTTAATGACATT    +750 
 Q  C  F  I  D  R  N  G  K  E  V  L  K  T  M  W  L  L  R  S  S  V  N  D  I      250 
 
GGTGATGACTGGAAAGCTACGCGTGTTGGTATCAACATCTTCACTAGATTGAGAACTCAAAAGGAATGA          +819 
 G  D  D  W  K  A  T  R  V  G  I  N  I  F  T  R  L  R  T  Q  K  E  .            272 
 
 
 
 
 
 
 
 
ButaIT (111bp) Avidin (381bp)
PstI NotI
IgG Hinge (30bp)
NotI
Figure 4.11. 
Nucleotide sequence, deduced amino acid sequence and schematic representation of 
the ButaIT-IgG Hinge-Avidin fusion protein - ‘ButaIT (IgG Hinge) Avidin.’ 
The yeast alpha factor sequence of pGAPZ!B is highlighted in grey. The ButaIT toxin 
sequence is highlighted in red. The IgG Hinge linker is underlined in black. The avidin 
sequence is highlighted in yellow. Diagram not to scale. 
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ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACA    +75 
 M  R  F  P  S  I  F  T  A  V  L  F  A  A  S  S  A  L  A  A  P  V  N  T  T      25 
 
ACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTT    +150 
 T  E  D  E  T  A  Q  I  P  A  E  A  V  I  G  Y  S  D  L  E  G  D  F  D  V      50 
 
GCTGTTTTGCCATTTTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCT    +225 
 A  V  L  P  F  S  N  S  T  N  N  G  L  L  F  I  N  T  T  I  A  S  I  A  A      75 
 
AAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGCTAGAAAATGCTCGCTGACTGGGAAATGG    +300 
 K  E  E  G  V  S  L  E  K  R  E  A  E  A  A  A  R  K  C  S  L  T  G  K  W      100 
 
ACCAACGATCTGGGCTCCAACATGACCATCGGGGCTGTGAACAGCAAAGGTGAATTCACAGGCACCTACACCACA    +375 
 T  N  D  L  G  S  N  M  T  I  G  A  V  N  S  K  G  E  F  T  G  T  Y  T  T      125 
 
GCCGTAACAGCCACATCAAATGAGATCAAAGAGTCACCACTGCATGGGACACAAAACACCATCAACAAGAGGACC    +450 
 A  V  T  A  T  S  N  E  I  K  E  S  P  L  H  G  T  Q  N  T  I  N  K  R  T      150 
 
CAGCCCACCTTTGGCTTCACCGTCAATTGGAAGTTTTCAGAAAGTACTACTGTCTTCACGGGCCAGTGCTTCATA    +525 
 Q  P  T  F  G  F  T  V  N  W  K  F  S  E  S  T  T  V  F  T  G  Q  C  F  I      175 
 
GACAGGAACGGGAAGGAGGTCCTGAAGACCATGTGGCTGCTGCGGTCAAGTGTTAATGACATTGGTGATGACTGG    +600 
 D  R  N  G  K  E  V  L  K  T  M  W  L  L  R  S  S  V  N  D  I  G  D  D  W      200 
 
AAAGCTACGCGTGTTGGTATCAACATCTTCACTAGATTGAGAACTCAAAAGGAAGCGGCCGCACCAAAGCCAAGT    +675 
 K  A  T  R  V  G  I  N  I  F  T  R  L  R  T  Q  K  E  A  A  A  P  K  P  S      225 
 
ACTCCACCAGGTAGTAGTGCGGCCGCAAGGTGTGGTCCTTGCTTTACAACTGATCCTCAAACACAAGCCAAGTGT    +750 
 T  P  P  G  S  S  A  A  A  R  C  G  P  C  F  T  T  D  P  Q  T  Q  A  K  C      250 
 
AGTGAGTGTTGTGGGCGAAAGGGTGGAGTATGCAAGGGCCCACAATGTATCTGTGGTATACAAGTCGACCATCAT    +825 
 S  E  C  C  G  R  K  G  G  V  C  K  G  P  Q  C  I  C  G  I  Q  V  D  H  H      275 
 
CATCATCATCATTGA                                                                +840 
 H  H  H  H  .                                                                  279 
 
 
 
 
 
 
 
 
PstI NotINotI SalI
(His)6 Avidin (381bp) IgG Hinge (30bp) ButaIT (111bp)
Figure 4.12. 
Nucleotide sequence, deduced amino acid sequence and schematic representation of 
the Avidin-IgG Hinge-ButaIT fusion protein - ‘Avidin (IgG Hinge) ButaIT (His)6.’ 
The yeast alpha factor sequence of pGAPZ!B is highlighted in grey. The avidin sequence 
is highlighted in yellow. The IgG Hinge linker is underlined in black. The ButaIT toxin 
sequence is highlighted in red. The (His)6 tag is underlined in red. Diagram not to scale. 
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2. Recombinant Expression of the IgG Hinge Avidin-ButaIT Fusion Proteins 
 The fusion protein expression construct vectors were transformed into 
protease-deficient P. pastoris. Clones expressing the fusion proteins were identified 
by western blotting analysis (anti-avidin antibodies) of culture supernatant from 
10ml cultures. High expressers were cultured separately in bench-top fermenters. 
 
 Recombinant ButaIT-IgG Hinge-Avidin was purified from culture 
supernatant by SP-Sepharose ion exchange chromatography (Figure 4.5), whilst 
Avidin-IgG Hinge-ButaIT was purified from culture supernatant by nickel affinity 
chromatography utilising the added (His)6 tag (Figure 4.4). 
 
 From the amino acid sequences, the predicted sizes of ButaIT-IgG Hinge-
Avidin and Avidin-IgG Hinge-ButaIT are 19.5kDa and 20.5kDa respectively. The 
presence of ButaIT-IgG Hinge-Avidin and Avidin-IgG Hinge-ButaIT was confirmed 
by western blotting (anti-avidin antibodies) of culture supernatant from the 
fermentation, and column eluates were also analysed by SDS-PAGE (Figure 4.13). 
 
 Recombinant ButaIT-IgG Hinge-Avidin and Avidin-IgG Hinge-ButaIT were 
present and reacted with anti-avidin antibodies, but ran at an indicated molecular 
weight slightly larger than that predicted from the nucleotide sequences (23.5kDa) 
(Figure 4.13(a)(ii) and (b)(ii)). This was most likely due to glycosylation by the P. 
pastoris host (see Chapter 3). 
 
 Once analysed, column eluates were dialysed to remove salts and lyophilised 
by freeze-drying. Lyophilised proteins were quantified by SDS-PAGE (Figure 4.7). 
Yields of approximately 10mg of fusion protein per litre of culture supernatant were 
obtained for both recombinant fusion proteins. 
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3. Insecticidal Activity of the Recombinant IgG Hinge Avidin-ButaIT Fusion 
Proteins 
 Neither of the recombinant IgG Hinge Avidin-ButaIT fusion proteins were 
found to have any insecticidal activity when assessed by injection into newly 
moulted fifth stadium M. brassicae larvae (Figure 4.14). Each 5µl injection 
contained a total of either 50µg or 100µg of fusion protein (quantified by SDS-
(a) ButaIT-IgG Hinge-Avidin (b) Avidin-IgG Hinge-ButaIT 
 
           
 
Figure 4.13. 
SDS-PAGE and western analysis of the recombinant IgG Hinge Avidin-ButaIT fusion 
proteins produced in P. pastoris. 
M is SDS7 molecular weight marker. (a) ButaIT-IgG Hinge-Avidin: (i) 15% SDS-PAGE 
analysis. Lane 1 is 25µl of SP-Sepharose column elution, showing ButaIT-IgG Hinge-
Avidin (23.5kDa). Lane 2 is 2.5µg of Avidin-ButaIT 3 (23kDa), showing signs of 
proteolytic degradation (19kDa). (ii) Western analysis (anti-avidin antibodies [1:10000], one 
second exposure). Lane 1 is 1µl of fermenter supernatant, showing unpurified ButaIT-IgG 
Hinge Avidin (23.5kDa) with proteolytic degradation products (22kDa and 20.5kDa). Lane 
2 is 10ng of recombinant avidin (20kDa). (b) Avidin-IgG Hinge-ButaIT: (i) 15% SDS-
PAGE analysis. Lane 1 is 15µl of nickel column elution, showing Avidin-IgG Hinge-ButaIT 
(23.5kDa). Lane 2 is 2.5µg of Avidin-ButaIT 3 (23kDa), showing signs of proteolytic 
degradation (19kDa). (ii) Western analysis (anti-avidin antibodies [1:10000], one second 
exposure). Lane 1 is 1µl of fermenter supernatant, showing unpurified Avidin-IgG Hinge-
ButaIT (23.5kDa) with proteolytic degradation products (22kDa and 19kDa) and high 
molecular weight yeast proteins. Lane 2 is 10ng of recombinant avidin (20kDa). 
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PAGE) re-suspended in PBS. Recombinant ButaIT-GNA was injected as a 
comparison and PBS was used as a negative control. 
 
 Injected M. brassicae larvae were completely unaffected by the recombinant 
IgG Hinge Avidin-ButaIT fusion proteins, with 100% survival and no obvious visual 
or developmental effects being observed. Recombinant ButaIT-GNA injected larvae 
showed 95% and 100% mortality at the two doses whilst the PBS negative control 
showed 100% survival (Figure 4.14). The absence of mortality at a 100µg dose of 
either recombinant IgG Hinge Avidin-ButaIT fusion protein suggests that the ButaIT 
toxin component of the fusion protein may still be incorrectly folded. 
 
 
 
4. Analysis of the Recombinant IgG Hinge Avidin-ButaIT Fusion Proteins 
 To evaluate the in vivo degradation of the recombinant IgG Hinge Avidin-
ButaIT fusion proteins, newly moulted fifth stadium M. brassicae larvae were 
injected with 5µl of solution containing 50µg of the fusion protein. Control larvae 
were injected with PBS. Haemolymph was extracted from five larvae after 24 and 48 
 
 
Figure 4.14. 
Mortality of M. brassicae larvae following injection with varying amounts of recombinant 
IgG Hinge Avidin-ButaIT or ButaIT-GNA fusion proteins. 
(n = 20 for each treatment - Two separate treatments with 10 individuals). 
 
Mortality of M. brassicae Larvae following
IgG Hinge Avidin-ButaIT and ButaIT-GNA Fusion Protein Injections
50
µg
10
0µ
g
0
20
40
60
80
100
ButaIT-IgG Hinge-Avidin 
ButaIT-GNA
Control
Avidin-IgG Hinge-ButaIT
Concentration of Fusion Protein
%
 M
o
rt
a
lit
y
 a
t 2
4
 H
o
u
rs
Chapter 4                                                           Expression of Recombinant Avidin Fusion Proteins 
 - 115 - 
hours, pooled together and analysed by western blotting (anti-avidin antibodies) 
(Figure 4.15). 
 
 The result shows that the fusion proteins are stable in the haemolymph of M. 
brassicae larvae (23.5kDa) for at least 48 hours following injection, further 
supporting that the ButaIT toxin must be incorrectly folded. 
 
 
  
 
Figure 4.15. 
Western analysis of M. brassicae larvae haemolymph 24 hours and 48 hours after 
injection of 50µg of recombinant IgG Hinge Avidin-ButaIT fusion protein. 
A one second exposure of the membrane transferred from a 15% SDS-PAGE gel, probed 
with anti-avidin antibodies (1:10000) is shown. M is SDS 7 molecular weight marker. Lane 
1 is haemolymph from larvae injected with PBS (control). Lanes 2 and 3 are haemolymph 
from larvae 24 hours following injection with ButaIT-IgG Hinge-Avidin and Avidin-IgG 
Hinge-ButaIT respectively. (25µl loaded for each sample). Lanes 4 and 5 are the equivalent 
haemolymph loadings at 48 hours. All of the IgG Hinge Avidin-ButaIT fusion protein 
samples show both the fusion protein (23.5kDa) and a proteolytic degradation product 
(19kDa). Lane 6 is 10ng of recombinant avidin (20kDa). 
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!ACTXHv1a-Avidin (Omega Atracotoxin) Fusion Protein 
 
 To establish that the inactivity of the Avidin-ButaIT fusion proteins was not 
due to an incompatibility between ButaIT toxin and avidin, a different toxin was 
used. 
 
1. Production of the !ACTXHv1a-Avidin Fusion Protein Expression Construct 
 An expression construct for a fusion protein incorporating the !ACTXHv1a 
toxin (Omega Atracotoxin) (Chapter 1) as a replacement for the ButaIT toxin was 
produced using the cloning strategy described in Chapter 2. The !ACTXHv1a-
Avidin construct contained !ACTXHv1a toxin fused N-terminally to avidin using a 
NotI restriction site linker (amino acid sequence: AAAA). The complete fusion 
protein expression construct was cloned in-frame with the yeast N-terminal "-mating 
factor pre-pro secretory signal within the pGAPZ"B expression vector. The 
nucleotide sequence, deduced amino acid sequence and schematic diagram of the 
expression construct is shown in Figure 4.16. 
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ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACA    +75 
 M  R  F  P  S  I  F  T  A  V  L  F  A  A  S  S  A  L  A  A  P  V  N  T  T      25 
 
ACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTT    +150 
 T  E  D  E  T  A  Q  I  P  A  E  A  V  I  G  Y  S  D  L  E  G  D  F  D  V      50 
 
GCTGTTTTGCCATTTTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCT    +225 
 A  V  L  P  F  S  N  S  T  N  N  G  L  L  F  I  N  T  T  I  A  S  I  A  A      75 
 
AAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGCATCTCCAACTTGTATTCCATCTGGTCAA    +300 
 K  E  E  G  V  S  L  E  K  R  E  A  E  A  A  A  S  P  T  C  I  P  S  G  Q      100 
 
CCATGTCCATATAATGAAAATTGTTGTTCTCAATCTTGTACTTTTAAAGAAAATGAAAATGGTAATACTGTTAAA    +375 
 P  C  P  Y  N  E  N  C  C  S  Q  S  C  T  F  K  E  N  E  N  G  N  T  V  K      125 
 
AGATGTGATGCGGCCGCCGCTAGAAAATGCTCGCTGACTGGGAAATGGACCAACGATCTGGGCTCCAACATGACC    +450 
 R  C  D  A  A  A  A  R  K  C  S  L  T  G  K  W  T  N  D  L  G  S  N  M  T      150 
 
ATCGGGGCTGTGAACAGCAAAGGTGAATTCACAGGCACCTACACCACAGCCGTAACAGCCACATCAAATGAGATC    +525 
 I  G  A  V  N  S  K  G  E  F  T  G  T  Y  T  T  A  V  T  A  T  S  N  E  I      175 
 
AAAGAGTCACCACTGCATGGGACACAAAACACCATCAACAAGAGGACCCAGCCCACCTTTGGCTTCACCGTCAAT    +600 
 K  E  S  P  L  H  G  T  Q  N  T  I  N  K  R  T  Q  P  T  F  G  F  T  V  N      200 
 
TGGAAGTTTTCAGAAAGTACTACTGTCTTCACGGGCCAGTGCTTCATAGACAGGAACGGGAAGGAGGTCCTGAAG    +675 
 W  K  F  S  E  S  T  T  V  F  T  G  Q  C  F  I  D  R  N  G  K  E  V  L  K      225 
 
ACCATGTGGCTGCTGCGGTCAAGTGTTAATGACATTGGTGATGACTGGAAAGCTACGCGTGTTGGTATCAACATC    +750 
 T  M  W  L  L  R  S  S  V  N  D  I  G  D  D  W  K  A  T  R  V  G  I  N  I      250 
 
TTCACTAGATTGAGAACTCAAAAGGAATGA                                                 +780 
 F  T  R  L  R  T  Q  K  E  .                                                   259 
 
 
 
 
 
 
 
 
!ACTXHv1a (114bp) Avidin (381bp)
PstI NotI
Figure 4.16. 
Nucleotide sequence, deduced amino acid sequence and schematic representation of 
the !ACTXHv1a-Avidin fusion protein - ‘!ACTXHv1a (AAAA) Avidin.’ 
The yeast alpha factor sequence of pGAPZ"B is highlighted in grey. The !ACTXHv1a 
toxin sequence is highlighted in blue. The avidin sequence is highlighted in yellow. 
Diagram not to scale. 
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2. Recombinant Expression of the !ACTXHv1a-Avidin Fusion Protein 
 The fusion protein expression construct vector was transformed into protease-
deficient P. pastoris. Clones expressing the fusion protein were identified by western 
blotting analysis (anti-avidin antibodies) of culture supernatant from 10ml cultures. 
A high expresser was cultured in a bench-top fermenter. 
 
 Recombinant !ACTXHv1a-Avidin was purified from culture supernatant by 
SP-Sepharose ion exchange chromatography (Figure 4.5). 
 
 From the amino acid sequence, the predicted size of !ACTXHv1a-Avidin is 
18.5kDa. The presence of !ACTXHv1a-Avidin was confirmed by western blotting 
(anti-avidin antibodies) of culture supernatant from the fermentation, and column 
eluate was also analysed by SDS-PAGE (Figure 4.17). 
 
 Recombinant !ACTXHv1a-Avidin was present and reacted with anti-avidin 
antibodies, but ran at an indicated molecular weight slightly larger than that 
predicted from the nucleotide sequence (23kDa) (Figure 4.17(b)). This was most 
likely due to glycosylation by the P. pastoris host (see Chapter 3). The SDS-PAGE 
analysis showed that there was a small amount of proteolytic degradation of the 
purified fusion protein (19kDa) (Figure 4.17(a)). However, the column eluate 
contained a majority of the intact fusion protein. 
 
 Once analysed, column eluate was dialysed to remove salts and lyophilised 
by freeze-drying. Lyophilised protein was quantified by SDS-PAGE (Figure 4.7). A 
yield of approximately 10mg of fusion protein per litre of culture supernatant was 
obtained. 
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3. Insecticidal Activity of the Recombinant !ACTXHv1a-Avidin Fusion Protein 
 The recombinant !ACTXHv1a-Avidin fusion protein was tested for 
insecticidal activity by injection into newly moulted fifth stadium M. brassicae 
larvae. Initially, to establish the amount of fusion protein to include and for a 
comparison of activity, 10µg-150µg amounts of recombinant !ACTXHv1a-GNA 
were injected. Dr Elaine Fitches supplied recombinant !ACTXHv1a-GNA fusion 
protein. 
 
 When injected into fifth stadium M. brassicae larvae, the recombinant 
!ACTXHv1a-GNA showed 100% mortality over 24 hours at all doses excluding 
10µg, where 80% mortality was observed (Figure 4.18). 
 
 
 
Figure 4.17. 
SDS-PAGE and western analysis of the recombinant !ACTXHv1a-Avidin fusion 
protein produced in P. pastoris. 
M is SDS7 molecular weight marker. (a) 15% SDS-PAGE analysis. Lane 1 is 25µl of SP-
Sepharose column elution, showing !ACTXHv1a-Avidin (23kDa) with slight proteolytic 
degradation (19kDa). Lane 2 is 5µg of recombinant avidin (20kDa). (b) Western analysis 
(anti-avidin antibodies [1:10000], one second exposure). Lane 1 is 1µl of fermenter 
supernatant, showing unpurified !ACTXHv1a-Avidin (23kDa) and a proteolytic 
degradation product (19kDa). Lane 2 is 10ng of recombinant avidin (20kDa). 
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 Based on these results, each 5µl injection contained a total of either 25µg or 
50µg of recombinant !ACTXHv1a-Avidin fusion protein (quantified by SDS-
PAGE) re-suspended in PBS. At those amounts, if the fusion protein activity was 
comparable to !ACTXHv1a-GNA, or if the toxin component of the fusion protein 
was active, mortality should be observed. Injections of PBS were also carried out as 
a negative control. 
 
 The recombinant !ACTXHv1a-Avidin fusion protein was found to have no 
insecticidal activity in M. brassicae larvae (Figure 4.18). Injected larvae were 
completely unaffected by the fusion protein, with 100% survival and no obvious 
visual or developmental effects being observed. Similar survival was observed in the 
PBS negative control injections (Figure 4.18). The absence of mortality at a 50µg 
dose of recombinant !ACTXHv1a-Avidin suggests that the !ACTXHv1a toxin used 
in this fusion protein is also inactive, presumably as a result of incorrect folding. 
 
 
 
 
Figure 4.18. 
Mortality of M. brassicae larvae following injection with varying amounts of recombinant 
!ACTXHv1a -GNA or !ACTXHv1a-Avidin fusion protein. 
(n = 20 for each treatment - Two separate treatments with 10 individuals). 
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eGFP-Avidin (enhanced Green Fluorescent Protein) Fusion Protein 
 
 To establish if the functionality of a protein is retained following fusion to 
avidin, a non-toxin alternative was used. 
 
1. Production of the eGFP-Avidin Fusion Protein Expression Construct 
 An expression construct for a fusion protein incorporating enhanced Green 
Fluorescent Protein (eGFP) as a replacement for a toxin was produced using the 
cloning strategy described in Chapter 2. The eGFP-Avidin construct contained eGFP 
fused N-terminally to avidin using a NotI restriction site linker (amino acid sequence: 
AAAA). The complete fusion protein expression construct was cloned in-frame with 
the yeast N-terminal !-mating factor pre-pro secretory signal within the pGAPZ!B 
expression vector. The nucleotide sequence, deduced amino acid sequence and 
schematic diagram of the expression construct is shown in Figure 4.19. 
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ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACA    +75 
 M  R  F  P  S  I  F  T  A  V  L  F  A  A  S  S  A  L  A  A  P  V  N  T  T      25 
 
ACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTT    +150 
 T  E  D  E  T  A  Q  I  P  A  E  A  V  I  G  Y  S  D  L  E  G  D  F  D  V      50 
 
GCTGTTTTGCCATTTTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCT    +225 
 A  V  L  P  F  S  N  S  T  N  N  G  L  L  F  I  N  T  T  I  A  S  I  A  A      75 
 
AAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGCAATGGTGAGCAAGGGCGAGGAGCTGTTC    +300 
 K  E  E  G  V  S  L  E  K  R  E  A  E  A  A  A  M  V  S  K  G  E  E  L  F      100 
 
ACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGC    +375 
 T  G  V  V  P  I  L  V  E  L  D  G  D  V  N  G  H  K  F  S  V  S  G  E  G      125 
 
GAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCC    +450 
 E  G  D  A  T  Y  G  K  L  T  L  K  F  I  C  T  T  G  K  L  P  V  P  W  P      150 
 
ACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTC    +525 
 T  L  V  T  T  L  T  Y  G  V  Q  C  F  S  R  Y  P  D  H  M  K  Q  H  D  F      175 
 
TTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACC    +600 
 F  K  S  A  M  P  E  G  Y  V  Q  E  R  T  I  F  F  K  D  D  G  N  Y  K  T      200 
 
CGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGAC    +675 
 R  A  E  V  K  F  E  G  D  T  L  V  N  R  I  E  L  K  G  I  D  F  K  E  D      225 
 
GGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAG    +750 
 G  N  I  L  G  H  K  L  E  Y  N  Y  N  S  H  N  V  Y  I  M  A  D  K  Q  K      250 
 
AACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAG    +825 
 N  G  I  K  V  N  F  K  I  R  H  N  I  E  D  G  S  V  Q  L  A  D  H  Y  Q      275 
 
CAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGC    +900 
 Q  N  T  P  I  G  D  G  P  V  L  L  P  D  N  H  Y  L  S  T  Q  S  A  L  S      300 
 
AAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATG    +975 
 K  D  P  N  E  K  R  D  H  M  V  L  L  E  F  V  T  A  A  G  I  T  L  G  M      325 
 
GACGAGCTGTACAAGGCGGCCGCCGCTAGAAAATGCTCGCTGACTGGGAAATGGACCAACGATCTGGGCTCCAAC    +1050 
 D  E  L  Y  K  A  A  A  A  R  K  C  S  L  T  G  K  W  T  N  D  L  G  S  N      350 
 
ATGACCATCGGGGCTGTGAACAGCAAAGGTGAATTCACAGGCACCTACACCACAGCCGTAACAGCCACATCAAAT    +1125 
 M  T  I  G  A  V  N  S  K  G  E  F  T  G  T  Y  T  T  A  V  T  A  T  S  N      375 
 
GAGATCAAAGAGTCACCACTGCATGGGACACAAAACACCATCAACAAGAGGACCCAGCCCACCTTTGGCTTCACC    +1200 
 E  I  K  E  S  P  L  H  G  T  Q  N  T  I  N  K  R  T  Q  P  T  F  G  F  T      400 
 
GTCAATTGGAAGTTTTCAGAAAGTACTACTGTCTTCACGGGCCAGTGCTTCATAGACAGGAACGGGAAGGAGGTC    +1275 
 V  N  W  K  F  S  E  S  T  T  V  F  T  G  Q  C  F  I  D  R  N  G  K  E  V      425 
 
CTGAAGACCATGTGGCTGCTGCGGTCAAGTGTTAATGACATTGGTGATGACTGGAAAGCTACGCGTGTTGGTATC    +1350 
 L  K  T  M  W  L  L  R  S  S  V  N  D  I  G  D  D  W  K  A  T  R  V  G  I      450 
 
AACATCTTCACTAGATTGAGAACTCAAAAGGAATGA                                           +1386 
 N  I  F  T  R  L  R  T  Q  K  E  .                                             461 
 
 
 
 
 
eGFP (814bp) Avidin (381bp)
PstI NotI
Figure 4.19. 
Nucleotide sequence, deduced amino acid sequence and schematic representation of 
the eGFP-Avidin fusion protein - ‘eGFP (AAAA) Avidin.’ 
The yeast alpha factor sequence of pGAPZ!B is highlighted in grey. The eGFP sequence is 
highlighted in green. The avidin sequence is highlighted in yellow. Diagram not to scale. 
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2. Recombinant Expression of the eGFP-Avidin Fusion Protein 
 The fusion protein expression construct vector was transformed into protease-
deficient P. pastoris. Clones expressing the fusion protein were identified by western 
blotting analysis (anti-avidin antibodies) of culture supernatant from 10ml cultures. 
A high expresser was cultured in a bench-top fermenter. 
 
 Recombinant eGFP-Avidin was partially purified from culture supernatant by 
phenyl-Sepharose hydrophobic interaction chromatography. A typical elution profile 
from a phenyl-Sepharose column chromatography purification is shown in Figure 
4.20. 
 
 From the amino acid sequence, the predicted size of eGFP-Avidin is 
41.4kDa. The presence of eGFP-Avidin was confirmed by western blotting (anti-
avidin antibodies) of culture supernatant from the fermentation, and column eluate 
was also analysed by SDS-PAGE (Figure 4.21). 
 
 Recombinant eGFP-Avidin was present and reacted with anti-avidin 
antibodies, but ran at an indicated molecular weight slightly larger than that 
predicted from the nucleotide sequence (46kDa) (Figure 4.21(b)). This was most 
likely due to glycosylation by the P. pastoris host (see Chapter 3). The SDS-PAGE 
analysis showed the presence of some high molecular weight proteins (>66kDa) 
(Figure 4.21(a)). 
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Figure 4.20. 
Phenyl-Sepharose column purification. 
(a) Typical purification profile. As indicated 
by the red NaCl concentration line, the NaCl 
gradient was held at 1M to allow elution of 
protein through the complete column volume. 
Typically, the 1M NaCl elution peak 
contained the majority of the larger molecular 
weight proteins associated with P. pastoris 
yeast. Fusion proteins were present in the 0M 
NaCl (water) elution peak. 
(b) Typical 15% SDS-PAGE analysis of a 
phenyl-Sepharose column purification. M is 
SDS7 molecular weight marker. Lane 1 is 1M 
NaCl elution peak. Lane 2 is 0M NaCl (water) 
elution peak. (25µl loaded for each sample). 
Lane 3 is 5µg of recombinant avidin (20kDa). 
(In this case, the fusion protein was eGFP-
Avidin). 
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 The partially purified protein did not show fluorescence, suggesting the 
fusion protein was inactive. To check this was not due to the presence of other 
proteins, the partially purified final product seen in Figure 4.21(a) was subjected to 
Sephacryl S-200 gel filtration to exclude high molecular weight proteins but 
degraded during the process. 
 
 
 
Figure 4.21. 
SDS-PAGE and western analysis of the recombinant eGFP-Avidin fusion protein 
produced in P. pastoris. 
M is SDS7 molecular weight marker. (a) 15% SDS-PAGE analysis. Lane 1 is 25µl of 
phenyl-Sepharose column elution, showing eGFP-Avidin (46kDa) with high molecular 
weight yeast proteins (>66kDa). Lane 2 is 5µg of recombinant avidin (20kDa). (b) Western 
analysis (anti-avidin antibodies [1:10000], one second exposure). Lane 1 is 1µl of fermenter 
supernatant, showing unpurified eGFP-Avidin (46kDa). Lane 2 is 10ng of recombinant 
avidin (20kDa). 
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ButaIT-GNA Fragment-Avidin (ButaIT-Gavidin) Fusion Proteins 
 
 The amino acid sequences of the ButaIT-Avidin 2 fusion protein produced 
earlier (page 96), and of the ButaIT-GNA fusion protein produced by Pham-Trung et 
al. (2006), were analysed for structural features using Protean (DNASTAR 
Lasergene 9 suite). These analyses revealed that the avidin fusion protein has regions 
of positive charge on either side of the fusion site, a major difference when compared 
to the GNA fusion protein, which has a region of negative charge at the N-terminal 
end of GNA (Figure 4.22). 
 
1. Production of the ButaIT-GNA Fragment-Avidin Fusion Protein Expression 
Construct 
 Based on the charge difference highlighted in Figure 4.22, a ButaIT-Avidin 
fusion protein expression construct incorporating a fragment of GNA as a linker 
(designated ButaIT-Gavidin) was produced using the cloning strategy described in 
Chapter 2. The GNA fragment was incorporated to introduce a negatively charged 
region between the ButaIT toxin and avidin (Figure 4.23). The ButaIT-Gavidin 
construct contained ButaIT toxin fused N-terminally to avidin using the first 17 
amino acids of GNA as a linker (amino acid sequence: DNILYSGETLSTGEFLN). 
The expression construct also had a C-terminal extension encoding a (His)6 tag. The 
complete fusion protein expression construct was cloned in-frame with the yeast N-
terminal !-mating factor pre-pro secretory signal within the pGAPZ!B expression 
vector. The nucleotide sequence, deduced amino acid sequence and schematic 
diagram of the expression construct is shown in Figure 4.24. 
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ButaIT-Avidin
ButaIT-GNA
(a)
(b)
Figure 4.22. 
Fusion protein secondary structure charge analysis using Protean (DNASTAR 
Lasergene 9 suite). 
(a) ButaIT-Avidin. (b) ButaIT-GNA. 
The green boxes outline the areas of charge difference between the two fusion proteins. 
 
 
ButaIT-Gavidin
Figure 4.23. 
ButaIT-Gavidin fusion protein secondary structure charge analysis using Protean 
(DNASTAR Lasergene 9 suite). 
The green box outlines the newly added negative charge (GNA fragment) between the 
ButaIT toxin and avidin. 
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ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACA    +75 
 M  R  F  P  S  I  F  T  A  V  L  F  A  A  S  S  A  L  A  A  P  V  N  T  T      25 
 
ACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTT    +150 
 T  E  D  E  T  A  Q  I  P  A  E  A  V  I  G  Y  S  D  L  E  G  D  F  D  V      50 
 
GCTGTTTTGCCATTTTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCT    +225 
 A  V  L  P  F  S  N  S  T  N  N  G  L  L  F  I  N  T  T  I  A  S  I  A  A      75 
 
AAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGCAAGGTGTGGTCCTTGCTTTACAACTGAT    +300 
 K  E  E  G  V  S  L  E  K  R  E  A  E  A  A  A  R  C  G  P  C  F  T  T  D      100 
 
CCTCAAACACAAGCCAAGTGTAGTGAGTGTTGTGGGCGAAAGGGTGGAGTATGCAAGGGCCCACAATGTATCTGT    +375 
 P  Q  T  Q  A  K  C  S  E  C  C  G  R  K  G  G  V  C  K  G  P  Q  C  I  C      125 
 
GGTATACAAGCGGCCGCCGACAATATTTTGTACTCCGGTGAGACTCTCTCTACAGGGGAATTTCTCAACGTCGAC    +450 
 G  I  Q  A  A  A  D  N  I  L  Y  S  G  E  T  L  S  T  G  E  F  L  N  V  D      150 
 
GCTAGAAAATGCTCGCTGACTGGGAAATGGACCAACGATCTGGGCTCCAACATGACCATCGGGGCTGTGAACAGC    +525 
 A  R  K  C  S  L  T  G  K  W  T  N  D  L  G  S  N  M  T  I  G  A  V  N  S      175 
 
AAAGGTGAATTCACAGGCACCTACACCACAGCCGTAACAGCCACATCAAATGAGATCAAAGAGTCACCACTGCAT    +600 
 K  G  E  F  T  G  T  Y  T  T  A  V  T  A  T  S  N  E  I  K  E  S  P  L  H      200 
 
GGGACACAAAACACCATCAACAAGAGGACCCAGCCCACCTTTGGCTTCACCGTCAATTGGAAGTTTTCAGAAAGT    +675 
 G  T  Q  N  T  I  N  K  R  T  Q  P  T  F  G  F  T  V  N  W  K  F  S  E  S      225 
 
ACTACTGTCTTCACGGGCCAGTGCTTCATAGACAGGAACGGGAAGGAGGTCCTGAAGACCATGTGGCTGCTGCGG    +750 
 T  T  V  F  T  G  Q  C  F  I  D  R  N  G  K  E  V  L  K  T  M  W  L  L  R      250 
 
TCAAGTGTTAATGACATTGGTGATGACTGGAAAGCTACGCGTGTTGGTATCAACATCTTCACTAGATTGAGAACT    +825 
 S  S  V  N  D  I  G  D  D  W  K  A  T  R  V  G  I  N  I  F  T  R  L  R  T      275 
 
CAAAAGGAAATCGACCATCATCATCATCATCATTGA                                           +861 
 Q  K  E  I  D  H  H  H  H  H  H  .                                             286 
 
 
 
 
 
 
 
 
ButaIT (111bp) Avidin (381bp)
PstI SalI
GNA Frag (51bp)
NotI
(His)6 
Figure 4.24. 
Nucleotide sequence, deduced amino acid sequence and schematic representation of 
the ButaIT-Gavidin fusion protein - ‘ButaIT (GNA Fragment) Avidin (His)6.’ 
The yeast alpha factor sequence of pGAPZ!B is highlighted in grey. The ButaIT toxin 
sequence is highlighted red. The GNA fragment sequence is highlighted in green. The 
avidin sequence is highlighted in yellow. The (His)6 tag is underlined in black. Diagram not 
to scale. 
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2. Recombinant Expression of the ButaIT-Gavidin Fusion Protein 
 The fusion protein expression construct vector was transformed into protease-
deficient P. pastoris. Clones expressing the fusion protein were identified by western 
blotting analysis (anti-avidin antibodies) of culture supernatant from 10ml cultures. 
A high expresser was cultured in a bench-top fermenter. 
 
 Recombinant ButaIT-Gavidin was purified from culture supernatant by nickel 
affinity chromatography utilising the added (His)6 tag (Figure 4.4). 
 
 From the amino acid sequence, the predicted size of ButaIT-Gavidin is 
21.5kDa. The presence of ButaIT-Gavidin was confirmed by western blotting (anti-
avidin antibodies) of culture supernatant from the fermentation, and column eluate 
was also analysed by SDS-PAGE (Figure 4.25). 
 
 Recombinant ButaIT-Gavidin was present and reacted with anti-avidin 
antibodies, but ran at an indicated molecular weight slightly larger than that 
predicted from the nucleotide sequence (26kDa) (Figure 4.25(b)). This was most 
likely due to glycosylation by the P. pastoris host (see Chapter 3). The SDS-PAGE 
analysis showed that the purified ButaIT-Gavidin fusion protein comprised less than 
50% of the protein isolated, with three degradation fragments also observed (21kDa, 
20.5kDa and 20kDa) (Figure 4.25(a)). 
 
 Once analysed, column eluate was dialysed to remove salts and lyophilised 
by freeze-drying. Lyophilised protein was quantified by SDS-PAGE (Figure 4.7). 
Due to relatively low solubility, a yield of approximately 2mg of fusion protein per 
litre of culture supernatant was obtained. 
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3. Insecticidal Activity of the Recombinant ButaIT-Gavidin Fusion Protein 
 The recombinant ButaIT-Gavidin fusion protein was initially tested for 
insecticidal activity by injection into newly moulted fifth stadium M. brassicae 
larvae. Each 5µl injection contained a total of 50µg of fusion protein (quantified by 
SDS-PAGE) re-suspended in PBS. 
 
 All of the injected M. brassicae larvae were paralysed immediately and did 
not recover, showing an almost instant death, suggesting that an active fusion protein 
with avidin had finally been produced. 
 
 Following these preliminary injections, a full evaluation of the insecticidal 
activity of recombinant ButaIT-Gavidin was carried out by injecting amounts in the 
 
 
Figure 4.25. 
SDS-PAGE and western analysis of the recombinant ButaIT-Gavidin fusion protein 
produced in P. pastoris. 
M is SDS7 molecular weight marker. (a) 15% SDS-PAGE analysis. Lane 1 is 20µl of 
nickel column elution, showing ButaIT-Gavidin (26kDa) with proteolytic degradation 
products (21kDa, 20.5kDa and 20kDa). Lane 2 is 5µg of recombinant avidin (20kDa). (b) 
Western analysis (anti-avidin antibodies [1:10000], one second exposure). Lane 1 is 4µl of 
fermenter supernatant, showing unpurified ButaIT-Gavidin (26kDa) with high molecular 
weight yeast proteins and proteolytic degradation products (21kDa and 20.5kDa). Lane 2 is 
10ng of recombinant avidin (20kDa). 
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range 1µg-50µg into newly moulted fifth stadium M. brassicae larvae. Recombinant 
ButaIT-GNA was injected as a comparison and PBS was used as a negative control. 
 
 Recombinant ButaIT-Gavidin was effective (causing mortality) at doses as 
low as 2.5µg, whereas recombinant ButaIT-GNA was only effective from a dose of 
20µg (Figure 4.26). Complete mortality was observed following injection with 10µg-
50µg of recombinant ButaIT-Gavidin and the instant toxicity described above was 
observed in all cases. Similar instant effects were observed in the lower doses (1µg-
10µg) in which mortality was recorded. The larvae that survived the initial injection 
progressed normally to pupation. A survival level of 100% was observed in the PBS 
negative control injections (Figure 4.26). 
 
 
 
 The oral activity of recombinant ButaIT-Gavidin towards M. brassicae larvae 
was also evaluated by feeding droplets containing total amounts of recombinant 
  
 
Figure 4.26. 
Mortality of M. brassicae larvae following injection with varying amounts of recombinant 
ButaIT-Gavidin or ButaIT-GNA fusion protein. 
(n = 20 for each treatment - Two separate treatments with 10 individuals). 
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ButaIT-Gavidin in the range 0.5µg-50µg. Droplets of PBS were fed to larvae as a 
negative control for the bioassay. 
 
 Recombinant ButaIT-Gavidin was effective (causing mortality) at doses as 
low as 1µg, with 100% mortality observed in all cases excluding the 0.5µg and 1µg 
doses (Figure 4.27). A survival level of 100% was observed in the PBS droplet fed 
negative control larvae (Figure 4.27). The results suggest that recombinant ButaIT-
Gavidin is as effective via oral delivery as it is through injection. In contrast to the 
instant effects observed following injection, droplet fed M. brassicae larvae showed 
paralysis of the hind abdominal and anal prolegs for approximately 20 minutes 
before their eventual mortality. The larvae continued to move around either by 
dragging their paralysed abdominal region or lifting it and holding it clear of the 
bench surface.  
 
 
  
 
Figure 4.27. 
Mortality of M. brassicae larvae fed a droplet containing varying amounts of 
recombinant ButaIT-Gavidin fusion protein. 
(n = 20 for each treatment - Two separate treatments with 10 individuals). 
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4. N-Terminal Sequencing of the Recombinant ButaIT-Gavidin Fusion Protein 
Fragments 
 As the recombinant ButaIT-Gavidin fusion protein showed insecticidal 
activity, an investigation into how to improve the production yield was conducted. 
As seen in Figure 4.25, the intact fusion protein only accounted for approximately 
40% of the total protein content, with three degradation fragments making up the 
remaining 60%. A western blot of recombinant ButaIT-Gavidin was carried out 
using anti-avidin, anti-GNA and anti-His-tag antibodies to establish which of the 
fragments reacted with each specific antibody (Figure 4.28). 
 
 The results suggest that avidin was present within all of the degradation 
fragments, albeit to a lesser extent in the smallest (Figure 4.28(a)). Only the largest 
degradation fragment contained enough GNA to react with the GNA antibody 
(Figure 4.28(b)). All three degradation fragments contained the (His)6 tag (Figure 
4.28(c)). 
 
 From the nucleotide sequence of the ButaIT-Gavidin construct (Figure 4.24), 
it was speculated that the cleavage of the fusion protein occurred within the GNA 
fragment. However, to identify the exact position of the cleavage sites, protein N-
terminal sequencing was conducted by Cambridge Peptides (Philip Victor Road, 
Birmingham, West Midlands, UK). 
 
 The protein N-terminal sequencing (Table 4.2) confirmed that the 
degradation of the recombinant ButaIT-Gavidin fusion protein was a result of the 
action of one or more chymotrypsin-like protease at two specific cleavage sites 
within the GNA fragment. The major product resulted from cleavage after amino 
acid residue 10 (L) in the GNA fragment, with a less abundant product resulting 
from cleavage after amino acid residue 16 (L). A third potential chymotrypsin site is 
also present in the GNA fragment region after amino acid residue 4 (L) (Figure 
4.29). 
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Figure 4.28. 
Western analysis of the recombinant ButaIT-Gavidin fusion protein degradation 
fragments. 
One second exposures of the membrane transferred from a 17.5% SDS-PAGE gel. M is 
SDS7 molecular weight marker. (a) Anti-avidin antibody (1:10000). Lane 1 is 25ng of 
ButaIT-Gavidin, showing ButaIT-Gavidin (26kDa) and three proteolytic degradation 
fragments (21kDa, 20.5kDa and 20kDa). (b) Anti-GNA antibody (1:3000). Lane 2 is 50ng 
of ButaIT-Gavidin, showing ButaIT-Gavidin (26kDa) and one proteolytic degradation 
fragment (21kDa). (c) Anti-His tag antibody (1:1000). Lane 3 is 200ng of ButaIT-Gavidin, 
showing ButaIT-Gavidin (26kDa) and three proteolytic degradation fragments (21kDa, 
20.5kDa and 20kDa). 
 
M 1 2 3
66kDa
45kDa
36kDa
29kDa
20kDa
24kDa
14kDa
(a) (b) (c)
Residue 
Number 
Read 1 Read 2 Read 3 
1 S N A 
    
2 T E V 
    
3 G D F 
    
4 E A L 
    
5 F N R 
    
 
Table 4.2. 
N-terminal sequence analysis of the ButaIT-Gavidin fusion protein degradation 
fragments. 
Read 1 identifies the STGEF sequence at the N-terminus of a ButaIT-Gavidin fragment. 
Reads 2 and 3 identify the NVDAR sequence at the N-terminus of another fragment. 
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ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACA    +75 
 M  R  F  P  S  I  F  T  A  V  L  F  A  A  S  S  A  L  A  A  P  V  N  T  T      25 
 
ACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTT    +150 
 T  E  D  E  T  A  Q  I  P  A  E  A  V  I  G  Y  S  D  L  E  G  D  F  D  V      50 
 
GCTGTTTTGCCATTTTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCT    +225 
 A  V  L  P  F  S  N  S  T  N  N  G  L  L  F  I  N  T  T  I  A  S  I  A  A      75 
 
AAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGCAAGGTGTGGTCCTTGCTTTACAACTGAT    +300 
 K  E  E  G  V  S  L  E  K  R  E  A  E  A  A  A  R  C  G  P  C  F  T  T  D      100 
 
CCTCAAACACAAGCCAAGTGTAGTGAGTGTTGTGGGCGAAAGGGTGGAGTATGCAAGGGCCCACAATGTATCTGT    +375 
 P  Q  T  Q  A  K  C  S  E  C  C  G  R  K  G  G  V  C  K  G  P  Q  C  I  C      125 
 
GGTATACAAGCGGCCGCCGACAATATTTTGTACTCCGGTGAGACTCTCTCTACAGGGGAATTTCTCAACGTCGAC    +450 
 G  I  Q  A  A  A  D  N  I  L  Y  S  G  E  T  L  S  T  G  E  F  L  N  V  D      150 
 
 
 
 
GCTAGAAAATGCTCGCTGACTGGGAAATGGACCAACGATCTGGGCTCCAACATGACCATCGGGGCTGTGAACAGC    +525 
 A  R  K  C  S  L  T  G  K  W  T  N  D  L  G  S  N  M  T  I  G  A  V  N  S      175 
 
AAAGGTGAATTCACAGGCACCTACACCACAGCCGTAACAGCCACATCAAATGAGATCAAAGAGTCACCACTGCAT    +600 
 K  G  E  F  T  G  T  Y  T  T  A  V  T  A  T  S  N  E  I  K  E  S  P  L  H      200 
 
GGGACACAAAACACCATCAACAAGAGGACCCAGCCCACCTTTGGCTTCACCGTCAATTGGAAGTTTTCAGAAAGT    +675 
 G  T  Q  N  T  I  N  K  R  T  Q  P  T  F  G  F  T  V  N  W  K  F  S  E  S      225 
 
ACTACTGTCTTCACGGGCCAGTGCTTCATAGACAGGAACGGGAAGGAGGTCCTGAAGACCATGTGGCTGCTGCGG    +750 
 T  T  V  F  T  G  Q  C  F  I  D  R  N  G  K  E  V  L  K  T  M  W  L  L  R      250 
 
TCAAGTGTTAATGACATTGGTGATGACTGGAAAGCTACGCGTGTTGGTATCAACATCTTCACTAGATTGAGAACT    +825 
 S  S  V  N  D  I  G  D  D  W  K  A  T  R  V  G  I  N  I  F  T  R  L  R  T      275 
 
CAAAAGGAAATCGACCATCATCATCATCATCATTGA                                           +861 
 Q  K  E  I  D  H  H  H  H  H  H  .                                             286 
 
 
Figure 4.29. 
Nucleotide sequence and deduced amino acid sequence of the ButaIT-Gavidin fusion 
protein showing chymotrypsin cleavage sites within the GNA fragment. 
The yeast alpha factor sequence of pGAPZ!B is highlighted in grey. The ButaIT toxin 
sequence is highlighted red. The GNA fragment sequence is highlighted in green. The 
arrows indicate chymotrypsin cleavage sites. The avidin sequence is highlighted in yellow. 
The (His)6 tag is underlined in black. 
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5. Production of Mutated ButaIT-Gavidin Fusion Protein Expression Constructs 
 Based on the protein N-terminal sequencing results, two mutated variants of 
ButaIT-Gavidin were produced to reduce the presence of the cleavage fragments. 
One fusion protein, designated ButaIT-Gavidin 1 Mutation, contained one mutated 
chymotrypsin enzyme site, while the other fusion protein, designated ButaIT-
Gavidin 3 Mutations, included three mutated chymotrypsin enzyme sites. The 
mutations were simple nucleotide base alterations introduced by site-directed 
mutagenesis as described in Chapter 2. The nucleotide and deduced amino acid 
sequences of the expression constructs are shown in Figures 4.30 and 4.31. 
 
 From Figure 4.30, the ButaIT-Gavidin 1 Mutation has 421C>G and 422T>C 
nucleotide base changes, creating a L141A amino acid change. From Figure 4.31, the 
ButaIT-Gavidin 3 Mutations has 403T>G, 404T>C, 406T>A, 407A>C, 421C>G, 
422T>C, 439C>G and 440T>C nucleotide base changes, creating L135A, Y136T, 
L141A and L147A amino acid changes. 
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ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACA    +75 
 M  R  F  P  S  I  F  T  A  V  L  F  A  A  S  S  A  L  A  A  P  V  N  T  T      25 
 
ACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTT    +150 
 T  E  D  E  T  A  Q  I  P  A  E  A  V  I  G  Y  S  D  L  E  G  D  F  D  V      50 
 
GCTGTTTTGCCATTTTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCT    +225 
 A  V  L  P  F  S  N  S  T  N  N  G  L  L  F  I  N  T  T  I  A  S  I  A  A      75 
 
AAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGCAAGGTGTGGTCCTTGCTTTACAACTGAT    +300 
 K  E  E  G  V  S  L  E  K  R  E  A  E  A  A  A  R  C  G  P  C  F  T  T  D      100 
 
CCTCAAACACAAGCCAAGTGTAGTGAGTGTTGTGGGCGAAAGGGTGGAGTATGCAAGGGCCCACAATGTATCTGT    +375 
 P  Q  T  Q  A  K  C  S  E  C  C  G  R  K  G  G  V  C  K  G  P  Q  C  I  C      125 
 
GGTATACAAGCGGCCGCCGACAATATTTTGTACTCCGGTGAGACTGCCTCTACAGGGGAATTTCTCAACGTCGAC    +450 
 G  I  Q  A  A  A  D  N  I  L  Y  S  G  E  T  A  S  T  G  E  F  L  N  V  D      150 
 
 
 
 
GCTAGAAAATGCTCGCTGACTGGGAAATGGACCAACGATCTGGGCTCCAACATGACCATCGGGGCTGTGAACAGC    +525 
 A  R  K  C  S  L  T  G  K  W  T  N  D  L  G  S  N  M  T  I  G  A  V  N  S      175 
 
AAAGGTGAATTCACAGGCACCTACACCACAGCCGTAACAGCCACATCAAATGAGATCAAAGAGTCACCACTGCAT    +600 
 K  G  E  F  T  G  T  Y  T  T  A  V  T  A  T  S  N  E  I  K  E  S  P  L  H      200 
 
GGGACACAAAACACCATCAACAAGAGGACCCAGCCCACCTTTGGCTTCACCGTCAATTGGAAGTTTTCAGAAAGT    +675 
 G  T  Q  N  T  I  N  K  R  T  Q  P  T  F  G  F  T  V  N  W  K  F  S  E  S      225 
 
ACTACTGTCTTCACGGGCCAGTGCTTCATAGACAGGAACGGGAAGGAGGTCCTGAAGACCATGTGGCTGCTGCGG    +750 
 T  T  V  F  T  G  Q  C  F  I  D  R  N  G  K  E  V  L  K  T  M  W  L  L  R      250 
 
TCAAGTGTTAATGACATTGGTGATGACTGGAAAGCTACGCGTGTTGGTATCAACATCTTCACTAGATTGAGAACT    +825 
 S  S  V  N  D  I  G  D  D  W  K  A  T  R  V  G  I  N  I  F  T  R  L  R  T      275 
 
CAAAAGGAAATCGACCATCATCATCATCATCATTGA                                           +861 
 Q  K  E  I  D  H  H  H  H  H  H  .                                             286 
 
 
Figure 4.30. 
Nucleotide sequence and deduced amino acid sequence of the ButaIT-Gavidin 1 
Mutation fusion protein showing the mutated chymotrypsin cleavage site within the 
GNA fragment. 
(421C>G and 422T>C nucleotide base change; L141A amino acid change). 
The yeast alpha factor sequence of pGAPZ!B is highlighted in grey. The ButaIT toxin 
sequence is highlighted red. The GNA fragment sequence is highlighted in green. The 
arrows indicate chymotrypsin cleavage sites. The crossed arrow indicates the mutation site 
(sequence changes coloured blue). The avidin sequence is highlighted in yellow. The (His)6 
tag is underlined in black. 
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ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACA    +75 
 M  R  F  P  S  I  F  T  A  V  L  F  A  A  S  S  A  L  A  A  P  V  N  T  T      25 
 
ACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTT    +150 
 T  E  D  E  T  A  Q  I  P  A  E  A  V  I  G  Y  S  D  L  E  G  D  F  D  V      50 
 
GCTGTTTTGCCATTTTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCT    +225 
 A  V  L  P  F  S  N  S  T  N  N  G  L  L  F  I  N  T  T  I  A  S  I  A  A      75 
 
AAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGCAAGGTGTGGTCCTTGCTTTACAACTGAT    +300 
 K  E  E  G  V  S  L  E  K  R  E  A  E  A  A  A  R  C  G  P  C  F  T  T  D      100 
 
CCTCAAACACAAGCCAAGTGTAGTGAGTGTTGTGGGCGAAAGGGTGGAGTATGCAAGGGCCCACAATGTATCTGT    +375 
 P  Q  T  Q  A  K  C  S  E  C  C  G  R  K  G  G  V  C  K  G  P  Q  C  I  C      125 
 
GGTATACAAGCGGCCGCCGACAATATTGCGACCTCCGGTGAGACTGCCTCTACAGGGGAATTTGCCAACGTCGAC    +450 
 G  I  Q  A  A  A  D  N  I  A  T  S  G  E  T  A  S  T  G  E  F  A  N  V  D      150 
 
 
 
 
GCTAGAAAATGCTCGCTGACTGGGAAATGGACCAACGATCTGGGCTCCAACATGACCATCGGGGCTGTGAACAGC    +525 
 A  R  K  C  S  L  T  G  K  W  T  N  D  L  G  S  N  M  T  I  G  A  V  N  S      175 
 
AAAGGTGAATTCACAGGCACCTACACCACAGCCGTAACAGCCACATCAAATGAGATCAAAGAGTCACCACTGCAT    +600 
 K  G  E  F  T  G  T  Y  T  T  A  V  T  A  T  S  N  E  I  K  E  S  P  L  H      200 
 
GGGACACAAAACACCATCAACAAGAGGACCCAGCCCACCTTTGGCTTCACCGTCAATTGGAAGTTTTCAGAAAGT    +675 
 G  T  Q  N  T  I  N  K  R  T  Q  P  T  F  G  F  T  V  N  W  K  F  S  E  S      225 
 
ACTACTGTCTTCACGGGCCAGTGCTTCATAGACAGGAACGGGAAGGAGGTCCTGAAGACCATGTGGCTGCTGCGG    +750 
 T  T  V  F  T  G  Q  C  F  I  D  R  N  G  K  E  V  L  K  T  M  W  L  L  R      250 
 
TCAAGTGTTAATGACATTGGTGATGACTGGAAAGCTACGCGTGTTGGTATCAACATCTTCACTAGATTGAGAACT    +825 
 S  S  V  N  D  I  G  D  D  W  K  A  T  R  V  G  I  N  I  F  T  R  L  R  T      275 
 
CAAAAGGAAATCGACCATCATCATCATCATCATTGA                                           +861 
 Q  K  E  I  D  H  H  H  H  H  H  .                                             286 
 
 
Figure 4.31. 
Nucleotide sequence and deduced amino acid sequence of the ButaIT-Gavidin 3 
Mutations fusion protein showing the mutated chymotrypsin cleavage sites within the 
GNA fragment. 
(403T>G, 404T>C, 406T>A, 407A>C, 421C>G, 422T>C, 439C>G and 440T>C 
nucleotide base changes; L135A, Y136T, L141A and L147A amino acid changes). 
The yeast alpha factor sequence of pGAPZ!B is highlighted in grey. The ButaIT toxin 
sequence is highlighted red. The GNA fragment sequence is highlighted in green. The 
crossed arrows indicate the chymotrypsin cleavage mutation sites (sequence changes 
coloured blue). The avidin sequence is highlighted in yellow. The (His)6 tag is underlined 
in black. 
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6. Recombinant Expression of the Mutated ButaIT-Gavidin Fusion Proteins 
 The mutated ButaIT-Gavidin fusion protein expression construct vectors 
were transformed into protease-deficient P. pastoris. Clones expressing the fusion 
proteins were identified by western blotting analysis (anti-avidin antibodies) of 
culture supernatant from 10ml cultures. High expressers were cultured separately in 
bench-top fermenters. 
 
 Both recombinant ButaIT-Gavidin 1 Mutation and ButaIT-Gavidin 3 
Mutations were purified from culture supernatant by nickel affinity chromatography 
utilising the added (His)6 tag (Figure 4.4). 
 
 From the amino acid sequences, the predicted sizes of ButaIT-Gavidin 1 
Mutation and ButaIT-Gavidin 3 Mutations are 21.4kDa and 21.3kDa respectively. 
The presence of the mutated ButaIT-Gavidin fusion proteins was confirmed by 
western blotting (anti-avidin antibodies) of culture supernatant from the 
fermentation, and column eluates were also analysed by SDS-PAGE (Figure 4.32). 
 
 Recombinant ButaIT-Gavidin 1 Mutation and ButaIT-Gavidin 3 Mutations 
were present and reacted with anti-avidin antibodies, but ran at an indicated 
molecular weight slightly larger than that predicted from the nucleotide sequences 
(24kDa and 24.5kDa respectively) (Figure 4.32(a)(ii) and (b)(ii)). This was most 
likely due to glycosylation by the P. pastoris host (see Chapter 3). The purified 
ButaIT-Gavidin 1 Mutation shows only two cleavage fragments (21kDa and 
20.5kDa) (Figure 4.32(a)), an improvement over the original ButaIT-Gavidin where 
three were observed (21kDa, 20.5kDa and 20kDa) (Figure 4.25(a)). Although the 
purified ButaIT-Gavidin 3 Mutations shows a marked reduction in the three original 
cleavage fragments (21kDa, 20.5kDa and 20kDa), two completely new cleavage 
fragments were observed (23kDa and 22kDa) (Figure 4.32(b)). 
 
 Once analysed, column eluates were dialysed to remove salts and lyophilised 
by freeze-drying. Lyophilised proteins were quantified by SDS-PAGE (Figure 4.7). 
Yields of approximately 10mg of ButaIT-Gavidin 1 Mutation fusion protein and 
20mg of ButaIT-Gavidin 3 Mutations fusion protein per litre of culture supernatant 
were obtained. 
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7. Insecticidal Activity of the Recombinant Mutated ButaIT-Gavidin Fusion Proteins 
 The recombinant mutated ButaIT-Gavidin fusion proteins were tested for 
insecticidal activity by injection into newly moulted fifth stadium M. brassicae 
larvae. Each 5µl injection contained a total of 50µg of fusion protein (quantified by 
SDS-PAGE) re-suspended in PBS. The original recombinant ButaIT-Gavidin was 
injected as a comparison and PBS was used as a negative control. 
 
(a) ButaIT-Gavidin 1 Mutation (b) ButaIT-Gavidin 3 Mutations 
 
             
 
Figure 4.32. 
SDS-PAGE and western analysis of the recombinant mutated ButaIT-Gavidin fusion 
proteins produced in P. pastoris. 
M is SDS7 molecular weight marker. (a) ButaIT-Gavidin 1 Mutation: (i) 15% SDS-PAGE 
analysis. Lane 1 is 20µl of nickel column elution, showing ButaIT-Gavidin 1 Mutation 
(24kDa) with two cleavage fragments (21kDa and 20.5kDa). Lane 2 is 5µg of recombinant 
avidin (20kDa). (ii) Western analysis (anti-avidin antibodies [1:10000], one second 
exposure). Lane 1 is 1µl of fermenter supernatant, showing unpurified ButaIT-Gavidin 1 
Mutation (24kDa) with two cleavage fragments (21kDa and 20.5kDa) and high molecular 
weight yeast proteins. (b) ButaIT-Gavidin 3 Mutations: (i) 15% SDS-PAGE analysis. Lane 1 
is 15µl of nickel column elution, showing ButaIT-Gavidin 3 Mutations (24.5kDa) with two 
cleavage fragments (23kDa and 22kDa). Lane 2 is 5µg of recombinant avidin (20kDa). (ii) 
Western analysis (anti-avidin antibodies [1:10000], one second exposure). Lane 1 is 1µl of 
fermenter supernatant, showing unpurified ButaIT-Gavidin 3 Mutations (24.5kDa) with one 
cleavage fragment (22kDa) and high molecular weight yeast proteins. Lane 2 is 10ng of 
recombinant avidin (20kDa). 
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 The recombinant ButaIT-Gavidin 1 Mutation fusion protein showed toxicity 
by injection (Figure 4.33). Complete mortality was observed in 48 hours and the 
effects were similar to the original recombinant ButaIT-Gavidin but 24 hours later. 
In contrast, the recombinant ButaIT-Gavidin 3 Mutations fusion protein showed no 
insecticidal activity (Figure 4.33). A survival level of 100% was observed in the PBS 
negative control injections (Figure 4.33). The activity of recombinant ButaIT-
Gavidin 1 Mutation over 48 hours and non-toxicity of recombinant ButaIT-Gavidin 3 
Mutations when compared to the original recombinant ButaIT-Gavidin (with activity 
over 24 hours) suggests that in vivo chymotrypsin cleavage of the ButaIT-Gavidin 
fusion protein is necessary for it to be active. 
 
 
 
 The oral activity of the recombinant mutated ButaIT-Gavidin fusion proteins 
was also evaluated by droplet feeding to newly moulted fifth stadium M. brassicae 
larvae. Each 5µl droplet contained a total of 50µg of the fusion protein. Equivalent 
droplets of the original recombinant ButaIT-Gavidin were fed as a comparison and 
PBS was fed to larvae as a negative control for the bioassay. 
 
 
Figure 4.33. 
Mortality of M. brassicae larvae following injection with 50µg of recombinant mutated 
ButaIT-Gavidin or ButaIT-Gavidin fusion proteins. 
(n = 20 for each treatment - Two separate treatments with 10 individuals). 
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 Both recombinant ButaIT-Gavidin 1 Mutation and ButaIT-Gavidin 3 
Mutations were non-toxic when delivered orally (Figure 4.34). Larvae were 
completely unaffected by both of the mutated fusion proteins, with 100% survival 
and no obvious visual or developmental effects being observed. The original 
recombinant ButaIT-Gavidin droplet fed larvae showed 100% mortality in 24 hours 
and 100% survival was observed in the PBS negative control (Figure 4.34). 
 
 
 
 
Figure 4.34. 
Mortality of M. brassicae larvae fed a droplet containing 50µg of recombinant mutated 
ButaIT-Gavidin or ButaIT-Gavidin fusion proteins. 
(n = 20 for each treatment - Two separate treatments with 10 individuals). 
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ButaIT-GNA Fragment and GNA Fragment-Avidin Fusion Proteins 
 
 To help to identify the mode of action of ButaIT-Gavidin, more fusion 
proteins were produced, each containing different components of ButaIT-Gavidin. 
 
1. Production of ButaIT-GNA Fragment and GNA Fragment-Avidin Fusion Protein 
Expression Constructs 
 Expression constructs for two fusion proteins (designated ButaIT-GNA 
Fragment and GNA Fragment-Avidin) were produced using the cloning strategy 
described in Chapter 2. The ButaIT-GNA Fragment construct contained ButaIT toxin 
fused N-terminally to the 17 amino acid GNA fragment (amino acid sequence: 
DNILYSGETLSTGEFLN) using a NotI restriction site linker (amino acid sequence: 
AAA). The expression construct also had a C-terminal extension encoding a (His)6 
tag. The GNA Fragment-Avidin construct contained the 17 amino acid GNA 
fragment (amino acid sequence: DNILYSGETLSTGEFLN) fused to Avidin using a 
SalI restriction site linker (amino acid sequence: VDA). The expression construct 
also had a C-terminal extension encoding a (His)6 tag. The complete expression 
constructs of the two fusion proteins were cloned in-frame with the yeast N-terminal 
!-mating factor pre-pro secretory signal within the pGAPZ!B expression vector. 
The nucleotide sequences, deduced amino acid sequences and schematic diagrams of 
the expression constructs are shown in Figures 4.35 and 4.36. 
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ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACA    +75 
 M  R  F  P  S  I  F  T  A  V  L  F  A  A  S  S  A  L  A  A  P  V  N  T  T      25 
 
ACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTT    +150 
 T  E  D  E  T  A  Q  I  P  A  E  A  V  I  G  Y  S  D  L  E  G  D  F  D  V      50 
 
GCTGTTTTGCCATTTTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCT    +225 
 A  V  L  P  F  S  N  S  T  N  N  G  L  L  F  I  N  T  T  I  A  S  I  A  A      75 
 
AAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGCAAGGTGTGGTCCTTGCTTTACAACTGAT    +300 
 K  E  E  G  V  S  L  E  K  R  E  A  E  A  A  A  R  C  G  P  C  F  T  T  D      100 
 
CCTCAAACACAAGCCAAGTGTAGTGAGTGTTGTGGGCGAAAGGGTGGAGTATGCAAGGGCCCACAATGTATCTGT    +375 
 P  Q  T  Q  A  K  C  S  E  C  C  G  R  K  G  G  V  C  K  G  P  Q  C  I  C      125 
 
GGTATACAAGCGGCCGCCGACAATATTTTGTACTCCGGTGAGACTCTCTCTACAGGGGAATTTCTCAACGTCGAC    +450 
 G  I  Q  A  A  A  D  N  I  L  Y  S  G  E  T  L  S  T  G  E  F  L  N  V  D      150 
 
CATCATCATCATCATCATTGA                                                          +471 
 H  H  H  H  H  H  .                                                            156 
 
 
 
 
 
 
 
 
ButaIT (111bp)
PstI
GNA Frag (51bp)
NotI
(His)6 
SalI
Figure 4.35. 
Nucleotide sequence, deduced amino acid sequence and schematic representation of 
the ButaIT-GNA Fragment fusion protein - ‘ButaIT (AAA) GNA Fragment (His)6.’ 
The yeast alpha factor sequence of pGAPZ!B is highlighted in grey. The ButaIT toxin 
sequence is highlighted in red. The GNA fragment sequence is highlighted in green. The 
(His)6 tag is underlined in black. Diagram not to scale. 
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ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACA    +75 
 M  R  F  P  S  I  F  T  A  V  L  F  A  A  S  S  A  L  A  A  P  V  N  T  T      25 
 
ACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTT    +150 
 T  E  D  E  T  A  Q  I  P  A  E  A  V  I  G  Y  S  D  L  E  G  D  F  D  V      50 
 
GCTGTTTTGCCATTTTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCT    +225 
 A  V  L  P  F  S  N  S  T  N  N  G  L  L  F  I  N  T  T  I  A  S  I  A  A      75 
 
AAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGCAGACAATATTTTGTACTCCGGTGAGACT    +300 
 K  E  E  G  V  S  L  E  K  R  E  A  E  A  A  A  D  N  I  L  Y  S  G  E  T      100 
 
CTCTCTACAGGGGAATTTCTCAACGTCGACGCTAGAAAATGCTCGCTGACTGGGAAATGGACCAACGATCTGGGC    +375 
 L  S  T  G  E  F  L  N  V  D  A  R  K  C  S  L  T  G  K  W  T  N  D  L  G      125 
 
TCCAACATGACCATCGGGGCTGTGAACAGCAAAGGTGAATTCACAGGCACCTACACCACAGCCGTAACAGCCACA    +450 
 S  N  M  T  I  G  A  V  N  S  K  G  E  F  T  G  T  Y  T  T  A  V  T  A  T      150 
 
TCAAATGAGATCAAAGAGTCACCACTGCATGGGACACAAAACACCATCAACAAGAGGACCCAGCCCACCTTTGGC    +525 
 S  N  E  I  K  E  S  P  L  H  G  T  Q  N  T  I  N  K  R  T  Q  P  T  F  G      175 
 
TTCACCGTCAATTGGAAGTTTTCAGAAAGTACTACTGTCTTCACGGGCCAGTGCTTCATAGACAGGAACGGGAAG    +600 
 F  T  V  N  W  K  F  S  E  S  T  T  V  F  T  G  Q  C  F  I  D  R  N  G  K      200 
 
GAGGTCCTGAAGACCATGTGGCTGCTGCGGTCAAGTGTTAATGACATTGGTGATGACTGGAAAGCTACGCGTGTT    +675 
 E  V  L  K  T  M  W  L  L  R  S  S  V  N  D  I  G  D  D  W  K  A  T  R  V      225 
 
GGTATCAACATCTTCACTAGATTGAGAACTCAAAAGGAAATCGACCATCATCATCATCATCATTGA             +741 
 G  I  N  I  F  T  R  L  R  T  Q  K  E  I  D  H  H  H  H  H  H  .               246 
 
 
 
 
 
 
 
 
Avidin (381bp)
PstI SalI
GNA Frag (51bp)
NotI
(His)6 
Figure 4.36. 
Nucleotide sequence, deduced amino acid sequence and schematic representation of 
the GNA Fragment-Avidin fusion protein - ‘GNA Fragment (VDA) Avidin (His)6.’ 
The yeast alpha factor sequence of pGAPZ!B is highlighted in grey. The GNA fragment 
sequence is highlighted in green. The avidin sequence is highlighted in yellow. The (His)6 
tag is underlined in black. Diagram not to scale. 
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2. Recombinant Expression of the ButaIT-GNA Fragment and GNA Fragment-
Avidin Fusion Proteins 
 The fusion protein expression construct vectors were transformed into 
protease-deficient P. pastoris. Clones expressing the fusion proteins were identified 
by western blotting analysis (anti-avidin antibodies) of culture supernatant from 
10ml cultures. High expressers were cultured separately in bench-top fermenters. 
 
 Both recombinant ButaIT-GNA Fragment and GNA Fragment-Avidin were 
purified from culture supernatant by nickel affinity chromatography utilising the 
added (His)6 tag (Figure 4.4). 
 
 From the amino acid sequences, the predicted sizes of ButaIT-GNA 
Fragment and GNA Fragment-Avidin are 7kDa and 17.4kDa respectively. The 
presence of ButaIT-GNA Fragment and GNA Fragment-Avidin were confirmed by 
western blotting (anti-GNA and anti-avidin antibodies respectively) of culture 
supernatant from the fermentation, and column eluates were also analysed by SDS-
PAGE (Figure 4.37). 
 
 Recombinant ButaIT-GNA Fragment and GNA Fragment-Avidin were 
present and reacted with the antibodies, but ran at an indicated molecular weight 
slightly larger than that predicted from the nucleotide sequences (10kDa and 21kDa 
respectively) (Figure 4.37(a)(ii) and (b)(ii)). This was most likely due to 
glycosylation by the P. pastoris host (see Chapter 3). The SDS-PAGE analysis 
showed a large amount of cleavage of the purified GNA Fragment-Avidin fusion 
protein (20.5kDa and 20kDa) (Figure 4.37(b)(i)). 
 
 Once analysed, column eluates were dialysed to remove salts and lyophilised 
by freeze-drying. Lyophilised proteins were quantified by SDS-PAGE (Figure 4.7). 
Yields of approximately 10mg of fusion protein per litre of culture supernatant were 
obtained for both recombinant fusion proteins. 
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3. Insecticidal Activity of the Recombinant ButaIT-GNA Fragment and GNA 
Fragment-Avidin Fusion Proteins 
 The recombinant ButaIT-GNA Fragment and GNA Fragment-Avidin fusion 
proteins were tested for insecticidal activity by injection into newly moulted fifth 
stadium M. brassicae larvae. Each 5µl injection contained a total of 50µg of fusion 
protein (quantified by SDS-PAGE) re-suspended in PBS. Injections of PBS were 
also carried out as a negative control. 
 
(a) ButaIT-GNA Fragment (b) GNA Fragment-Avidin 
 
             
 
Figure 4.37. 
SDS-PAGE and western analysis of the recombinant ButaIT-GNA Fragment and GNA 
Fragment-Avidin fusion proteins produced in P. pastoris. 
M is SDS7 molecular weight marker. (a) ButaIT-GNA Fragment: (i) 20% SDS-PAGE 
analysis. Lane 1 is 15µl of nickel column elution, showing ButaIT-GNA Fragment (10kDa). 
(ii) Western analysis (anti-GNA antibodies [1:3000], five second exposure). Lane 1 is 1µl of 
fermenter supernatant, showing unpurified ButaIT-GNA Fragment (10kDa). (b) GNA 
Fragment-Avidin: (i) 15% SDS-PAGE analysis. Lane 1 is 15µl of nickel column elution, 
showing GNA Fragment-Avidin (21kDa) with proteolytic degradation products (20.5kDa and 
20kDa). Lane 2 is 5µg of recombinant avidin (20kDa). (ii) Western analysis (anti-avidin 
antibodies [1:10000], one second exposure). Lane 1 is 1µl of fermenter supernatant, showing 
unpurified GNA Fragment-Avidin (21kDa) with high molecular weight yeast proteins. Lane 
2 is 10ng of recombinant avidin (20kDa). 
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 Both recombinant ButaIT-GNA Fragment and GNA Fragment-Avidin 
injected larvae showed 100% mortality in 48 hours (Figure 4.38). However, no 
paralysis was observed in insects injected with either fusion protein. A survival level 
of 95% was observed in the PBS negative control injections (Figure 4.38). 
 
 
 
 An attempt was made to establish the lowest effective dose (causing 
mortality) of both fusion proteins. However, 100% mortality was observed in 48 
hours at injection doses as low as 0.05µg. 
 
 The oral activity of the recombinant ButaIT-GNA Fragment and GNA 
Fragment-Avidin fusion proteins was also evaluated by droplet feeding to newly 
moulted fifth stadium M. brassicae larvae. Each 5µl droplet contained a total of 
50µg of the fusion protein. Droplets of PBS were fed to larvae as a negative control 
for the bioassay. 
 
 
 
Figure 4.38. 
Mortality of M. brassicae larvae following injection with 50µg of recombinant ButaIT-
GNA Fragment or GNA Fragment-Avidin fusion protein. 
(n = 20 for each treatment - Two separate treatments with 10 individuals). 
 
Mortality of M. brassicae Larvae following
50µg Injections of ButaIT-GNA Fragment and GNA Fragment-Avidin
Fusion Proteins
24 48
0
20
40
60
80
100
ButaIT-GNA Fragment
Control
GNA Fragment-Avidin
Time (Hours)
%
 M
o
rt
a
lit
y
Chapter 4                                                           Expression of Recombinant Avidin Fusion Proteins 
 - 149 - 
 Both recombinant ButaIT-GNA Fragment and GNA Fragment-Avidin were 
non-toxic when delivered orally. Larvae were completely unaffected by the fusion 
proteins, with 100% survival and no obvious visual or developmental effects being 
observed. Similar survival was also observed for the PBS negative control. 
 
 The presence of insecticidal activity by injection of the fusion proteins at 
such low doses and the absence of oral activity were unusual. Also, the absence of 
paralysis upon injection and the activity of recombinant GNA Fragment-Avidin (not 
including a toxin) were surprising, suggesting that these fusion proteins were acting 
on the larvae via a different mechanism to ButaIT-Gavidin. 
 
4. In vivo Analysis of Recombinant ButaIT-Gavidin 
 As a result of the paralysis observed in the recombinant ButaIT-Gavidin 
droplet feeding assay described on page 131, an investigation into one suggestion 
that ButaIT-Gavidin may be exerting an effect on the mandibula nerve in the head of 
M. brassicae larvae was conducted. A droplet feeding and dissection experiment was 
carried out, where starved, newly moulted fifth stadium M. brassicae larvae were 
droplet fed 50µg of either recombinant ButaIT-Gavidin or ButaIT-Gavidin 1 
Mutation fusion protein to allow for the analysis of any differences. After 10 
minutes, five larvae fed the recombinant ButaIT-Gavidin were rapidly dissected 
during the paralysis to obtain the head proteins. Guts were also extracted. The larvae 
fed recombinant ButaIT-Gavidin 1 Mutation were dissected similarly three hours 
later. Droplets of PBS were fed to larvae as a negative control for the experiment. 
 
 Western blotting (anti-avidin antibodies) of the extracted proteins from the 
head capsule and the gut showed that both of the fusion proteins were degraded in 
vivo (Figure 4.39). Only avidin was detected, suggesting that the degradation of the 
fusion protein occurs in a matter of minutes and that this would allow the toxin to 
access any nerve endings, including the mandibula nerve, around the mouth-parts. 
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 Following on from this, recombinant ButaIT-Gavidin was fluorescently 
labeled and a 2µg droplet fed to newly moulted fifth stadium M. brassicae larvae on 
a microscope slide in situ, to identify any areas of localised binding within the head 
capsule. Unfortunately, large amounts of autofluorescence masked any specific 
binding. 
 
5. Recombinant ButaIT-Gavidin Production Process Analysis 
 The experiments described above had given no insight into why and how 
recombinant ButaIT-Gavidin showed high levels of toxicity when injected or 
delivered orally. The results were both contradictory and confusing. Consequently, 
 
 
Figure 4.39. 
Western analysis of M. brassicae larvae head capsules and guts 20 minutes after 
feeding on a 50µg recombinant ButaIT-Gavidin fusion protein droplet and three 
hours after feeding on a 50µg recombinant ButaIT-Gavidin 1 Mutation fusion protein 
droplet. 
A one second exposure of the membrane transferred from a 15% SDS-PAGE gel, probed 
with anti-avidin antibodies (1:10000) is shown. M is SDS 7 molecular weight marker. Lane 
1 is head capsules from larvae fed with PBS (control). Lane 2 is head capsules from larvae 
fed with ButaIT-Gavidin for 20 minutes. Lane 3 is head capsules from larvae fed with 
ButaIT-Gavidin 1 Mutation for three hours. Lane 4 is guts from larvae fed with PBS 
(control). Lane 5 is guts from larvae fed with ButaIT-Gavidin for 20 minutes. Lane 6 is guts 
from larvae fed with ButaIT-Gavidin 1 Mutation for three hours. All of the fusion protein 
samples show recombinant avidin (20kDa) with some proteolytic degradation (15kDa and 
14kDa) and avidin dimerisation (36kDa). (20µl loaded for each sample). Lane 7 is 10ng of 
recombinant avidin (20kDa). 
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an in depth analysis of the preparation of recombinant ButaIT-Gavidin was carried 
out to ensure that the insecticidal effects that were observed were not due to 
contaminants carried over from the production process. 
 
 To obtain the correct working concentrations of recombinant ButaIT-Gavidin 
after lyophilisation, the protein was resuspended in small volumes of PBS solution 
(50µl-200µl). This would cause problems if the use of such small volumes 
‘amplified’ the concentration of any residual salts that remained after the dialysis 
step. Imidazole in particular is toxic and is present in the nickel column elution 
buffer. 
 
 To investigate this further, an aliquot of elution buffer equal to the amount 
contained in a ButaIT-Gavidin column elution was put through a dialysis process 
identical to that used in preparing recombinant fusion proteins. The elution buffer 
blank showed some residual salt following lyophilisation, suggesting that the dialysis 
process was not working as efficiently as first thought. The lyophilised powder 
obtained from the elution buffer was resuspended in 100µl of PBS in the same way 
as recombinant ButaIT-Gavidin and 5µl of it was injected into newly moulted fifth 
stadium M. brassicae larvae. 
 
 The residual salt showed similar instant paralysis and mortality effects to the 
recombinant ButaIT-Gavidin fusion protein described on page 130, suggesting that 
that activity was not entirely due to the fusion protein, but also partly to the residual 
salt remaining within the protein sample. 
 
 To establish the actual activity of the recombinant ButaIT-Gavidin fusion 
protein without the contaminants, an existing 2mg batch of the fusion protein was 
desalted using a PD10 desalting column and subsequently 50µg and 100µg was 
injected into newly moulted fifth stadium M. brassicae larvae. Injections of PBS 
were also carried out as a negative control. 
 
 The desalted recombinant ButaIT-Gavidin fusion protein showed no 
insecticidal activity (Figure 4.40). The injected M. brassicae larvae were completely 
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unaffected by the injected fusion protein, with 100% survival and no obvious visual 
or developmental effects being observed. Similar survival was observed in the PBS 
negative control injections (Figure 4.40). 
 
 
 
 To confirm this result, a further batch of recombinant ButaIT-Gavidin fusion 
protein was produced by fermentation and purification as described on page 129, but 
more extensive dialysis was carried out over three days to ensure all of the elution 
buffer salts were removed. Following lyophilisation and fusion protein content 
analysis by SDS-PAGE, injections of 50µg and 100µg of the recombinant ButaIT-
Gavidin were carried out in newly moulted fifth stadium M. brassicae larvae. 
Injections of PBS were also carried out as a negative control. 
 
 As with the desalted recombinant ButaIT-Gavidin, no activity was observed 
(100% survival in all cases), showing that the recombinant ButaIT-Gavidin fusion 
protein was not insecticidal and residual salts in the sample caused the results 
described on pages 130, 131 and 132. 
 
 
Figure 4.40. 
Survival of M. brassicae larvae following injection with varying amounts of desalted 
recombinant ButaIT-Gavidin fusion protein. 
(n = 20 for each treatment - Two separate treatments with 10 individuals). 
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6. Insecticidal Activity of Imidazole 
 If the nickel column imidazole elution buffer was to be used in further 
studies, it was important to establish the exact toxicity of imidazole to M. brassicae 
larvae. Newly moulted fifth stadium M. brassicae larvae were injected with 5µl of 
imidazole re-suspended in PBS at concentrations in the range 0.1mM-300mM. 
Injections of PBS were also carried out as a negative control. 
 
 The imidazole had instant insecticidal effects at concentrations above 1mM, 
with 50% mortality observed at a concentration of 10mM and 100% mortality 
observed at a concentration of 100mM (Figure 4.41). A survival level of 100% was 
observed in the PBS negative control injections (Figure 4.41). From the injections, it 
can be seen that the LD50 of imidazole in M. brassicae larvae is a concentration of 
10mM. 
 
 
 
 
Figure 4.41. 
Mortality of M. brassicae larvae following injection with varying concentrations of 
imidazole. 
(n = 20 for each concentration - Two separate treatments with 10 individuals). 
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Discussion 
 
 This chapter presents the experiments carried out in an attempt to produce an 
insecticidal recombinant avidin fusion protein in Pichia pastoris. 
 
 The three recombinant Avidin-ButaIT fusion proteins (Figures 4.1, 4.2 and 
4.3) produced initially are based on existing GNA fusion proteins (Pham-Trung et 
al., 2006). All three show similar expression levels in SMD1168 P. pastoris. 
Although this is the protease deficient strain of P. pastoris, some proteolytic 
degradation is still observed (Figure 4.6). This is because the yeast is only deficient 
in the major proteases and it still requires some protease activity to survive. Unlike 
the GNA fusion proteins, the recombinant Avidin-ButaIT fusion proteins have no 
insecticidal activity towards M. brassicae larvae even when injected at doses up to 
100µg (Figure 4.8). Fusing the ButaIT toxin at the N-terminal or the C-terminal of 
avidin gives no difference in activity. The interaction with immobilised biotin 
(Figure 4.10) shows that the avidin within the fusion protein is fully functional. It 
must therefore be the ButaIT toxin that is inactive, most likely due to incorrect 
folding of the protein during its production and processing. However, the only 
functional assay for ButaIT toxin is toxicity when injected into lepidopteran larvae as 
carried out here. Physical studies to establish whether or not the ButaIT toxin has 
indeed folded correctly would be a valuable indication of functionality, but the 
lyophilised fusion proteins are not homogeneous enough for spectroscopic analysis. 
In vivo transport analysis following oral delivery (Figure 4.9) also shows that these 
fusion proteins are degraded within the gut of the insect, but that avidin (slightly 
degraded) is still transported and detected in the haemolymph. In contrast, intact 
GNA fusion protein can be detected in the haemolymph of lepidopteran larvae 
following oral delivery (Fitches et al., 2004; Pham-Trung et al., 2006). Perhaps 
another contributing factor to the differences in gut degradation and transport 
between GNA and avidin fusion proteins could also be the actual mechanism of 
transport It is well documented that GNA binds to mannose residues in the gut and is 
subsequently translocated to the haemolymph, however, very little is actually known 
about avidin transport; is it due to the ‘leaky’ nature of the lepidopteran gut as 
described in Chapter 3, or does a more sophisticated method like with GNA exist? 
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The absence of fusion protein activity and degradation within the gut shows that their 
design must be researched further. 
 
 Mamestra brassicae larvae were unaffected by injection of the recombinant 
IgG Hinge Avidin-ButaIT fusion proteins (Figures 4.11, 4.12 and 4.14), suggesting 
that the absence of insecticidal activity might not be due to a spatial constraint on the 
folding of the ButaIT toxin. The IgG Hinge linker region included here has 
previously been proven to successfully allow more space for fusion protein 
component folding in avidin fusions produced by Airenne and Kulomaa (1995). 
However, this one experiment does not rule out the influence of a spatial constraint 
on the folding of the ButaIT toxin, as it may be the case that the IgG Hinge linker 
region only works with the Schistosoma japonicum glutathione S-transferase fusion 
protein (Airenne and Kulomaa, 1995). It is possible that the IgG Hinge linker region 
is too short, too long or even biochemically incompatible to maintain the correct 
folding of the ButaIT toxin. Degradation analysis (Figure 4.15) shows that the 
recombinant IgG Hinge Avidin-ButaIT fusion proteins are stable within the 
haemolymph of the insect. This confirms that the absence of insecticidal activity of 
the recombinant fusion proteins is not due to degradation of the ButaIT toxin and 
again supports the fact that the ButaIT toxin component of the fusion protein may 
still be incorrectly folded. However, this does not rule out the possibility that the 
recombinant IgG Hinge Avidin-ButaIT fusion proteins are too stable within the 
haemolymph of the insect, even though similar enzyme restriction sites to those 
utilised in GNA fusion proteins were used. Of course, avidin could also hinder the 
target interaction or direct the toxin away from the target completely. This would 
require further investigation. 
 
 The recombinant !ACTXHv1a-Avidin fusion protein (Figure 4.16) produced 
subsequently does not show insecticidal activity towards M. brassicae larvae either 
(Figure 4.18). This clearly establishes that using an alternative toxin has no effect on 
the activity of the fusion protein, presumably as this toxin is also incorrectly folded. 
 
 Although non-toxic, all six of these fusion proteins express with only slightly 
lower yields in comparison to the corresponding GNA fusion proteins, where 
insecticidal activity is observed (Pham-Trung et al., 2006). The most accurate 
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method of protein quantification in this case is SDS-PAGE (Figure 4.7). Although it 
is known that different proteins stain differently, other methods such as bicinchoninic 
acid assays only give total protein quantification. Analysis by SDS-PAGE allows the 
actual fusion protein content to be quantified. In this investigation, the aim was to 
produce and test the fusion proteins for insecticidal activity. However, where fusion 
proteins are eluted as a single peak from a nickel column (Figure 4.4), it is likely that 
the elution peak contains a mixture of his-tagged fusion proteins due to proteolytic 
degradation. Quantification by SDS-PAGE would not distinguish between these 
variants if the proteolysis did not result in a significant change in molecular weight, 
for example, removal of a single amino acid from the N-terminus. 
 
 The attempt to produce a non-toxin avidin fusion protein (Figure 4.19), to 
establish if the functionality of a protein is retained following fusion to avidin, was 
also unsuccessful. 
 
 The conclusion following these attempts is that the component fused to the 
avidin is not being processed correctly. Avidin may actually be interfering with the 
folding. The toxins do however appear to be processed correctly in the GNA based 
fusion proteins: GNA may even promote the correct folding of the fused 
components. 
 
 Hence, the final attempt at producing an avidin fusion protein incorporated a 
17 amino acid fragment of GNA as a linker. This is based on structural analysis of 
the Avidin-ButaIT fusion protein and the corresponding GNA fusion protein (Figure 
4.22). The GNA fragment was included to reverse the charge of the protein between 
the ButaIT toxin and the avidin to make it similar to that contained within a GNA 
fusion protein (Figures 4.23 and 4.24). 
 
 The recombinant ButaIT-Gavidin fusion protein showed some degradation 
during production (Figure 4.25), but following injection and droplet feeding in M. 
brassicae larvae (Figures 4.26 and 4.27), it appeared to be active. The paralysis 
observed after feeding a single droplet looked identical to that which would be 
associated with a toxin, but the insecticidal activity was ten times greater than that of 
the GNA fusion proteins on a per amount of protein basis. 
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 Subsequently, the mode of action of the recombinant ButaIT-Gavidin fusion 
protein was analysed. Protein N-terminal sequencing showed that the cleavage of 
recombinant ButaIT-Gavidin during production in P. pastoris was due to one or 
more chymotrypsin-like protease (Figure 4.29 and Table 4.2). Mutation of these 
cleavage sites increased the yield at the expense of the fusion protein activity 
(Figures 4.30, 4.31, 4.32, 4.33 and 4.34). The evidence at this point indicated that 
fusion proteins must be cleaved in vivo to be active. 
 
 The ButaIT-GNA Fragment and GNA Fragment-Avidin fusion protein 
experiments show that an insecticidal protein can be produced utilising only the 17 
amino acid N-terminal fragment of GNA. An explanation for this is that the fragment 
of GNA used contains the two relatively hydrophobic beta strands in close proximity 
to the active binding site and may be able to bind to physiologically active receptors 
in the insect, resulting in mortality. This is surprising and although these fusion 
proteins are not orally active following feeding of a single droplet, they may be 
insecticidal during prolonged exposure in artificial diet. Perhaps further investigation 
is warranted here as the original ButaIT-GNA fusion protein may not require the 
complete GNA protein sequence to be orally active. 
 
 Based on the evidence from the injection and feeding bioassay experiments 
described earlier, it is difficult to provide a scientific explanation of the activity of 
the recombinant ButaIT-Gavidin fusion protein. Fluorescence microscopy and 
western blotting (Figure 4.39) show no convincing evidence as to the mode of action 
of this fusion protein. No differences in degradation are observed between the 
recombinant ButaIT-Gavidin and the recombinant ButaIT-Gavidin 1 Mutation 
(Figure 4.39), although the recombinant ButaIT-Gavidin 1 Mutation is active over 48 
hours when compared to recombinant ButaIT-Gavidin without mutation (less than 24 
hours) following injection into M. brassicae larvae (Figure 4.33). 
 
 Process analysis shows that the initial conclusion of the existence of an active 
fusion protein is a mistake. The observed activity is due to the presence of imidazole 
that is included in the nickel column elution buffer and has not dialysed out 
efficiently, even though dialysis was carried out following the manufacturer 
recommended procedure. Protein elution peaks containing 300mM imidazole elution 
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buffer were initially diluted 1 in 10 before dialysis in 10 litres of purified water. The 
water was refreshed twice, at three-hour intervals, with the final change being left 
overnight (a total of 24 hours dialysis). Calculations show that the concentration of 
imidazole in the protein sample should be reduced to 30nM in that time, if the 
dialysis proceeds to completion. When resuspended in 100µl of PBS, the 
concentration of imidazole in the protein sample would therefore have been 0.3µM. 
However, the presence of salts in the lyophilised buffer sample alone shows that for 
the nickel column elution buffer, the dialysis process works less efficiently. 
 
 In order to avoid the same problem in future studies, the insecticidal activity 
of imidazole is presented in Figure 4.41. All dialysis and resuspension following 
lyophilisation must ensure that the imidazole concentration is at 1mM or below. This 
would have been the case if the dialysis had worked at maximum efficiency. 
Moreover, the effects of imidazole on M. brassicae larvae appeared to be similar to 
those of a toxin (paralysis of the hind abdominal and anal prolegs). 
 
 In conclusion, none of the attempts to produce an active recombinant avidin 
fusion protein in P. pastoris were successful: avidin seems unsuitable for use as a 
‘carrier’ based on these cases of synthetic fusion protein technology. 
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Chapter 5 
 
Production of Recombinant Avidin Conjugates 
 
Introduction 
 
 Avidin can form stable conjugates via its biotin-binding sites (Chapter 1). 
Avidin conjugates are not limited to those with biotin itself, but can include a range 
of compounds to which biotin has been chemically linked. These will bind via the 
biotin-binding sites on avidin. This is the basis for the biotin-agarose interaction with 
avidin described in Chapter 3. Binding biotin-linked compounds to avidin is an 
alternative, practical method of forming fusions because of the very strong 
interaction between avidin and biotin. The availability of methods for producing 
biotinylated peptides and proteins allows a range of novel conjugates to be produced. 
There are no records of insecticidal avidin conjugates in the scientific literature. 
 
 Previous research has shown that biotin remains bound to avidin following 
transfer to the haemolymph of Mamestra brassicae (cabbage moth) (Lepidoptera: 
Noctuidae, Linnaeus 1758) larvae (Hinchliffe, 2007). This study also shows that 
avidin behaves differently in aphids, it being held in the gut instead of being 
transported to the haemolymph (Chapter 3). This information should allow specific 
toxins to be chosen for the different insect species. 
 
 The experiments in this chapter describe attempts to produce an insecticidal 
avidin conjugate as an alternative to ‘conventional’ fusion proteins (Chapter 4). 
Whilst the synthetic fusion proteins contain components linked by covalent peptide 
bonds in a single polypeptide chain, the avidin conjugates will contain components 
linked by the non-covalent avidin-biotin binding interaction. Beginning with aphids, 
where avidin is held in the gut and not transported, a conjugate with the 
leucomyosuppressin (LMS) neuropeptide from Leucophaea maderae (cockroach) 
(Orthoptera: Blaberidae, Fabricius 1781) will be produced. Specifically, LMS 
inhibits muscular gut contractions, making it an ideal initial candidate as aphids rely 
heavily on gut motility for digestion and therefore survival. Peptide toxins such as 
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ButaIT from Mesobuthus tamulus (Indian red scorpion) (Scorpiones: Buthidae, 
Fabricius 1798) utilised in Chapter 4 would not be suitable for use on aphids as the 
toxin target lies on the haemolymph side of the gut, where it is established avidin 
does not reach (Chapter 3). Finally, a conjugate with the allatostatin neuropeptide 
from Manduca sexta (tobacco hornworm) (Lepidoptera: Sphingidae, Linnaeus 1763) 
will be produced and analysed for activity on lepidopteran larvae (M. brassicae). 
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Results 
 
Conjugation to Avidin Causes a Peptide to be Retained in the Hemipteran Gut 
 To determine whether a molecule conjugated to avidin was retained in the 
aphid gut just as avidin alone is (Chapter 3), fluorescently labelled biotin 
(fluorescein-biotin) and a fluorescently labelled, biotinylated peptide (biotin-
Cys[AlexaFluor488]-Leucomyosuppressin) were conjugated to avidin (Figure 5.1). 
 
 The Acyrthosiphon pisum (pea aphid) (Hemiptera: Aphididae, Harris 1776) 
genome contains a predicted gene encoding a precursor to leucomyosuppressin 
(LMS) (LOC100163798), which is translated into a 1077 nucleotide mRNA. The 
predicted hormone protein sequence from this gene is QDLDHVFLRF-amide, where 
the C-terminal amidation is inferred from the presence of a C-terminal -GRRRR 
sequence. The N-terminal of the hormone is predicted by a dibasic residue cleavage 
sequence, -KR-. This protein sequence was not available when the experiment was 
designed, and a peptide sequence similar to the LMS peptide isolated from 
Leucophaea maderae (cockroach) (Orthoptera: Blaberidae, Fabricius 1781) (Chapter 
1), with the exception that the N-terminal glutamic acid residue was replaced with 
glutamine (substitution E1Q), was used. This differs from the A. pisum LMS 
sequence only by a single amino acid substitution near the N-terminus (V3L), which 
is unlikely to have a major effect on biological activity in aphids, since it is the C-
terminal regions of FLRFamide peptides in insects that are known to be critical for 
activity. The peptide was synthesised with an extra N-terminal cysteine residue, and 
labelled on the cysteine side chain with a fluorophore (AlexaFluor488) (product: 
Cys[AlexaFluor488]-QDVDHVFLRF-amide). A biotin residue was also added to the 
N-terminus of the peptide to allow affinity conjugation to avidin. The resulting 
peptide (biotin-Cys[AlexaFluor488]-QDVDHVFLRF-amide) and fluorescein-biotin 
were conjugated to avidin by incubation in molar excess (2:1), followed by dialysis 
to remove the unbound biotin or peptide. 
 
 The labelled conjugates and controls (unconjugated fluorescein-biotin and 
biotin-Cys[AlexaFluor488]-LMS) were included in separate treatments of artificial 
diet at a concentration of 0.1mg/ml (100ppm, 100µM) and fed to A. pisum for 48 
hours. Half of the aphids then received a chase of diet containing no added 
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compounds for 24 hours. Propidium iodide was also included in the artificial diet at a 
concentration of 0.1mg/ml to fluorescently stain DNA, which is present at the 
highest concentration within the gut cells, thereby outlining the gut of the aphids. 
Following the feeding treatments, whole aphids were viewed on a fluorescence 
microscope and images were captured in Openlab (see Chapter 2) (Figure 5.2). 
 
 As expected, all of the labelled compounds and conjugates were detected 
throughout the gut when fed, but their retention after the chase period differed 
according to the compound. Identical to the results obtained for feeding fluorescein 
isothiocyanate (FITC) label alone, fluorescein-biotin was not retained in the aphid 
and disappeared during the chase period. On the other hand, the avidin : fluorescein-
biotin conjugate was retained in the aphid foregut region. Unconjugated biotin-
Cys[AlexaFluor488]-LMS peptide was removed from the aphid during the chase 
period, but the avidin : biotin-Cys[AlexaFluor488]-LMS conjugate was retained in 
the aphid foregut region after the chase (Figure 5.2). These results show that 
conjugating a peptide to avidin will cause it to be retained in the aphid, as a result of 
the avidin binding to the stomach region of the gut. 
 
 
 
 
 
 
*LMS (33bp)Avidin (381bp) B
Avidin (381bp) *B
(a)
(b)
Figure 5.1. 
Schematic representation of the fluorescent avidin conjugates. 
(a) Avidin : biotin-Cys[AlexaFluor488]-LMS. (b) Avidin : fluorescein-biotin. 
Diagram not to scale. 
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Figure 5.2. 
Fluorescence micrographs of A. pisum (pea aphid) after feeding on 0.1mg/ml 
fluorescein-biotin, avidin : fluorescein-biotin, biotin-Cys[AlexaFluor488]-LMS or 
avidin : biotin-Cys[AlexaFluor488]-LMS. 
(Left hand side) After feeding for 48 hours. (Right hand side) After chasing fluorescent 
label with control diet for 24 hours. Green channel images show fluorescence from labelled 
compounds. Red channel images show fluorescence from propidium iodide used as a 
general stain. 
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Preparation and Insecticidal Activity of an Avidin : biotin-LMS Conjugate in 
Hemiptera 
 If avidin binding can be used to ‘anchor’ conjugated molecules at the gut 
surface in the aphid stomach, the resulting high local concentrations of a potential 
toxin could increase its insecticidal activity. This hypothesis was tested by preparing 
a conjugate between avidin and N-terminally biotinylated LMS (avidin : biotin-LMS, 
with the LMS being the QDVDHVFLRF-amide identical to that described on page 
161) (Figure 5.3). 
 
 Avidin is insecticidal to A. pisum at concentrations greater than 0.25mg/ml 
(250ppm, 3.8µM) (Chapter 3). A sub-lethal concentration of 0.1mg/ml avidin 
(100ppm, 1.6µM) in artificial diet was therefore selected, at which more than 60% of 
pea aphids survived from neonate to maturity (10 days) compared to control survival 
of 90%-100%. Biotin-LMS was non-toxic to A. pisum at concentrations up to 
0.25mg/ml (250ppm; highest tested), with no significant differences to controls. The 
avidin : biotin-LMS conjugate was prepared by incubation of avidin with a molar 
excess (2:1) of biotin-LMS, followed by removal of the excess peptide by dialysis 
(Figure 5.4). To compare their insecticidal effects, avidin, biotin-LMS, and avidin : 
biotin-LMS conjugate were fed to A. pisum at the same concentration in artificial diet 
(0.1mg/ml, 100ppm) and the effects on survival were recorded. Survival curves are 
presented in Figure 5.5. 
 
 Over the 12-day bioassay, survival of the control and LMS fed aphids was 
!90%. Survival of the avidin-fed aphids declined to 70% by day 12 and they showed 
some growth retardation as expected. In contrast, aphids fed the avidin : biotin-LMS 
conjugate showed a continuous decline in survival throughout the bioassay, with 
survival down to 25% by day 12 (Figure 5.5). Comparison of the survival curves 
shows that survival for the aphids fed diet containing avidin : biotin-LMS conjugate 
was statistically different from the survival of the aphids fed with any other treatment 
(Mantel-Cox log-rank, P<0.001). The other survival curves did not differ 
significantly from each other, with the exception of the aphids fed avidin, which 
differed marginally from the control (Mantel-Cox log-rank, P=0.047) (Figure 5.5). 
The data shows that the avidin : biotin-LMS conjugate displays insecticidal activity 
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towards aphids that is not shown by either of the constituents of the conjugate on 
their own. 
 
 
 
 
 
 
 
 
LMS (30bp)Avidin (381bp) B
Figure 5.3. 
Schematic representation of the avidin : biotin-LMS conjugate. 
Diagram not to scale. 
 
 
 
Figure 5.4. 
17.5% SDS-PAGE analysis of avidin : biotin-LMS conjugate. 
M is SDS 7 molecular weight marker. Lane 1 is 10µl of avidin : biotin-LMS conjugate. The 
conjugate dissociates upon boiling, showing both the avidin (20kDa) and LMS (1.3kDa) 
components. 
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Preparation, Insecticidal Activity and Transport of an Avidin : biotin-allatostatin 
Conjugate in Lepidoptera 
 As an avidin-biotin conjugate is transported to the haemolymph in 
lepidoptera (Hinchliffe, 2007), the hypothesis that a biotinylated peptide could be 
conjugated to avidin and similarly transported, possibly to show insecticidal activity, 
was tested. A conjugate between avidin and N-terminally biotinylated allatostatin 
(avidin : biotin-allatostatin) was used as the subject for assays (Figure 5.6). 
 
 Allatostatin, similar to that isolated from Manduca sexta (tobacco hornworm) 
(Lepidoptera: Sphingidae, Linnaeus 1763) (Chapter 1), was synthesised with a biotin 
residue added to the N-terminus of the peptide to allow affinity conjugation to 
 
 
Figure 5.5. 
Survival of A. pisum fed on artificial diet containing 0.1mg/ml recombinant avidin, 
biotin-LMS or avidin : biotin-LMS conjugate. 
(n = 20 for each treatment - Two separate treatments with 10 individuals). 
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avidin. The resulting peptide (biotin-QVRFRQCYFNPISCF) was conjugated to 
avidin by incubation in molar excess (2:1), followed by dialysis to remove the 
unbound peptide (Figure 5.7). 
 
 Initially, to check the activity of the biotin-allatostatin and avidin : biotin-
allatostatin conjugate, 5µl injections of amounts between 1µg and 10µg were carried 
out in newly moulted fifth stadium Mamestra brassicae (cabbage moth) 
(Lepidoptera: Noctuidae, Linnaeus 1758) larvae. These amounts were based on the 
injections carried out by Audsley et al. (2001) in Lacanobia oleracea (tomato moth) 
(Lepidoptera: Noctuidae, Linnaeus 1758) larvae. As biotin-allatostatin was 
resuspended in 10% (v/v) Dimethyl suphoxide (DMSO), injections of 5µl of 10% 
DMSO were carried out as a negative control. 
 
 At the 10µg dose, both the biotin-allatostatin and avidin : biotin-allatostatin 
conjugate gave 100% mortality in 48 hours, whereas the DMSO negative control 
larvae showed 100% survival (Mantel-Cox log-rank statistical analysis, P<0.0001) 
(Figure 5.8). At the 5µg dose, the biotin-allatostatin gave 80% mortality and the 
avidin : biotin-allatostatin conjugate gave 50% mortality in 48 hours, both of which 
are statistically significant (Mantel-Cox log-rank statistical analysis, compared to 
control, P=0.0006 and P=0.0162 respectively). At the 1µg dose, 100% survival was 
observed for both samples (Figure 5.8). These results suggest that both the biotin-
allatostatin and avidin : biotin-allatostatin conjugate are active. 
 
 
 
 
 
 
Allatostatin (45bp)Avidin (381bp) B
Figure 5.6. 
Schematic representation of the avidin : biotin-allatostatin conjugate. 
Diagram not to scale. 
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Figure 5.7. 
17.5% SDS-PAGE analysis of avidin : biotin-allatostatin conjugate. 
M is SDS 7 molecular weight marker. Lane 1 is 10µl of avidin : biotin-allatostatin 
conjugate. The conjugate dissociates upon boiling, showing both the avidin (20kDa) and 
allatostatin (2kDa) components. 
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Figure 5.8. 
Mortality of M. brassicae larvae following injection with varying amounts of biotin-
allatostatin and avidin : biotin-allatostatin conjugate. 
(n = 20 for each treatment - Two separate treatments with 10 individuals). 
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 The next step was to look for insecticidal activity when the avidin : biotin-
allatostatin conjugate was fed to M. brassicae larvae. The avidin : biotin-allatostatin 
conjugate was fed at a dose of 1000ppm (5mg conjugate in 5g artificial diet), an 
amount of allatostatin well in excess of that fed by Matthews et al. (2008). However, 
the insecticidal activity of avidin alone towards M. brassicae larvae when included at 
1000ppm in artificial diet (5mg in 5g diet) had previously been established 
(Hinchliffe, 2007). This insecticidal activity of avidin needed to be taken into 
account when determining the insecticidal effect of the conjugate containing avidin. 
Thus, a separate treatment of recombinant avidin (1000ppm, 5mg in 5g artificial diet) 
was fed to neonate M. brassicae larvae alongside avidin : biotin-allatostatin 
conjugate (1000ppm, 5mg in 5g artificial diet). Any effects deviating from those of 
avidin would be due to the allatostatin component of the conjugate. A biotin-
allatostatin (1000ppm, 5mg in 5g artificial diet) and a diet-only treatment were also 
included as negative controls. Survival was recorded over 20 days for all treatments. 
 
 The avidin : biotin-allatostatin conjugate had no significant effects on the 
survival of the M. brassicae larvae as only 5% mortality was observed (Figure 5.9). 
The recombinant avidin treatment showed 100% mortality spread over the 20-day 
bioassay. The diet-only control and biotin-allatostatin showed 100% survival. This 
suggests that the avidin : biotin-allatostatin conjugate is not insecticidal. 
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 To investigate the in vivo transport of the avidin : biotin-allatostatin 
conjugate, M. brassicae larvae from the above experiment were allowed to continue 
feeding on 1000ppm of avidin : biotin-allatostatin conjugate until they reached fifth 
stadium. At this point, haemolymph was extracted from three larvae, pooled together 
and analysed by western blotting (anti-allatostatin and anti-avidin antibodies). 
Haemolymph from larvae fed with artificial diet only was included as a control 
(Figure 5.10). 
 
 The results show the presence of two bands in the avidin : biotin-allatostatin 
conjugate positive control (20kDa and 2kDa), indicating that the conjugate had not 
dissociated completely into avidin and biotin-allatostatin upon boiling in preparation 
for the blot (Figure 5.10(a)). Hence, it can be seen that there is an absence of avidin : 
 
 
Figure 5.9. 
Survival of M. brassicae larvae fed on artificial diet containing 1000ppm 
recombinant avidin, biotin-allatostatin or avidin : biotin-allatostatin conjugate. 
(n = 20 for each treatment - Two separate treatments with 10 individuals). 
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biotin-allatostatin conjugate within the haemolymph of the M. brassicae larvae. 
There is also an absence of any free biotin-allatostatin within the haemolymph of the 
larvae (Figure 5.10(a)), suggesting that the conjugate is degraded before it reaches 
the haemolymph. However, the remaining avidin (19kDa) was transported and 
readily detected in the haemolymph (Figure 5.10(b)). 
 
 
 
 
 
Figure 5.10. 
Western analysis of M. brassicae extracted haemolymph after feeding on 1000ppm 
avidin : biotin-allatostatin conjugate. 
One second exposures of the membrane transferred from a 15% SDS-PAGE gel. M is 
SDS7 molecular weight marker. (a) Anti-allatostatin antibody (1:5000). Lane 1 is 
haemolymph from larvae fed with artificial diet (control). Lane 2 is haemolymph from 
larvae fed with avidin : biotin-allatostatin conjugate. (25µl loaded for each sample). Lane 3 
is 3µg of avidin : biotin-allatostatin conjugate, showing the conjugate (20kDa) and 
unconjugated biotin-allatostatin (2kDa). The presence of two bands indicates the conjugate 
has not completely dissociated into avidin and biotin-allatostatin upon boiling in 
preparation for the blot. (b) Anti-avidin antibody (1:10000). Lane 4 is haemolymph from 
larvae fed with artificial diet (control). Lane 5 is haemolymph from larvae fed with avidin : 
biotin-allatostatin conjugate, showing the presence of avidin (19kDa). (25µl loaded for each 
sample). Lane 6 is 10ng of avidin : biotin-allatostatin conjugate (20kDa). 
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Discussion 
 
 This chapter presents the experiments carried out with the aim of producing 
an insecticidal avidin conjugate. 
 
 It clearly demonstrates that conjugation of a peptide to avidin causes the 
resultant conjugate to be retained within the aphid gut (Figure 5.2). 
 
 The toxicity of the avidin : biotin-LMS conjugate when fed to A. pisum 
observed in the experiments described in this chapter is comparable to that observed 
in previous experiments reported by Wiles (2007). In these earlier experiments, the 
retention of avidin in the aphid stomach region after feeding was not demonstrated 
and therefore the basis for the toxicity of the conjugate was not established. 
 
 The results presented here (Figures 5.5 and 5.2) also establish that the toxicity 
of the avidin : biotin-LMS conjugate to A. pisum is due to the retention of the peptide 
in the stomach, as a result of conjugation to avidin. Proteolytic activity in the pea 
aphid gut is low (Hinchliffe et al., 2010) and although protection of the peptide from 
proteolysis cannot be ruled out, the role of the avidin is more likely to be that of 
anchoring a high concentration of peptide at the gut surface. The absence of biotin-
LMS binding in the gut of the aphid dismisses the suggestion in Chapter 3 that 
binding of avidin in hemiptera is mediated through biotin. 
 
 In contrast to the results observed in A. pisum, the avidin : biotin-allatostatin 
conjugate is not orally insecticidal to M. brassicae larvae (Figure 5.9). One point to 
be noted from the feeding experiment is that the insecticidal effects of avidin are also 
abolished upon conjugation with biotin-allatostatin. The biotin-binding sites are 
saturated by the conjugated biotin-allatostatin, hence no dietary biotin can be 
sequestered. This evidence also supports the toxicity of the avidin : biotin-LMS 
conjugate in A. pisum is due to the conjugated biotin-LMS and not as a result of any 
toxicity from the avidin. 
 
 Further analysis shows there is an absence of any avidin : biotin-allatostatin 
conjugate or free biotin-allatostatin within the haemolymph of the larvae (Figure 
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5.10). The presence of avidin within the haemolymph shows that the allatostatin is 
cleaved from the conjugate, most likely by enzymes in the gut prior to transport of 
the avidin. The cleavage site is most likely to be between the biotin molecule and the 
allatostatin, because as previously shown, biotin remains bound to avidin upon 
transfer to the haemolymph (Hinchliffe, 2007). The absence of any allatostatin due to 
cleavage of the conjugate would explain the absence of any insecticidal effects. 
Lepidopteran larvae show high levels of gut proteolysis and the degradation of 
allatostatin in the gut has been documented previously (Audsley et al., 2002). The 
allatostatin used for these experiments similarly contains arginine residues that may 
be susceptible to trypsin-like serine protease cleavage in the gut of M. brassicae 
larvae. The presence of some immunoreactive, higher molecular weight bands 
(Figure 5.10) shows that some molecular association may have occurred, which 
could have affected the conjugate activity. Although this is unlikely to be the cause 
of the absence of insecticidal activity, it would require further investigation. 
 
 In conclusion, the use of avidin for insecticidal conjugates requires further 
investigation using different biotinylated toxins. However, unless a biotinylated toxin 
that is resistant to proteolysis can be produced, the results here indicate that the 
avidin conjugate method may only be suitable for use on insect pests that have lower 
levels of gut proteolysis, such as hemiptera. 
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Chapter 6 
 
General Discussion 
 
 Herbivorous insect pests are a major constraint on agricultural production. It 
is estimated that 30-40% of the world’s crop produce is destroyed by agricultural 
pests and associated diseases. In the UK, over 25 million pounds is spent on 
insecticides, but the withdrawal of many broad-spectrum pesticides and insecticide 
resistance has prompted the research into more sustainable, protein-based 
alternatives. 
 
 Many insecticidal proteins exist, including those discussed in detail in 
Chapter 1, but very few protein-based biopesticides have been employed 
successfully in crop protection. The aim of this project was to investigate the use of 
recombinant avidin for the protection of crops against insect pests. Recombinant 
avidin produced in Pichia pastoris has now been characterised (Chapter 3, Hinchliffe 
et al., 2010) and has been shown to have a similar tetrameric structure to egg white 
avidin. Its functional properties are also similar; the difference in glycosylation that 
results from expression in the yeast (which can only carry out core N-glycosylation 
and the addition of mannose residues to carbohydrate side chains on proteins) does 
not affect the biotin-binding activity of recombinant avidin. Further exploration of 
this expression system for the production of modified versions of avidin, as 
suggested by Zocchi et al. (2003), would seem justified, as the yields obtained make 
the production method economically viable for high-value products, if not for a 
potential biopesticide. 
 
 Recombinant avidin feeding bioassays with hemiptera in this study are the 
first reported and extend the range of insects against which avidin has insecticidal 
effects. As with the other insects, the cause of the insecticidal activity in 
Acyrthosiphon pisum (pea aphid) (Hemiptera: Aphididae, Harris 1776) is shown to 
be attributable to sequestration of dietary biotin by the recombinant avidin. However, 
the retarded growth observed in Sitobion avenae (cereal aphid) (Hemiptera: 
Aphididae, Fabricius 1775) highlights the differences in susceptibility to avidin 
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between different insect species. Although completely immune insects are rare, the 
susceptibility towards the biotin-sequestration effects of avidin is largely dependent 
on the levels of maternally-derived biotin (Markwick et al., 2001; Christeller et al., 
2010). This effect could play a role in the differential susceptibility of these two 
aphid species, since both are parthenogenetic, and the young could readily 
accumulate biotin from the mother prior to ‘birth’; the hypothesis would then be that 
S. avenae embryos accumulate more biotin from the parent aphid than A. pisum. An 
alternative hypothesis, based on the ability of the aphid to ‘scavenge’ biotin from 
ingested recombinant avidin, has been advanced earlier (Chapter 3, Hinchliffe et al., 
2010). This differential sensitivity has relevance to the possible use of recombinant 
avidin as a biopesticide, since adaptation of the insect to gain resistance to the 
pesticide would need to be considered. Like the use of other pesticides, unless the 
usage of avidin is carefully managed, it is likely that insects could increase the 
amount of maternally-derived biotin to overcome its insecticidal effects. 
 
 A primary finding of the bioassays was that unlike Mamestra brassicae 
(cabbage moth) (Lepidoptera: Noctuidae, Linnaeus 1758) larvae, recombinant avidin 
is not transported to the haemolymph of A. pisum and S. avenae, highlighting 
possible differences in protein transport from the gut to the haemolymph between 
hemiptera and lepidoptera (Chapter 3, Hinchliffe et al., 2010). Although attempts 
were made in this study to begin to explain the differences between the two insect 
orders, they remain largely unknown. It may be possible however, that recombinant 
avidin transports to the haemolymph of M. brassicae due to the ‘leaky’ nature of the 
lepidopteran gut. This has been observed with other large proteins (Jeffers and Roe, 
2008). In this respect, transport of avidin differs from transport of GNA, which 
involves the carbohydrate binding activity of the lectin for interaction with the gut 
surface (Powell et al., 1998). The failure of avidin to transport to the haemolymph of 
hemiptera, in contrast to GNA, may result from the lack of binding to suitable 
receptors at the gut surface, although binding to the stomach does occur, as shown by 
the chase-feed experiment with FITC-labelled recombinant avidin described in 
Chapter 3. Beyond the time constraints of this project, further investigation of 
recombinant avidin transport in other insect orders may highlight trends in the 
differences and help to explain exactly how avidin transport works in nature. There is 
also currently renewed interest in elucidating the exact avidin binding and 
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transportation mechanism. Evidence from past experiments shows that avidin 
associates with condensed chromatin, mast cell granules and heparin (Heggeness, 
1977; Tharp et al., 1985; Kett et al., 2003). Just recently, avidin has been shown to 
bind to adenosine (Bing et al., 2012). These new developments may also help to 
explain the results obtained in this study. Perhaps an addition may be to develop a 
yeast two-hybrid system. 
 
 The use of avidin in synthetic fusion protein technology proved unsuccessful 
(Chapter 4). Evidence suggests that the fused peptide component folded incorrectly 
in Pichia pastoris when attached covalently to avidin. Similar results were also 
observed with garlic lectin (Allium sativum agglutinin; ASA) (Fitches et al., 2008). 
Consistent with this idea is the observation that toxin sequences themselves fold 
poorly in P. pastoris, since their insecticidal activity is much lower than literature 
values for toxins purified from natural sources (data not presented). Avidin may 
further inhibit the folding process, resulting in products that have no insecticidal 
activity at all. Cereghino and Cregg (2000) noted that when using P. pastoris as an 
expression host, the resultant glycosylation can interfere with protein folding, 
especially any attached proteins. This study shows that recombinant avidin expressed 
in P. pastoris is glycosylated. Therefore, perhaps a further investigation would 
involve attempting to mutate and replace the asparagine residue glycosylation site 
(amino acid number 25 including the N-terminal extension, Appendix 1) and see if 
avidin remains functional. If it retains activity, it should be tested again as part of a 
fusion protein. It may also be useful to look at glycosylation of the toxins utilised 
here. Extra glycosylation by the P. pastoris expression host may also affect their 
folding, not just avidin affecting them. Incorrect folding of the fused peptide was still 
apparent with an IgG hinge linker region incorporated to increase the spatial 
distribution between the peptide and avidin. Other claims of insecticidal avidin 
fusion proteins (Airenne et al., 1999) are limited and show very little evidence of 
activity or of further processing after their production. Unlike snowdrop lectin 
(Galanthus nivalis agglutinin; GNA), avidin may not be suitable for use as a ‘carrier’ 
in synthetic fusion protein technology. A further line of investigation however, 
before ruling out its usage in the technology, would be to increase the size of the 
linker, perhaps making it greater than 50 amino acids in length, and study whether or 
not this produces an active protein. Had time have not been limiting, a more 
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thorough investigation of the ButaIT-GNA Fragment and GNA Fragment-Avidin 
fusion proteins would be necessary, as more experimental data is required before any 
firm conclusions around the use of the 17 amino acid fragment instead of the 
complete GNA, can be drawn. There is also an important point to note; the GNA 
Fragment-Avidin fusion protein showed activity by injection, which implies the 51bp 
GNA Fragment folds correctly (51bp is around half the size of the ButaIT toxin). 
This being the case, if a toxin that was roughly 50bp in size was utilised in a fusion 
with avidin and expressed in P. pastoris, it should follow that this would also be 
active. This would require further investigation and although it is not an answer as to 
why the larger toxin fusion proteins are inactive, it would show if any toxin can be 
used with avidin at all. The mutational studies (ButaIT-Gavidin 1 Mutation and 
ButaIT-Gavidin 3 Mutations) in this case gave very little information on the 
mechanism of fusion proteins as a whole due to the imidazole mistake. However, it 
may be a useful investigation to try similar mutations with ButaIT-GNA or another 
GNA fusion protein to determine if chymotrypsin cleavage is required for fusion 
protein activity in insects. The published literature describes the current use of avidin 
fusion proteins in medical applications. The majority of these are fusion proteins 
with antibodies and use different expression hosts (Lesch et al., 2009; Lesch et al., 
2010; Suzuki et al., 2010). This shows that active fusion proteins with avidin can be 
produced, but alternative expression hosts to the P. pastoris used in synthetic fusion 
protein technology may be required. This would require further investigation. 
 
 On the other hand, an insecticidal recombinant avidin conjugate was 
successfully produced (Chapter 5). However, this study found that conjugates of this 
type may only be useful as an oral insecticide in insects with low levels of gut 
proteolysis. With more time, further investigation with different insect species would 
be required to confirm this. Certainly, a further line of enquiry would be to try a 
conjugate with a different allatostatin without the arginine residue where proteolysis 
is known to occur before any final conclusions can be made. The option of further 
biotinylated toxins also exists, but these need to be chosen based on how avidin 
transports inside the target insect. The scientific literature again describes examples 
of avidin conjugates used within medical applications (Xia et al., 2009; Zhou et al., 
2011), but none show examples of insecticidal conjugates. There will however, be 
limitations with an insecticidal avidin conjugation method, such as practical 
Chapter 6                                                                                                                  General Discussion 
 - 178 - 
production on a large scale. More cost-effective, alternative methods of peptide 
biotinylation may be required. 
 
 In conclusion, avidin is not currently used for the control of insect pests 
although the results obtained here, alongside those others reported, show that with 
management it is clearly an alternative for use alone as a biopesticide. The use of 
avidin in P. pastoris synthetic fusion protein technology was unsuccessful, but this 
does not rule out its use with other expression hosts. The avidin conjugate method 
described in this study also shows promising results and potential for insect pest 
control. Perhaps the key to using avidin as a ‘carrier’ in avidin fusion proteins and 
conjugates at all is its actual mechanism of transport in insects compared to GNA. 
 
 Finally, the recent literature shows that the avidin-biotin system is still under 
research and development, with several modified types of avidin now available, 
including chimeric avidin, Tamavidin, NeutrAvidin and CaptAvidin (Morag et al., 
1996; Takakura et al., 2010; Riihimaki et al., 2011). These new, modified varieties 
of avidin may be useful in future attempts to construct insecticidal fusion proteins 
and conjugates. 
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ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACA    +75 
 M  R  F  P  S  I  F  T  A  V  L  F  A  A  S  S  A  L  A  A  P  V  N  T  T      25 
 
ACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTT    +150 
 T  E  D  E  T  A  Q  I  P  A  E  A  V  I  G  Y  S  D  L  E  G  D  F  D  V      50 
 
GCTGTTTTGCCATTTTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCT    +225 
 A  V  L  P  F  S  N  S  T  N  N  G  L  L  F  I  N  T  T  I  A  S  I  A  A      75 
 
AAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGAATTCGCCCTTCGCGTCGACGCTAGAAAA    +300 
 K  E  E  G  V  S  L  E  K  R  E  A  E  A  A  E  F  A  L  R  V  D  A  R  K      100 
 
TGCTCGCTGACTGGGAAATGGACCAACGATCTGGGCTCCAACATGACCATCGGGGCTGTGAACAGCAAAGGTGAA    +375 
 C  S  L  T  G  K  W  T  N  D  L  G  S  N  M  T  I  G  A  V  N  S  K  G  E      125 
 
TTCACAGGCACCTACACCACAGCCGTAACAGCCACATCAAATGAGATCAAAGAGTCACCACTGCATGGGACACAA    +450 
 F  T  G  T  Y  T  T  A  V  T  A  T  S  N  E  I  K  E  S  P  L  H  G  T  Q      150 
 
AACACCATCAACAAGAGGACCCAGCCCACCTTTGGCTTCACCGTCAATTGGAAGTTTTCAGAAAGTACTACTGTC    +525 
 N  T  I  N  K  R  T  Q  P  T  F  G  F  T  V  N  W  K  F  S  E  S  T  T  V      175 
 
TTCACGGGCCAGTGCTTCATAGACAGGAACGGGAAGGAGGTCCTGAAGACCATGTGGCTGCTGCGGTCAAGTGTT    +600 
 F  T  G  Q  C  F  I  D  R  N  G  K  E  V  L  K  T  M  W  L  L  R  S  S  V      200 
 
AATGACATTGGTGATGACTGGAAAGCTACGCGTGTTGGTATCAACATCTTCACTAGATTGAGAACTCAAAAGGAA    +675 
 N  D  I  G  D  D  W  K  A  T  R  V  G  I  N  I  F  T  R  L  R  T  Q  K  E      225 
 
ATCGACCATCATCATCATCATCATTGA                                                    +750 
 I  D  H  H  H  H  H  H  .                                                      250 
 
Appendix 1. 
Nucleotide sequence and deduced amino acid sequence of recombinant avidin. 
The yeast alpha factor sequence of pGAPZ!B is highlighted in grey. The avidin 
sequence is highlighted in yellow. The (His)6 tag is underlined in black. 
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Insecticidal activity of recombinant avidin produced in yeast
Gareth Hinchliffe a, David P. Bown a, John A. Gatehouse a, Elaine Fitches b,*
a School of Biological and Biomedical Sciences, University of Durham, Science Laboratories, South Road, Durham DH1 3LE, UK
b Food and Environment Research Agency, Sand Hutton, York YO41 1LZ, UK
1. Introduction
Avidin, a protein found in the egg white of birds, reptiles and
amphibians, is thought to function as an antibacterial, host-defence
protein, by virtue of its ability to bind biotin, an essential vitamin for
most organisms. In nature, avidin exists as a homotetramer,
comprising four 16 kDa singly glycosylated subunits, each able to
bind a biotin molecule with extreme specificity and affinity (Green,
1990).
The search for protein-based approaches to crop protection has
been prompted by the growing demand for more environmentally
compatible approaches to pest control, and encouraged by the
successful use of insecticidal protein toxins from the soil microor-
ganism Bacillus thuringensis (Bt) as a spray and in transgenic crops.
The insecticidal activity of avidin was first identified 50 years ago,
when dietary avidin was found to have detrimental effects on the
growth of housefly larvae (Musca vicina) (Levinson and Bergmann,
1959). Avidin, and the related bacterial protein streptavidin, have
since been shown to be toxic to a wide range of insects including
representatives of Lepidoptera (Morgan et al., 1993; Du and
Nickerson, 1995; Markwick et al., 2001; Burgess et al., 2002; Zhu
et al., 2005), Diptera (Levinson and Bergmann, 1959; Tsiropoulos,
1985; Bruins et al., 1991), Coleoptera (Levinson et al., 1967; Allsopp
and McGhie, 1996; Kramer et al., 2000; Yoza et al., 2005; Cooper et
al., 2006; Murdock and Shade, 2008) and Orthoptera (Christeller et
al., 2000). Avidin is a normal component of humandiet, and thus has
potential for adoption as an insect control agent. Furthermore,
dietary levels of the protein required for effective insecticidal
activity against a wide range of pests are much lower than levels
present in normal human diet. Expression of avidin in transgenic
plantshasbeenput forwardasa strategy toconferprotectionagainst
insect pests, with engineering of maize, corn, tobacco, potato, apple
and rice having been reported (Kramer et al., 2000; Burgess et al.,
2002; Murray et al., 2002; Markwick et al., 2003; Yoza et al., 2005).
However, the initial report of expression of avidin inmaize,with the
intention of producing protein which could be extracted for use as a
biochemical reagent (Hood et al., 1997) remains the only example of
large-scale expression in planta.
The insecticidal effects of avidin aremediated through its biotin-
binding activity. Inmany cases insecticidal effects have been shown
to be eliminated in diets supplemented with biotin, supporting the
hypothesis that avidin acts through the sequestration of biotin from
ingested food, thereby preventing absorption and causing biotin
deficiency in the insect. Biotin, as a cofactor of major carboxylases
involved in key process such as gluconeogenesis, lipogenesis, and
fatty acid and amino acid catabolism is essential for insect growth
(Wood and Barden, 1977; Knowles, 1989). Most insects fed on
avidin-containing diets show retarded growth, leading to eventual
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mortality. However, susceptibility to the insecticidal effects of the
protein shows considerable variability, even between related
species (Morgan et al., 1993). This variability in susceptibility is
thought to depend upon variations in levels of maternally derived
biotin (Markwick et al., 2001).
Most avidin for commercial purposes is purified from hen egg
white, although expression systems for producing the protein
based on bacteria and insect cells have been described (Airenne et
al., 1999). Here, we report the production of recombinant avidin
utilising the yeast Pichia pastoris as an expression host, which gives
a biologically active product at high yield. Bioassays to compare
the insecticidal activity of recombinant avidin with native avidin
have been conducted, and the potential use of avidin for the control
of hempiteran pests is demonstrated. This is the first published
report of insecticidal effects of avidin against aphids, important
globally as pests of crops not only for the direct damage caused by
infestation, but also through their role as vectors of plant diseases.
2. Materials and methods
2.1. Materials and recombinant DNA techniques
All chemical reagents were of GPR or better grade and were
supplied by BDH, Sigma or Merck unless otherwise stated. Hen egg
white avidin and anti-avidin antibodies were obtained from Sigma.
Sub-cloning was carried out using a TOPO-TA cloning kit purchased
from Invitrogen. Expression vector pGAPZaB, P. pastoris X33 strain,
andEasycompPichia transformationkitwere suppliedby Invitrogen.
Oligonucleotide primers were synthesised by Sigma-Genosys. PCR
reactions were performed with Phusion high fidelity DNA polymer-
ase from New England Biolabs following their product recommen-
dations. PlasmidDNAwaspreparedusing the PromegaWizardmini-
prep kit. Restriction enzymes and DNA ligase were provided by
Promega. All general procedures were based on standard protocols
described by Sambrook and Russell (2001). DNA sequencing was
carried out using Applied Biosystems ABI Prism 3730 automated
DNA sequencers by the DNA Sequencing Service (DBS Genomics),
SchoolofBiological andBiomedicalSciences,DurhamUniversity,UK.
SequencedatawasanalysedusingSequencher software (version4.5)
running on Mac OS computers.
2.2. Electrophoresis and Western blotting
Proteins were routinely separated and analysed by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970).
Samples were prepared by adding 5! SDS sample buffer (contain-
ing 10% 2-mercaptoethanol) and boiled for 10 min prior to loading.
Gels were either stained with Coomassie Blue or transferred to
nitrocellulose membrane using an ATTO HorizBlot semi-dry
electroblotting system according to manufacturer’s instructions.
Western blotting was carried out as described previously (Fitches
and Gatehouse, 1998), except for chemiluminescent reagents.
Enhanced Chemiluminescence detection was carried out using
coumaric acid (0.2 mM) and luminol (1.25 mM) in 1 MTris (pH 8.5)
with the addition of 0.009% (v/v) hydrogen peroxide.
2.3. Recombinant avidin preparation
Genomic DNA, used as a template to amplify the avidin coding
sequence, was extracted from a 5-day-old chicken (Gallus gallus)
embryo. The avidin gene contains four exons, with the majority of
the mature polypeptide coding sequence present in exons 2 and 3.
Exons 2 and 3were amplified separately using primers; Ex12f with
Ex23r (exon 2) and Ex3f with Ex3r (exon 3) (Table 1) and
individually sub-cloned into pCR2.1. Positive clones were identi-
fied by DNA sequencing. An expression construct for the complete
avidin coding sequence (Fig. 1A) was subsequently assembled in a
two-step process. In the first step, exons 2 and 3 were assembled
together by restricting pCR2.1 clones with PstI and ScaI (exon 2) or
ScaI and EcoRI (exon 3) followed by ligation into pUC18 (restricted
PstI and EcoRI). Again, positive clones were confirmed by DNA
sequencing. In the second step, the combined exons 2 and 3 were
assembled with annealed oligonucleotides containing the exon 4
sequence (Ex4f and Ex4r; Table 1) and cloned directly into the P.
pastoris expression vector pGAPZaB. To this end exons 2 and 3
were restricted from pUC18 (PstI and MluI) and ligated to exon 4
(viaMluI site) and inserted into pGAPZaB (restricted with PstI and
SalI). A clone containing the complete expression construct which
includes an N-terminal extension of 9 amino acid acids (Fig. 1B)
was verified by DNA sequencing, and transformed into the wild-
type X33 P. pastoris strain using the Invitrogen ‘Easycomp’ Pichia
transformation kit in accordance with the manufacturer’s instruc-
tions. Transformants were selected by plating onmedia containing
zeocin (100 mg/ml). High-expressing clones were identified by
western blot analysis of supernatant from small-scale cultures
using anti-avidin antibodies (1:5000 dilution).
2.4. Recombinant avidin expression and purification
P. pastoris containing a selected avidin construct was grown in a
7.5 l BioFlo 110 bench-top fermenter (New Brunswick Scientific)
and the cells were processed as previously described (Fitches et al.,
2004), with one exception: the growing culture was maintained at
pH 4.5. Culture supernatant was adjusted and diluted (50:50) with
sodium acetate pH 4.0 and sodium chloride to a final concentration
of 50 mM and 0.5 M, respectively. Recombinant avidin was
purified using nickel affinity chromatography on a HisTrap crude
nickel column (GE Healthcare) with a flow rate of 2 ml/min. Bound
protein was eluted by the addition of imidazole (300 mM) in
50 mM sodium acetate pH 7.4. Purified avidin was de-salted by
dialysis and freeze-dried. The concentration of avidin in lyophi-
lised samples was estimated by comparison with known amounts
of standard native avidin (Sigma) on SDS-PAGE gels.
2.5. Gel filtration of recombinant avidin and commercial hen egg
white avidin
Analytical gel filtration was carried out on a column of
Sephacryl S-200 (GE Healthcare), 1.6 cm diameter ! 70 cm, in
phosphate-buffered saline (PBS; pH 7.2), at a flow rate of 15 ml/h.
The columnwas calibratedwith standard proteins BSA, ovalbumin,
Table 1
Primers and oligonucleotides used to assemble the avidin coding sequence. Enzyme restriction sites are underlined. For Ex4f50 and Ex4r30, bases
compatible with restriction sites are underlined.
Primer Sequence Enzyme site
Ex12f 50 CGCGTCGACGCTAGAAATGCTCGCTGACTGGGAAATGG SalI
Ex23r 30 CGCGAGTACTTTCTGAAAACTTCCAATTGACGGTG ScaI
Ex3f 50 CGCGAGTACTACTGTCTTCACGGGCCAGTGC ScaI
Ex3r 30 CGCGACGCGTAGCTTTCCAGTCATCACC MluI
Ex4f 50 CGCGTGTTGGTATCAACATCTTCACTAGATTGAGAACTCAAAAGGAAA MluI
Ex4r 30 ACAACCATAGTTGTAGAAGTGATCTAACTCTTGAGTTTTCCTTTAGCT SalI
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and soybean Kunitz trypsin inhibitor, and the elution volume of
recombinant and egg white avidin was compared to a standard
curve of log (mol. wt.) vs. elution volume.
2.6. Recombinant avidin: in vitro activity
The ability of recombinant avidin to bind biotin was assayed in
vitro using biotin–agarose (Thermo Scientific). Matrix (1:1
suspension in 100 ml PBS)was incubatedwith 5mg of recombinant
avidin at room temperature for 30 min. Following centrifugation
(1 min at 2000 ! g) the pellet was washed two times with PBS.
Avidin bound to biotin was eluted from the matrix by boiling, and
fractions were analysed by SDS-PAGE.
2.7. Recombinant avidin de-glycosylation
Recombinant avidin was de-glycosylated using PNGase F (New
England Biolabs), 10 mg of test protein was incubated at 37 8C
overnightwith 500 units of PNGase F, following themanufacturer’s
recommended protocol. Yeast invertase (Sigma) was used as a
positive control. Reaction products were analysed by SDS-PAGE on
15% acrylamide gels.
2.8. Insects
Insect cultures originally obtained from the Food and Environ-
ment Research Agency, York, UK, were subsequentlymaintained at
the University of Durham. Mamestra brassicae (cabbage moth)
were maintained on artificial diet (Bown et al., 1997) at 23 8C.
Acyrthosiphon pisum (pea aphid) were reared on established broad
bean (Vicia fabae) plants at 18 8C, 30% relative humidity. Sitobion
avenae (cereal aphid) were kept on 4-week old oat (Avena sativa)
plants at 18 8C, 30% relative humidity. All insects were maintained
under a 16 h light:8 h dark regime.
2.9. Lepidopteran bioassay
Purified recombinant avidin was incorporated at known con-
centrations in artificial diet (Bio-Serv; powder containing cornflour,
raw wheat germ, brewers yeast, ascorbic acid, benzoic acid, methyl
parabenzoate) to assay for insecticidal activity against newly
hatched M. brassicae larvae. To prepare diets 1 g diet powder was
mixedwith 1 ml dist. water. Boiled agar (40 mg in 2 ml dist. water),
was added to the mix and the test protein finally added in 1 ml of
dist.water. Thisdiet containsbiotinasa componentofbrewersyeast
and wheat germ (1 g diet powder contains approximately 0.1mg
biotin; equivalent to approximately 0.02 ppm, based onwetweight,
in final diet, or approximately 0.08mM). Treatments consisted of
1000 ppm, 100 ppm and 10 ppm (based on wet weight) of
recombinant avidin re-suspended in water and incorporated into
5 gwetweightofdiet.Diets containingeggwhiteavidin (Sigma)and
casein at the highest concentration of 1000 ppm were prepared as
positive and negative controls, respectively. For each diet concen-
tration, 20 larvae were maintained in clear plastic pots (5 per pot)
containing moist filter paper to prevent diet desiccation. Survival
was monitored daily and individual weights were recorded daily
after 9 days at which time the larvae were large enough to handle
without damage.
2.10. Aphid bioassays
Liquid artificial diet (Douglas and Prosser, 1992) was used for
the oral delivery of recombinant avidin to A. pisum and S. avenae.
The diet contains biotin at a concentration of 1.0mg/ml (4.1mM).
Fig. 1. (A) Diagrammatic representation of avidin expression construct for expression in P. pastoris showing restriction sites used for assembly of the gene from fragments
amplified from G. gallus genomic DNA. (B) Nucleotide and predicted amino acid sequence of avidin expression construct in the vector pGAPZaB. The N-terminal a-factor
prepro-sequence (amino acids 1–89) is underlined, predicted Kex2 and Ste13 signal cleavage sites are denoted with * and the mature avidin polypeptide sequence (amino
acids 98–227) is highlighted in grey.
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Avidin was incorporated into diet at concentrations ranging from
0.05 to 2.0 mg/ml (0.75–30mM). Diet-only negative controls
(100 ml artificial diet) were also included. A total of 100 ml of
solution was used for each aphid feeding chamber, consisting of
Perspex rings (40 mmdiameter) overlainwith 2 layers of stretched
parafilm between which the diet was sandwiched. The ability of
aphids to survive on diets containing a range of biotin concentra-
tions was assessed by adding biotin at the required concentration
to diet prepared without biotin. In addition, a separate assay was
conducted where avidin and biotin were included in the diets at
concentrations of 0.2 mg/ml (3.0mM) and 0.1 mg/ml (410 mM),
respectively. For assays A. pisum and S. avenae adult aphids were
placed on artificial diet and left to produce nymphs overnight.
Adults were then removed and the nymphs were maintained on
the diet for a further 24 h. Twenty nymphs per treatment were
then transferred to feeding chambers (10 per replicate) containing
test diets. Survival of the aphids was monitored daily for 10 days,
with the diet refreshed as required. For determination of the effect
of avidin on the growth of S. avenae, assays were set up as above.
After 14 days, aphids were imaged using a Nikon binocular
microscope with camera. Captured images were analysed using
ImageJ software (NIH; http://rsb.info.nih.gov/ij), measuring overall
length and width of aphids.
2.11. Amplification of genomic region containing biotin synthesis
genes from Buchnera genomic DNA
DNA was extracted from whole adult aphids using TRI reagent
(T9424, Sigma Chemical Company) according to the manufac-
turer’s protocol. Primers for PCR were designed based on the
published pea aphid Buchnera genome sequence (http://buchner-
a.gsc.riken.go.jp), using sequences in flanking glyA and ybhE genes
to amplify the region containing genes encoding biotin synthesis
enzymes (forward primer 50-CAAGGTGGACCATTAATGCAT-30, bas-
es 318,674–318,694: reverse primer 50-GGTCCGCGTCATAT-
CATCTTTCATCC-30, bases 323,153–323,128; numbering from
accession CP001158). Experiments using A. pisum total DNA as a
positive control showed that a product of the correct size was
amplified; this was cloned into pJET (Clontech) and DNA
sequencing was used to confirm that it corresponded to the
expected fragment. Amplification of total DNA extracted from S.
avenae gave a fragment of similar size to that obtained from A.
pisum. This was cloned as before, and analysed by DNA sequencing,
using a ‘‘primer walking’’ method to obtain the complete sequence
of the fragment.
2.12. Stability of avidin
Analysis of the stability of recombinant avidin in vivo after
ingestion by aphids was carried out as follows: 2 day old A. pisum
and S. avenae aphids (20 per treatment) were fed for 48 h on diet
containing 2 mg/ml avidin, and for 48 h with diet containing 2 mg/
ml avidin followed by control artificial diet for 48 h. Control
samples were obtained from aphids fed on artificial diet for 48 h.
Aphids were then rapidly frozen in liquid nitrogen and homo-
genised in 100 ml PBS. Following centrifugation (12,000 ! g;
2 min), supernatants were analysed for the presence of avidin
by western blotting. Mature aphids were starved for 1 h and then
fed with control diet and diet containing 2 mg/ml recombinant
avidin. Each replicate assay contained 10 aphids contained in a 1.5-
ml Eppendorf tube fed on 100ml of diet. Honeydew was collected
from the tubes after 72 h by adding 25 ml SDS-PAGE sample
loading buffer to the tubes, and spreading over the surface of the
tube. The buffer was collected by brief centrifugation, and the
whole sample was loaded into a single well for gel electrophoresis.
The proteins present in honeydew were separated by SDS-PAGE.
2.13. Statistical analysis
All data analysis was conducted using the statistical functions
of GraphPad Prism 5.0. Kaplan–Meier insect survival curves were
compared using Mantel–Cox log-rank tests. Insect weights and
sizes were analysed using either Student’s t-tests or one-way
analysis of variance (ANOVA). Analysis of growth curves was
carried out by non-linear regression, fitting to a Weibull growth
curve model. The accepted level of significance was P < 0.05 in all
cases.
3. Results
3.1. Expression, purification and characterisation of
recombinant avidin
A construct encoding a mature avidin polypeptide (i.e. without
the predicted signal peptide) was assembled by PCR using gene
specific primers for the three exons of the published sequence of
the chicken avidin gene (accession no. AJ311647), and G. gallus
genomic DNA as a template. The assembled sequence encoded a
protein identical to the published sequence for chicken avidin
(accession no. CAC34569), with the exception of one amino acid
substitution; Asp11 in the database mature protein sequence was
replaced by Thr in the assembled sequence. Sequence encoding the
mature avidin polypeptide was cloned into the yeast expression
vector pGAPZaB, which directs constitutive expression of the
recombinant polypeptide. The predicted protein product (Fig. 1B)
contains a C-terminal extension coding for a hexahistidine tag, and
an N-terminal extension of 9 amino acids derived from the cloning
vector, arranged in frame with the N-terminal yeast a-mating
factor prepro-sequence present in the expression vector, which
directs secretion of the recombinant protein product into the
culture medium. The predicted product, after post-translational
removal of the a-factor prepro-sequence, contains 144 residues
and has a predicted molecular mass of 16.26 kDa. The protein has
one predicted glycosylation site (N-X-S/T) located at residue 25.
DNA from verified clones was linearised and transformed into the
X33 wild-type strain of P. pastoris. Clones were selected on zeocin-
containing media, and screened for avidin expression by western
blotting of culture supernatant.
Ahigh-expressingyeastclonewasselected for large-scaleculture
in a bench-top fermenter. Recombinant avidin was purified from
culture supernatant to almost 100% homogeneity by nickel affinity
chromatography (Fig. 2A), giving yields of up to 80 mg/l culture
supernatant after dialysis and freeze-drying. Purified recombinant
avidin runs as a single bandof approximately 20 kDawhen analysed
by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), as com-
pared to chicken avidin (commercial) that has an indicated
molecular mass of 16 kDa. The recombinant avidin is reactive with
anti-avidin antibodies (Fig. 2B) after western blotting, at a level
similar to protein purified from egg white. Gel filtration of
recombinant avidin and egg white avidin gave identical elution
volumes for the two samples within the experimental error of the
technique (Fig. 2E), suggesting that the recombinant avidin forms
tetrameric molecules similar to ‘‘wild-type’’ avidin, although both
samples ran at an indicated molecular weight of approximately
50,000 compared to standard proteins. Recombinant avidin was
glycosylated by the yeast expression host, as shown by de-
glycosylation in vitro. Treatment of the protein using PNGase F
resulted in a progressive disappearance of the 20 kDa band seen
after SDS-PAGE, and the appearance of a band at 16 kDa (Fig. 2D).
Thus the higher molecular weight of recombinant avidin, as
compared to native protein, can be attributed to glycosylation by
the yeast expression host and also to the presence of N- and C-
terminal extensions in the expression construct.
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The ability of recombinant avidin to bind to biotin was
confirmed in vitro by incubation with a molar excess of
immobilised biotin. SDS-PAGE analysis (Fig. 2C) showed the
presence of avidin in biotin-bound fractions and absence of protein
in wash fractions, suggesting that 100% of the purified protein was
able to bind to biotin, and that the recombinant protein is fully
biologically active.
3.2. Insecticidal activity of orally delivered avidin towards
lepidopteran larvae
Neonate larvae of cabbage moth (M. brassicae) were fed on
artificial diet containing recombinant avidin at concentrations of
1000 ppm, 100 ppm and 10 ppm (wet weight; equivalent to 1.0,
0.1 and 0.01 mg/g diet, or estimated concentrations of 15, 1.5 and
0.15mM) and egg white avidin at 1000 ppm. As shown in Fig. 3A,
recombinant avidin and egg white avidin at 1000 ppm caused a
progressive, significant reduction in larval survival with 100%
mortality recorded after 21 days and 20 days, respectively. Survival
of larvae fed on control diet was !90% over this period, which
extended from neonate to the final larval instar. The survival
curves for the two avidin treatments were similar suggesting that
recombinant avidin has a similar insecticidal activity to egg white
avidin. Reductions in survival coincided with periods of moults in
control larvae suggesting that the limited growth of larvae reduced
reserves available for successful ecdysis. Insects fed avidin at
1000 ppm (15mM) showed severe growth inhibition; after 9 days
exposure (first point at which insects could be individually
weighed) experimental insects were approximately 70% of control
weight. Control insects increased their mean weight by nearly 18-
fold over the remainder of the experiment (12.3 mg on day 9 to
216 mg by day 21), with a steady increase in mean weight over
time, whereas surviving avidin-fed insects at most doubled their
weight, and showed no consistent trend of weight increase. The
effects of recombinant and eggwhite avidins at 1000 ppm (15mM)
on larval growth were similar.
The insecticidal effects shown by recombinant avidin were
dose-dependent (Fig. 3B). Feeding recombinant avidin at concen-
trations of 1000 and 100 ppm (15 mMand 1.5 mM) both resulted in
100% larvalmortality over 21 days, with similar survival curves. On
the other hand, feeding recombinant avidin at a concentration of
10 ppm (0.15mM) had no effect on survival, with 90% survival over
21 days, and a survival curve similar to control insects. The LD50 for
recombinant avidin in these assays can thus be estimated as being
approximately 30 ppm (approximately 0.5 mM). Effects of
1000 ppm and 100 ppm (15mM and 1.5mM) avidin treatments
on larval growth were similar, with very strong inhibitory effects
on surviving larvae observed (approximately 90% reduction in
mean weight compared to control to day 20). On the other hand,
the 10 ppm (0.15 mM) avidin treatment had only a marginal effect
on growth, with no effect compared to controls over the first 13
days of the assay, and approximately 15% reduction in growth over
remaining period of the assay, with a final difference inmean larval
weights of approximately 20%. The reduction in growth was
statistically significant when data were analysed using a Weibull
growth curve model (P < 0.02, null hypothesis that one curve fits
all data).
3.3. Insecticidal activity of orally delivered avidin towards aphids
The oral activity of avidin towards two hemipteran pest species
was evaluated by feeding pea aphids (A. pisum), and cereal aphids
Fig. 2. Characterisation of recombinant avidin. (A) SDS-PAGE of fractions from purification of recombinant avidin from yeast culture supernatant by Ni-NTA affinity
chromatography; L, F.T., and E1 denote load, flow through, and elution fractions, St.1 is Sigma avidin (10mg)M in all cases is standardmolecularweightmarker SDS-7 (Sigma).
(B) Western analysis (anti-avidin antibodies) of purified recombinant avidin (E2, 10 ng), St.2 shows 10 ng Sigma avidin. (C) SDS-PAGE demonstrating In vitro binding of
recombinant avidin to immobilised biotin–agarose; Un, W1, W2, and E denote unbound, wash, and elution fractions. St.1 is recombinant avidin (2.5mg). (D) SDS-PAGE
following in vitro de-glycosylation of recombinant avidin by PNGase F; St.2 and D1 denote avidin and deglycosylated avidin, C.St. and C.D. denote control yeast invertase and
de-glycosylated yeast invertase (10mg loaded in all lanes). Arrows depict PNGase F enzyme. (E) Gel filtration of commercial hen egg white avidin (dashed line) and
recombinant avidin (solid line) on Sephacryl S-200 column. Labelled arrow heads show elution volumes of standard proteins: (a) bovine serum albumin dimer (134 kDa); (b)
bovine serum albumin (67 kDa); (c) ovalbumin (45 kDa); (d) soya bean Kunitz trypsin inhibitor (20 kDa).
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(S. avenae) on artificial diets containing recombinant avidin.
Concentrations of avidin in the range 0.05–2.0 mg/ml (0.75–
30 mM, 50–2000 ppm) were employed. The standard aphid diet
contained a background level of biotin of 4.1mM.
Recombinant avidin had a dose-dependent insecticidal activity
towards A. pisum, causing a reduction in aphid survival (Fig. 4).
Acute toxicity was observed in diets containing 1 mg/ml, 0.5 mg/
ml, and 0.25 mg/ml avidin with 100% mortality (Mantel–Cox tests,
P < 0.0001) recorded for all treatments 4 days after the onset of the
assay. Aphid survival was also reduced in treatments containing
0.2 mg/ml, 0.1 mg/ml, and 0.05 mg/ml avidin with respective
values of 20%, 70%, and 80% recorded at the end of the 10-day assay,
as compared to 95% control survival. Differences in survival as
compared to controls were significant for the 0.2 mg/ml treatment
(Mantel–Cox, P < 0.0001) but not for the 0.1 mg/ml and 0.05 mg/
ml treatments. At sub-lethal levels of avidin, mortality was
observed in the first 6 days of the assay, afterwhich no further drop
in survival was recorded. Control survival was greater than 90%
over the assay period. Fitting data to a dose–response curve
equation allowed an LC50 of 0.14 mg/ml (2.1mM) to be estimated
for avidin toxicity to pea aphid (Fig. 4B); similar values were
obtained whether survival at day 4 or day 10 of the assay was used
to estimate LC50. Supplementation of diet with biotin prevented
the insecticidal effects of avidin; pea aphids fed diets containing
avidin and biotin (at concentrations of 2.0 mg/ml and 0.1 mg/ml;
3.0 mMand 410mM, respectively) showed no reduction in survival
compared to controls (results not shown). This demonstrated that
the insecticidal activity of recombinant avidin towards pea aphids
was attributable to biotin deficiency caused by the sequestering of
biotin by avidin.
Fig. 3. Effects of avidin on survival and development of cabbage moth (M. brassicae) neonate larvae. (A) Comparison of egg white avidin and recombinant avidin incorporated
into diets at 1000 ppm (wet weight). Larval weights were recorded from day 9 onwards when the insects were large enough to handle without damage. Points on weight
graph show mean ! S.E. (B) Dose–response effects of recombinant avidin incorporated into diets at levels 10–1000 ppm (wet weight). Points on weight graph show mean ! S.E.
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In contrast to effects on A. pisum, when recombinant avidin was
fed to S. avenae no significant effects on aphid survival at
concentrations up to 1.0 mg/ml (15 mM; Fig. 4A and B) were
observed. Evenwhen avidinwas added to diet at a concentration of
2.0 mg/ml (30 mM) aphid survival after 10 days of feedingwas only
reduced to 75%, compared to 95% for control fed insects (Fig. 4B).
However, avidin did have an effect on growth of S. avenae, since all
of the aphids exposed to avidin-containing diets (concentration
range 0.25–2.0 mg/ml, 3.8–30 mM) were observed to be smaller
than the control aphids after the initial 3–4 days of the assay, and
during the remainder of the assay period. Measurements carried
out on S. avenae fed avidin at 2.0 mg/ml (30 mM) showed that after
14 days exposure to avidin-containing diet, aphids had only grown
to approximately 60% of the size of controls (Fig. 4D).
3.4. Mechanism of toxicity of avidin towards aphids
When A. pisum and S. avenae were fed on diets containing
varying amounts of biotin, from 0 to 4mM (normal diet level),
mortality was observed in both species at biotin levels!3 mM, but
the two species showed differing responses to sub-optimal
concentrations of biotin (Fig. 5A). Pea aphids fed control diet
containing 4 mM biotin grew normally with no mortality,
whereas aphids fed levels of biotin !3 mM showed similar
mortality to aphids fed no biotin at all, with 100% mortality at
day 9 for all treatments. Survival curves for A. pisum fed biotin in
the range 0–3 mMwere not significantly different. S. avenaewere
less sensitive to sub-optimal biotin levels in diet, with 100%
mortality at day 9 and similar survival curves for treatments in
the range 0–2 mM, but only partial mortality (55%) for the 3 mM
biotin treatment (0% mortality for 4 mM biotin control). The
survival curve for the 3 mM biotin treatment was significantly
different from both the ‘‘normal’’ diet control and the 0–2 mM
biotin treatment curves.
The two aphid species also showed differing responses when
fed diet containing no biotin, or a sub-lethal level of avidin (0.2 mg/
ml for A. pisum, 2 mg/ml for S. avenae; Fig. 5B). In this assay,
survival curves for pea aphid on biotin-free diet " avidin were not
significantly different, with 100% mortality at day 7 (without added
avidin) or day 9 (with added avidin). In contrast, addition of avidin to
the S. avenae diet improved survival significantly; 100%mortalitywas
observed at day 10 for aphids on diet with no added avidin, but 75% of
aphids on diet containing 2 mg/ml avidin survived to day 10. Survival
curves for these two treatments were significantly different.
Fig. 4. Survival of pea aphids (A. pisum) and cereal aphids (S. avenae) aphids fed on artificial diet containing recombinant avidin. (A) Comparison of effects of avidin at 1.0 mg/
ml on survival of pea aphid and cereal aphid. Survival of pea and cereal aphids on control treatments was identical (symbols overlap on graph). (B) Dose–response curves for
survival at day 4 of assay. Data for pea aphid are fitted to a standard dose–response curve using non-linear regression. Data for cereal aphid did not fit to a curve due to low
mortality at all doses. (C) Survival curves for pea aphids fed doses of avidin lower than estimated LC50. (D) Effect of avidin on growth of cereal aphids. Aphids were fed from
neonate on diet with and without added avidin (2 mg/ml); measurements taken after 14 days show mean length (L) and width (W) " S.E. (n = 10 per treatment).
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Supplying recombinant avidin to S. avenae therefore compensated
almost wholly for a lack of biotin.
To investigate the possibility that the Buchnera symbionts in S.
avenae contained a functional operon for biotin synthesis, the
sequence of the region of Buchnera genome containing the biotin
operon was determined. A fragment of approximately 4.5 kbp was
amplified from DNA isolated from S. avenae, using primers based
on the published A. pisum Buchnera genome sequence. This
fragment was fully sequenced (Fig. 6). The determined sequence
was very similar to the published genome sequence for Buchnera
aphidicola from A. pisum, containing parts of the glyA and ybhE
genes which flank the bio operon (Fig. 6), and open reading frames
for the polypeptides encoded by the bioA, bioB and bioD genes (data
not presented). This result shows that the S. avenae symbionts, like
Fig. 5.Mechanism of avidin toxicity towards aphids. (A) Survival of aphids fed on diet containing varying levels of biotin. Survival at day 9 (100%mortality of aphids on biotin-
free diet) is plotted against concentration of biotin in diet. (B) Survival of aphids on biotin-free diets containing sub-lethal levels of avidin. Survival curves for different
treatments as described in legend. (C) Western analysis (anti-avidin antibodies) of whole S. avenae and A. pisum protein extracts prepared directly after feeding on
recombinant avidin for 24 h (Av.), or after chasing avidinwith control diet for 48 h (Av.C). C denotes samples from control-fed aphids. St. is 10 ng standard recombinant avidin,
the position of standard protein marker mix (SDS-7, Sigma) run on the blotted gel is depicted. (D) Proteins present in honeydew from aphids feeding on control diet and diet
containing recombinant avidin; analysis of honeydew by SDS-PAGE. Lanes are taken from a single gel; omitted tracks contain replicates. C denotes honeydew from control
diet-fed aphids, Av honeydew from aphids fed on avidin-containing diet. St is recombinant avidin standard (2mg) and M is the molecular weight marker.
Fig. 6.Map of region of genome (from Buchnera aphidicola; accession CP001158) sequenced in Buchnera from S. avenae. Genes flanking the bio operon are shown in light grey,
bio operon genes in dark grey.
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A. pisum symbionts, lack the full complement of genes necessary
for biotin synthesis.
To determine whether differences in the insecticidal activity of
avidin towards the two aphid species were attributable to
differences in the susceptibility of the protein to proteolytic
degradation in vivo, whole insect protein extracts from aphids fed
avidin-containing diet were analysed bywestern blotting. Samples
were prepared directly from aphids fed diets containing avidin at
2 mg/ml (30mM) for 48 h, and also from aphids that had been
chase-fed with control diet. As shown in Fig. 5C, avidin was
detected in extracts from both aphid species. Although levels of
avidin detected in extracts from aphids that had been ‘‘chased’’
with control diet were lower than in aphids without the chase, the
protein was still present in readily detectable amounts, suggesting
that ingested avidin had bound to the gut or had been sequestered,
and that not all ingested protein had been excreted in honeydew.
No avidin was detected in aphids fed control diet. The major band
of approximately 20 kDa in extracts of A. pisum and S. avenae
detected by anti-avidin antibodies corresponds to the molecular
mass of recombinant avidin. Immunoreactivity of a higher
molecular weight protein (approximately 36 kDa) is thought to
represent the presence of dimeric avidin. A polypeptide of
approximately 16 kDa, also immunoreactive with anti-avidin
antibodies, is present in S. avenae but only at very much lower
levels in A. pisum. This suggests that avidin may be more subject to
proteolytic degradation following ingestion by S. avenae than in A.
pisum, although most of the protein present in the insect remains
largely intact in both species. To confirm that S. avenae is able to
carry out proteolysis on ingested avidin, honeydew produced by
cereal aphids feeding on avidin-containing diet was analysed. As
shown in Fig. 5D, excreted avidin showed evidence of proteolytic
degradation, with a prominent fragment band at approximately
14 kDa.
4. Discussion
Avidin is a commonly used tool in numerous biological
applications, collectively known as (strept)avidin–biotin technol-
ogy. Bacterial and eukaryotic expression systems have been
developed for the production of recombinant avidin, although
relatively poor yields (5–10 mg/l culture) have been reported
(reviewed by Laitinen et al., 2006). Poor yields are often
encountered due to detrimental effects of biotin sequestration
by expressed avidin on cell growth. Themost successful system for
producing recombinant avidin has been transgenic maize, where
yields of 150–300 mg avidin were obtained per kg of seed (Hood et
al., 1997); the product is commercially available (e.g. Sigma–
Aldrich A8706), although most applications continue to use avidin
purified from hen egg white.
The P. pastoris expression system described in this paper yields
80–100 mg avidin/l culture supernatant, through the use of a
secreting system based on the yeast a-factor prepro-sequence to
overcome negative effects of biotin sequestration in cells. Despite a
constitutive promoter being used to direct avidin expression,
cultures grew to high cell densities, and high levels of recombinant
proteinwere produced. In a previous report, an inducible promoter
system (AOX) was used to express a modified avidin in P. pastoris
(Zocchi et al., 2003). Yields of 330 mg/l of avidin after methanol
feeding were reported. The use of the constitutive GAPDH
promoter in the present work avoids the use of potentially
hazardous feedstocks such as methanol, at the cost of a lower yield
of recombinant protein. In both cases, P. pastoris offers an attractive
expression system for efficient production of functional recombi-
nant avidin.
The recombinant avidin produced in P. pastoris forms tetra-
meric molecules similar to egg white avidin, and is fully functional
in terms of biotin binding, although a binding constant for the
interaction was not measured. The indicated molecular weight on
SDS-PAGE of recombinant avidin is significantly greater than egg
white avidin, to a greater extent than would be accounted for by
the N-terminal extension of 9 amino acids and the hexahistidine
tag sequence added to the C-terminus. The single N-glycosylation
site in avidin is utilised in both egg white and recombinant avidin.
P. pastoris carries out core glycosylation plus the addition of
mannose residues, normally adding approximately 2 kDa to the
molecular weight of a polypeptide (Cregg et al., 1993). In
agreement with the present results, glycosylation of recombinant
avidin expressed in P. pastoris has been reported previously
(Schenk et al., 2008). De-glycosylation of recombinant avidin gives
a polypeptide whose estimated molecular weight is in agreement
with the predicted value. Glycosylation of egg white avidin (Green,
1990) differs from that observed in recombinant avidin expressed
in P. pastoris, but the carbohydrate side chain does not affect the
functional properties of the protein (Nardone et al., 1998).
Much research has been conducted to explore the potential use
of avidin as an insect control agent, and early reports of avidin
toxicity (Morgan et al., 1993; Du and Nickerson, 1995) suggest that
avidin is generally toxic to lepidopteran larvae. The present results
showing toxicity towards M. brassicae larvae are consistent with
previously published data.When incorporated into artificial diet at
100mg/ml (100 ppm; 0.15mM), avidin was found to cause greater
than 90% mortality of lepidopteran light brown apple moth
Epiphyas postivittana and green-headed leaf-roller Ctenopseustis
obliquana after 28 days of feeding (Markwick et al., 2001). Burgess
et al. (2002) reported 100% mortality of Helicoverpa armigera and
Spodoptera litura larvae after feeding for 22 and 25 days
respectively, on transgenic tobacco expressing 3.1–17.3mM avidin,
and transgenic tobacco and apple plants expressing avidin at 3.1–
4.6mM and 1.9–11.2mM were resistant to larvae of potato tuber
moth (Phthorimaea operculella) and E. postvittana respectively, with
>90% mortality observed on tobacco after 9 days, and 80–90%
mortality on apple after 21 days (Markwick et al., 2003). The dose
response observed in the present assays, with no effect on survival
produced by avidin at 10 ppm (0.15mM), compared to 100%
mortality at 100 ppm and 1000 ppm (1.5mM and 15mM), is also in
agreement with previous studies which have shown a threshold
effect, whereby avidin concentrations above a certain level cause
significant mortality, and those below do not (Morgan et al., 1993;
Markwick et al., 2001; Burgess et al., 2002; Zhu et al., 2005).
While toxicity of avidin to insects from a range of orders has
been demonstrated, no previous studies have reported effects on
hemipteran insects. Here we report that avidin shows dose-
dependent toxicity to A. pisum. The dose–response curve for avidin
in these assays shows a sharp transition between no significant
effect on survival, and complete mortality, similar to the threshold
effect described previously, although an LC50 value of 2.1mMcould
be estimated. This value is comparable to the level of biotin in the
standard diet (4.1 mM; onemolecule of avidin binds 4molecules of
biotin, and thus the LC50 is a 2-fold molar excess of avidin binding
sites over biotin), and suggests that these insects are highly biotin-
dependent. In contrast, avidin had no significant effects on the
survival of cereal aphids (S. avenae) even when incorporated at
2.0 mg/ml (2000 ppm; 30 mM) in artificial diet. Both insect
cultures were maintained on plants, and thus have a similar
biotin ‘‘background’’.
Reports of immunity to the effects of avidin are rare. Kramer et
al. (2000) reported that of 11 coleopteran species tested only one,
the larger grain borer (Prostephanus truncates), exhibited a
tolerance for avidin, where 17% mortality was recorded at a
dietary level of 1000 ppm.Malone et al. (2002) reported thatwhilst
avidin had detrimental effects on larvae of clover root weevil
(Sitona lepidus) it was ineffective against adults; similarly,
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Markwick et al. (2001) found that avidin had limited toxicity to
larvae of green-headed leaf-roller (Planotortrix octo) at concentra-
tions up to 100mg/ml (100 ppm; 0.15mM). The failure of avidin to
show insecticidal effects on some species has been ascribed to
availability of biotin sequestered into eggs and/or embryos by
parental generations, a view supported by experiments in which
the LC50 of avidin towards E. postvittana larvae was decreased over
10-fold as a result of feeding for 5 generations on biotin-free diet
(Markwick et al., 2001).
The lack of toxicity of avidin towards S. avenae cannot be due to
a lack of dependence on exogenous biotin, because these aphids
do not survive on diets containing no biotin, or low levels of biotin,
although they appear to be slightly less sensitive than A. pisum to
sub-optimal biotin concentrations. The symbiotic Buchnera
bacteria in aphids have varying complements of the genes
involved in the biotin biosynthesis pathway, depending on aphid
host species (BuchneraBase; http://www.buchnera.org), but B.
aphidicola APS in A. pisum has lost the capacity to synthesise
biotin, having only 3 of the 5 genes involved in biotin biosynthesis
(KEGG database; http://www.genome.jp/kegg/kegg2.html). The
requirement of A. pisum for dietary biotin is thus not surprising.
Based on the assays carried out, the Buchnera symbiont in S.
avenae (genome not available) cannot complement a biotin
deficiency either. Amplification of the biotin synthesis operon
from S. avenae provided confirmation that the Buchnera symbiont
in this aphid species lacks the full complement genes necessary
for ‘‘de novo’’ synthesis of biotin.
Another possible explanation for the lack of toxicity of avidin
towards S. avenae compared to A. pisum might be differences in
avidin interactions with the gut surface. However, in both aphids
the protein is retained in the gut, and is detected in the insect even
after a chase with non-avidin-containing diet, showing that rapid
elimination of avidin, which might prevent sequestration of
endogenous biotin, does not occur in cereal aphids. The most
plausible explanation for the lack of toxicity of avidin towards S.
avenae is that biotin bound to avidin, which is not available as a
metabolic cofactor, can be recovered from the protein. The ability
of S. avenae, but not A. pisum, to survive on biotin-free diets
supplemented with avidin is direct evidence to support biotin
scavenging in S. avenae. Recombinant avidin contains biotin, as
the culture medium in which the yeast is grown is supplemented
with this vitamin. The biotin-binding sites on recombinant avidin
cannot be saturated, since theproteinbinds to immobilised biotin,
but since tetrameric molecules are formed (Fig. 2E), if a
proportion of binding sites contain biotin the protein will still
show functional activity and contain biotin. The strength of the
biotin–avidin interaction means that the only feasible mechan-
isms for biotin scavenging are either denaturationof avidin,which
is not likely under conditions in the aphid gut, or proteolytic
degradation. Evidence for degradation of avidin by S. avenae in
vivo has been presented (Fig. 5C and D). Although protein
digestion in the guts of aphids has been considered unlikely, more
recent results have shown that cotton-melon aphid (Aphis
gossypii), contains cathepsin L-like cysteine proteinase activity
in the gut (Deraison et al., 2004), and have identified a gut-
expressed family of cathepsinB-like proteases inA. pisum (Rispe et
al., 2008). In the present case, the data suggest that a combination
of lower sensitivity to sub-optimal levels of biotin, and a more
effective system for scavenging biotin from avidin in the diet,
makes S. avenae relatively insensitive to the insecticidal effects of
this protein when compared to A. pisum. In support of this
conclusion, measurements of protein digestion in gut extracts
from S. avenae and A. pisum, using a labelled protein substrate,
have shown that the cereal aphid has approximately twice as
much gut proteolytic activity as pea aphid on a per aphid basis
(data not presented).
Avidin may have potential to control some homopteran plant
pests, as well as other insects, if expressed in transgenic plants so
that it is available to phloem feeders. Further investigation of its
insecticidal activity is warranted, especially in view of the
significance of homopteran spp. as global plant pests (not only
throughdirect damage to plants, but also as vectors of plant disease)
for which no Bt-based crop protection is currently available.
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